Polecompetitivite

Dgcis

Ubifrance-logo
France-logo

Attendee list


Take a look at the list of registered attendees.
Review their company profile.
Contact them via e-mail and arrange to meet up there.

Choose an organization type :

Company

Abbott - USA

As a world leader in pharmaceutical operations, Abbott's contract manufacturing business unit provides companies with technically strong and geographically broad services to help them gain a competitive advantage. Abbott's biologics contract manufacturing services includes: Cell Line Development, Mammalian Cell Culture, Process Development, Process Characterization and Pilot thru Full Scale Commer...
As a world leader in pharmaceutical operations, Abbott's contract manufacturing business unit provides companies with technically strong and geographically broad services to help them gain a competitive advantage. Abbott's biologics contract manufacturing services includes: Cell Line Development, Mammalian Cell Culture, Process Development, Process Characterization and Pilot thru Full Scale Commercial Production. Abbott has announced the launch of their new production suite utilizing entirely single use cell culture and purification equipment. Benefits of this addition address the ever-growing market demands for faster and lower cost early phase production. This suite is in addition to Abbott's significant inventory of existing fixed and portable production equipment that spans two North American facilities. We now effectively serve our clients needs from preclinical through commercial manufacturing. In addition to our bioligics contract manufacturing, we also provide small molecule and potent API production, secondary finishing and packaging contract manufactirng services.
More

Contact

Value chain

  • Manufacturing / Production

Business Model

  • Service Provider - CMO
  • Product Developer - pharmaceuticals
  • Product Developer - biopharmaceuticals

Activities

  • Biomanufacturing

Needs and interest

  • Commercial Alliance - Comarketing
  • Commercial Development
Close

Abbott - USA

More

Contact

  • Firstname / Lastname :
    Amy Kutilek
  • Job title :
    Senior Sales Manager
  • Email :
    amy.kutilek@abbott.com
  • Phone :
    847-935-4591

Value chain

  • Manufacturing / Production

Business Model

  • Service Provider - CMO
  • Product Developer - pharmaceuticals
  • Product Developer - biopharmaceuticals

Activities

  • Biomanufacturing

Needs and interest

  • Commercial Alliance - Comarketing
  • Commercial Development
Close

Adjuvance Technologies, Inc. - USA

Adjuvance Technologies, Inc. is a Delaware incorporated, clinical stage, privately-owned biopharmaceutical company based in New York, USA. Triterpene Saponin Synthesis Technology (TriSST™) is the proprietary platform chemistry of Adjuvance Technologies that has resulted in the synthesis of a diverse portfolio of novel compounds that possess significant adjuvant activity with a desirable tolerabi...
Adjuvance Technologies, Inc. is a Delaware incorporated, clinical stage, privately-owned biopharmaceutical company based in New York, USA. Triterpene Saponin Synthesis Technology (TriSST™) is the proprietary platform chemistry of Adjuvance Technologies that has resulted in the synthesis of a diverse portfolio of novel compounds that possess significant adjuvant activity with a desirable tolerability profile. It is this unique understanding of the chemistry of saponins and related compounds that has placed Adjuvance Technologies in the forefront of adjuvant design and manufacture. For the first time, TriSST provides a commercially viable source for vaccine manufacturers of the active saponin compounds within the plant-derived extract known as QS-21. As an extract from the Soap Bark tree, QS-21, the world’s leading investigational vaccine adjuvant candidate, is extremely difficult to procure due to low yields with variable and unpredictable impurity profiles. TriSST permits for the first time, the large-scale synthesis of highly pure materials for human use via our SAPONEX™ adjuvant. The application of TriSST by Adjuvance Technologies has also resulted in the synthesis of over fifty (>50) proprietary adjuvant molecules in our TiterQuil™ family of adjuvants, which exhibit improved in vivo efficacy, efficiency and tolerability.
More

Contact

Value chain

  • Research
  • Clinical
  • Manufacturing / Production

Business Model

  • Service Provider - scientifique
  • Product Developer - pharmaceuticals
  • Product Developer - biopharmaceuticals

Activities

  • Chemistry
  • Vaccine
  • Drug Discovery
  • Models (animal, cellular, ...)

Application Fields

  • Animal Health
  • Human Health
  • Immunology
  • Infectious Diseases
  • Pediatrics
  • Geriatrics
  • Cancer

Needs and interest

  • R&d Partnership
  • Commercial Development
Close

Aepodia - FRANCE

Aepodia is known as a reliable partner using Best Fit solutions to client’s needs, with a lean/flexible organization and processes leading to cycle time and costs decrease. From Aepodia’s creation in 2007, we have established solid and effective collaborations with World Pharmaceutical Leaders as well as with small biotech companies.
Aepodia is known as a reliable partner using Best Fit solutions to client’s needs, with a lean/flexible organization and processes leading to cycle time and costs decrease. From Aepodia’s creation in 2007, we have established solid and effective collaborations with World Pharmaceutical Leaders as well as with small biotech companies.
More

Contact

Value chain

  • Clinical

Business Model

  • Service Provider - CRO
  • Service Provider - scientifique

Activities

  • Clinical Trials

Application Fields

  • Metabolic Diseases
  • Cancer
  • CNS related Diseases

Needs and interest

  • R&d Partnership
Close

Aepodia - FRANCE

More

Contact

Activities

  • Clinical Trials
Close

Affilogic - FRANCE

Affilogic develops and sells custom binders as an alternative to antibodies (Nanofitins), in a broad variety of applications (Therapeutics, reagents for research, diagnostics, bioprocessing,..). Nanofitins are small, extremely resistant, industry-friendly affinity binders. They behave like building blocks in such that they can be assembled in pairs, triplets, or other multimeric forms to enhance a...
Affilogic develops and sells custom binders as an alternative to antibodies (Nanofitins), in a broad variety of applications (Therapeutics, reagents for research, diagnostics, bioprocessing,..). Nanofitins are small, extremely resistant, industry-friendly affinity binders. They behave like building blocks in such that they can be assembled in pairs, triplets, or other multimeric forms to enhance affinity properties and confer multiple binding moieties. The company provides custom Nanofitins as a service, and co-develops Nanofitin-based applications in bioprocessing and therapeutics.
More

Contact

Value chain

  • Research

Business Model

  • Product Developer - biopharmaceuticals
  • Product Developer - other health

Activities

  • Protein / Proteomics
  • Diagnostics / Analysis Methods
  • Drug Discovery
  • Nanotechnology

Application Fields

  • Animal Health
  • Immunology
  • Infectious Diseases
  • Inflammatory Diseases
  • Autoimmune Diseases

Needs and interest

  • R&d Partnership
Close

Alaxia - FRANCE

Alaxia, an innovative company (JEI and FCPI qualified) develops airway medicinal therapeutic products for respiratory diseases. Alaxia has ongoing R&D program on cystic fibrosis, COPD and URTI. Its Meveol product, 1st product exiting the pipeline, is recognised Orphan medicinal product for cystic fibrosis, CF, condition by both EMA and FDA. Meveol is an antimicrobial without any risk of antibi...
Alaxia, an innovative company (JEI and FCPI qualified) develops airway medicinal therapeutic products for respiratory diseases. Alaxia has ongoing R&D program on cystic fibrosis, COPD and URTI. Its Meveol product, 1st product exiting the pipeline, is recognised Orphan medicinal product for cystic fibrosis, CF, condition by both EMA and FDA. Meveol is an antimicrobial without any risk of antibiotic resistance and an anti inflammatory product , targeting to kills bacteria, including very strong to adress (eg MRSA, B Dolosa,...) and to compensate innate lung defense system.
More

Contact

Value chain

  • Research
  • Manufacturing / Production
  • Other

Business Model

  • Product Developer - pharmaceuticals
  • Product Developer - biopharmaceuticals

Activities

  • Biomanufacturing
  • Drug Discovery
  • Medical Device
  • Drug Delivery

Application Fields

  • Human Health
  • Infectious Diseases
  • Genetic / Rare Diseases
  • Inflammatory Diseases
  • Orhpan Diseases

Needs and interest

  • R&d Partnership
Close

ALIZE PHARMA - FRANCE

The Alizé Pharma Group is specialized in the development of innovative therapeutics for the treatment of metabolic diseases and cancer. The business strategy is to acquire or in-license R&D programs from academic or private laboratories, handle preclinical and early clinical development and establish partnerships with the pharmaceutical industry via co-development or out-licensing agreements....
The Alizé Pharma Group is specialized in the development of innovative therapeutics for the treatment of metabolic diseases and cancer. The business strategy is to acquire or in-license R&D programs from academic or private laboratories, handle preclinical and early clinical development and establish partnerships with the pharmaceutical industry via co-development or out-licensing agreements. Founded in April 2007, the Alizé Pharma group is based in Lyon, France. Its management is made up of a team of drug development experts and a board of directors offering wide international experience. Since its inception, the group has raised Eur 5 M with private and institutional investors and has signed strategic partnerships with Eli Lilly (US) and EUSA Pharma (UK). The first of the two entities of the Group, Alizé Pharma SAS, is dedicated to AZP-01, a program based on unacylated ghrelin (UAG) agonists, a new therapeutic class for the treatment of Type II diabetes. UAG and its analogs have the potential not only to control the disease but also to have a positive impact on other cardiovascular risk factors such as obesity, dyslipidemia and impaired vascular remodeling. The parent molecule and its analogs are protected by four patent families worldwide. The second entity is Alizé Pharma II SAS. It is focused on the development of Asparec® (AZP-02), a new, long-acting PEGylated recombinant L-asparaginase with reduced immunogenicity for the treatment of acute lymphoblastic leukemia. The Asparec® product is currently at the preclinical stage of development, a first Phase I clinical trial is planned to be launched by year-end.
More

Contact

  • Firstname / Lastname :
    Thierry Abribat
  • Job title :
    President
  • Email :
    tabribat@alz-pharma.com
  • Phone :
    +33 472 18 94 28

Value chain

  • Research
  • Preclinical
  • Clinical

Business Model

  • Product Developer - pharmaceuticals
  • Product Developer - biopharmaceuticals

Activities

  • Clinical Trials
  • Preclinical Trials
  • Drug Discovery
  • Models (animal, cellular, ...)

Application Fields

  • Human Health
  • Infectious Diseases
  • Metabolic Diseases
  • Cancer
Close

Almetis - FRANCE

Almetis is a french biopharmaceutical company created in 2010 and dedicated to the discovery and the development of innovative metal-based drugs in oncology. Our expertise in organometallic compounds is unique and our objective is to develop proprietary candidates up to proof of concept in man. Our mission is to deliver a new class of drugs using the innovative properties of our compounds and addr...
Almetis is a french biopharmaceutical company created in 2010 and dedicated to the discovery and the development of innovative metal-based drugs in oncology. Our expertise in organometallic compounds is unique and our objective is to develop proprietary candidates up to proof of concept in man. Our mission is to deliver a new class of drugs using the innovative properties of our compounds and addressing unmeet needs in oncology.
More

Contact

Value chain

  • Research
  • Preclinical

Business Model

  • Product Developer - biopharmaceuticals

Activities

  • Chemistry
  • Tissue / Cells
  • Drug Discovery
  • Models (animal, cellular, ...)

Application Fields

  • Human Health
  • Cancer

Needs and interest

  • R&d Partnership
Close

Altograph, Inc. - USA

Altograph provides market access and commercialization expertise to our clients around the world.
Altograph provides market access and commercialization expertise to our clients around the world.
More

Contact

Value chain

  • Marketing / Distribution

Business Model

  • Service Provider - non scientifique

Activities

  • Gene / Genomics
  • Protein / Proteomics
  • Tissue / Cells
  • Imagery
  • Lab Equipment
  • Diagnostics / Analysis Methods
  • Preclinical Trials
  • Drug Discovery
  • Instrumentation
  • Bioinformatics / Modeling

Application Fields

  • Animal Health
  • Human Health

Needs and interest

  • Commercial Alliance - Comarketing
  • Commercial Development
Close

Alzprotect - FRANCE

AlzProtect is a biotech start-up developing anti-Alzheimer drugs acting through an original mechanism of action. Its main lead molecule, AZP2006, has achieved proof of concept in animals and will enter clinical Phase 1 in the first quarter of 2012. Additional programs are focused on Alzheimer’s disease and other neurodegenerative diseases (Parkinson, etc…) The company also develops its own bio...
AlzProtect is a biotech start-up developing anti-Alzheimer drugs acting through an original mechanism of action. Its main lead molecule, AZP2006, has achieved proof of concept in animals and will enter clinical Phase 1 in the first quarter of 2012. Additional programs are focused on Alzheimer’s disease and other neurodegenerative diseases (Parkinson, etc…) The company also develops its own biomarkers. The objective of the company is to bring its candidate drugs up to clinical Phases and then license them to a pharmaceutical partner.
More

Contact

Value chain

  • Research
  • Preclinical
  • Clinical

Business Model

  • Product Developer - pharmaceuticals

Activities

  • Clinical Trials
  • Preclinical Trials
  • Drug Discovery
  • Models (animal, cellular, ...)

Application Fields

  • Human Health
  • CNS related Diseases
Close

AMATSI - FRANCE

AMATSI is a CDMO specialized in Pharmaceutical Development and Clinical Supplies services. We already work with the top leading US and EU Biotechs to develop their drug products.
AMATSI is a CDMO specialized in Pharmaceutical Development and Clinical Supplies services. We already work with the top leading US and EU Biotechs to develop their drug products.
More

Contact

  • Firstname / Lastname :
    Lorie Benedicto
  • Job title :
    Business Development Manager
  • Email :
    l.benedicto@amatsi.com
  • Phone :
    0033 4 99 58 35 86

Business Model

  • Service Provider - CRO
  • Service Provider - CMO

Activities

  • Other

Application Fields

  • Animal Health
  • Human Health

Needs and interest

  • Commercial Development
Close

AMATSI - FRANCE

More

Contact

Business Model

  • Service Provider - CRO
  • Service Provider - CMO

Activities

  • Other

Application Fields

  • Animal Health
  • Human Health

Needs and interest

  • Commercial Development
Close

AMATSI - FRANCE

More

Contact

  • Firstname / Lastname :
    Amel Hadri
  • Job title :
    Scientific & Technical Director
  • Email :
    a.hadri@amatsi.com

Business Model

  • Service Provider - CRO
  • Service Provider - CMO

Activities

  • Other

Application Fields

  • Animal Health
  • Human Health

Needs and interest

  • Commercial Development
Close

American Air Liquide - USA

Air Liquide is the world leader in supplying medical gases in cylinders, bulk industrial and medical gases complying multicompendial requirements and large medical gases requirement through onsite gases generation systems for the healthcare industry. The company has over $2 billion healthcare and pharmaceutical division that provides innovative technologies to the industry's top pharmaceutical and...
Air Liquide is the world leader in supplying medical gases in cylinders, bulk industrial and medical gases complying multicompendial requirements and large medical gases requirement through onsite gases generation systems for the healthcare industry. The company has over $2 billion healthcare and pharmaceutical division that provides innovative technologies to the industry's top pharmaceutical and biotech customers.
More

Contact

Value chain

  • Other

Business Model

  • Service Provider - scientifique

Activities

  • Vaccine
  • Biomanufacturing
  • Medical Device

Application Fields

  • Animal Health
  • Human Health
  • Immunology

Needs and interest

  • R&d Partnership
  • Commercial Development
Close

ANIMASCOPE - FRANCE

Animascope is a company providing multimodality imaging services to international customers.In vivo imaging has become a cornerstone in clinical and preclinical studies. Non-invasive technologies facilitate studies of structures, functions and dysfunctions through real-time acquisition, processing and quantification of whole-body images. Preclinical imaging is suitable for phenotyping, for model v...
Animascope is a company providing multimodality imaging services to international customers.In vivo imaging has become a cornerstone in clinical and preclinical studies. Non-invasive technologies facilitate studies of structures, functions and dysfunctions through real-time acquisition, processing and quantification of whole-body images. Preclinical imaging is suitable for phenotyping, for model validation and for biodistribution studies, as well as for assessment of drug.
More

Contact

Value chain

  • Preclinical

Business Model

  • Service Provider - CRO

Activities

  • Imagery
  • Clinical Trials
  • Drug Discovery
  • Drug Delivery
  • Cell Therapy

Application Fields

  • Animal Health
  • Human Health
  • Immunology
  • Infectious Diseases
  • Nutrition / Food
  • Geriatrics
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Metabolic Diseases
  • Cancer
  • CNS related Diseases

Needs and interest

  • Commercial Alliance - Comarketing
  • Commercial Development
Close

Aposense - ISRAEL

Core Business: Apoptosis Targeting and Extended Drug Residence Time. Aposense Targeted Therapy (ATT) represents a new, membrane based, approach to rational-drug design and delivery. Aposense selected the cellular membranes as the pharmacophore for providing its drug candidates with the desired targeting properties and residence time. Manipulation of drug-membrane interactions by leveraging membran...
Core Business: Apoptosis Targeting and Extended Drug Residence Time. Aposense Targeted Therapy (ATT) represents a new, membrane based, approach to rational-drug design and delivery. Aposense selected the cellular membranes as the pharmacophore for providing its drug candidates with the desired targeting properties and residence time. Manipulation of drug-membrane interactions by leveraging membrane structural and electric features, allows ATT compounds to achieve selective affinity to membranes of cells undergoing apoptosis (regulated cell death), or increased affinity to normal cellular membranes for increasing drug residence time in blood plasma and tissues. Cell loss by apoptosis is associated with many disease processes, such as inflammation, ischemia and infection, as well as genetic and metabolic disorders. Apoptosis is also abundant in tumors, both untreated and as a result of treatment. Adding apoptosis targeting to a drug candidate can provide higher drug concentrations at the disease site while avoiding toxicity to healthy tissues, thus expanding the drug’s therapeutic window. Notably, the resulting ATT conjugates are new and patentable chemical entities. Technology: 1. Extension of Drugs’ PK Profile Through high affinity to cell membranes, ATT molecules can achieve high residence time in blood plasma and body tissues, creating a “depot” from which the drug is slowly released. This quality results in stable plasma levels, increased effectiveness period and reduced intake burden. This approach is implemented for example in the ATT-11T anti-cancer compound, partnered with Teva Pharmaceuticals. 2: Apoptosis imaging. Aposense has developed a proprietary, rationally-designed Interfacial NanoSwitch? motif, which selectively activates upon interaction with an apoptotic cell membrane, by recognition of a set of unique membrane alterations present from early stages of the cellular death process. The nanoswitch can be attached to various small molecules for targeting apoptosis inflicted tissues. For clinical imaging of apoptosis, Aposense has developed the ML-10 compound (molecular weight 206D), which is labeled with the radio-isotope 18F for imaging with PET (Positron Emission Tomography). The 18F-ML-10 demonstrated specific uptake by apoptotic cells in several phase 2 clinical trials in different settings, including tumor cells apoptosis (both pre-treatment and as enhanced by treatment) and neuronal damage following ischemic stroke.
More

Contact

  • Firstname / Lastname :
    Zohar Koren
  • Job title :
    BD Manager
  • Email :
    zohar@aposense.com
  • Phone :
    +972-52-7331424

Value chain

  • Research
  • Preclinical
  • Clinical

Business Model

  • Product Developer - pharmaceuticals

Activities

  • Drug Discovery
  • Drug Delivery

Needs and interest

  • R&d Partnership
Close

Applied Pharma Research - USA

APR Applied Pharma Research s.a. is an R&D Company headquartered in Switzerland with a subsidiary in Charlotte (NC, USA). APR develops and licenses innovative, value added and patented healthcare products and proprietary drug delivery systems primarily in oral and topical form.
APR Applied Pharma Research s.a. is an R&D Company headquartered in Switzerland with a subsidiary in Charlotte (NC, USA). APR develops and licenses innovative, value added and patented healthcare products and proprietary drug delivery systems primarily in oral and topical form.
More

Contact

Value chain

  • Research
  • Preclinical
  • Clinical
  • Manufacturing / Production
  • Other

Business Model

  • Product Developer - pharmaceuticals

Activities

  • Drug Delivery

Application Fields

  • Animal Health
  • Dermocosmetics
  • CNS related Diseases

Needs and interest

  • R&d Partnership
  • Commercial Development
Close

Aquapharm - UNITED KINGDOM

Aquapharm® is an innovative drug discovery company focussed on developing new pharmaceutical products founded on the chemical diversity of marine micro-organisms. Our core focus is the development of novel antibiotics, targeting both Gram negative and Gram positive infections, anti-oxidants and anti-inflammatories inhibitors of IL-6 and IL-17.
Aquapharm® is an innovative drug discovery company focussed on developing new pharmaceutical products founded on the chemical diversity of marine micro-organisms. Our core focus is the development of novel antibiotics, targeting both Gram negative and Gram positive infections, anti-oxidants and anti-inflammatories inhibitors of IL-6 and IL-17.
More

Contact

Value chain

  • Research
  • Preclinical

Business Model

  • Product Developer - pharmaceuticals
  • Product Developer - biopharmaceuticals

Activities

  • Chemistry
  • Preclinical Trials
  • Drug Discovery
  • Models (animal, cellular, ...)

Application Fields

  • Human Health
  • Immunology
  • Infectious Diseases
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Metabolic Diseases

Needs and interest

  • R&d Partnership
Close

Aquapharm Biodiscovery Ltd - UNITED KINGDOM

More

Contact

  • Firstname / Lastname :
    Andrew Mearns Spragg
  • Job title :
    Founder & CTO
  • Email :
    andrew@aquapharm.co.uk
  • Phone :
    +44 (0) 131 526 3190

Value chain

  • Research
  • Preclinical

Business Model

  • Product Developer - biopharmaceuticals

Activities

  • Chemistry
  • Drug Discovery

Application Fields

  • Immunology
  • Infectious Diseases
  • Nutrition / Food
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Orhpan Diseases

Needs and interest

  • R&d Partnership
  • Commercial Development
Close

Ariana Pharmaceuticals - FRANCE

ArianaTM, a spin-off of the Institut Pasteur, is a leading decision support and data mining company, focused on transforming data into information to accelerate the discovery and development of biomarkers and pharmaceutical drugs. Ariana has developed KEM® (Knowledge Extraction Management), a proprietary decision support technology for rapid analysis of multi-parametric / multi-ob...

ArianaTM, a spin-off of the Institut Pasteur, is a leading decision support and data mining company, focused on transforming data into information to accelerate the discovery and development of biomarkers and pharmaceutical drugs. Ariana has developed KEM® (Knowledge Extraction Management), a proprietary decision support technology for rapid analysis of multi-parametric / multi-objective data. KEM is routinely applied to the identification of Biomarkers, optimization in drug discovery, analysis of clinical data and early signal detection in drug safety.

Ariana Pharma is a leading decision support company focused on improving Clinical Trial outcomes, rescuing failed Clinical Trials, and developing Multiplexed Biomarkers. Critical supporting data for Clinical Trials design and analysis: - Improved protocol design (optimal inclusion/exclusion criteria) - Early Adverse Events detection and characterization - Identification of surrogate Endpoints - Design of new Composite Efficacy/Safety Endpoints - Expedite product registration and effective product repositioning For identification of in-vivo, in-vitro, surrogate or efficacy biomarkers, KEM? provides: - Exhaustive, multi-criteria, multi-objective discriminant analysis - Systematic combination of gene and protein expression levels, polypharmacology, and clinical characteristics - Robust handling of small or large populations Effective Risk Management: - Early detection of Adverse Events - Identification of risk factors and of population at risk - Systematic evaluation of relations between Adverse Events and products or drug interactions - Exhaustive analysis and hypotheses generation for End-of-Study and Periodic Safety Reports - Bias characterization in Pharmacovigilance databases Drug Discovery: a multi-parametric process - Suggestion of specific chemical changes for meeting multiple objectives in Lead Optimization - Maximizing information extracted from experimental data - Systematic generation and exploration of hypotheses consistent with the data - Robust handling of missing data Ariana provides KEM® through data analysis service or software licensing.

More

Contact

Value chain

  • Research

Business Model

  • Service Provider - scientifique
  • Other

Activities

  • Bioinformatics / Modeling

Application Fields

  • Human Health
  • Immunology
  • Infectious Diseases
  • Allergology
  • Nutrition / Food
  • Pediatrics
  • Cancer
  • Dermocosmetics
  • CNS related Diseases
Close

Assay Depot - USA

Assay Depot operates the world’s largest online marketplace for drug discovery research services. Researchers use the marketplace to find, compare and purchase services from hundreds of contract research organizations (CROs). CROs use the marketplace to offer their services to the global research community.
Assay Depot operates the world’s largest online marketplace for drug discovery research services. Researchers use the marketplace to find, compare and purchase services from hundreds of contract research organizations (CROs). CROs use the marketplace to offer their services to the global research community.
More

Contact

  • Firstname / Lastname :
    Corey Jacklin
  • Job title :
    Vice President, Business Development
  • Email :
    cjacklin@assaydepot.com
  • Phone :
    12153690965

Value chain

  • Research
  • Preclinical

Business Model

  • Other

Activities

  • Gene / Genomics
  • Protein / Proteomics
  • Chemistry
  • Vaccine
  • Tissue / Cells
  • Imagery
  • Diagnostics / Analysis Methods
  • Biomanufacturing
  • Preclinical Trials
  • Drug Discovery
  • Cell Therapy
  • Models (animal, cellular, ...)

Application Fields

  • Human Health
  • Immunology
  • Infectious Diseases
  • Allergology
  • Genetic / Rare Diseases
  • Pediatrics
  • Geriatrics
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Orhpan Diseases
  • Metabolic Diseases
  • Cancer
  • CNS related Diseases

Needs and interest

  • R&d Partnership
Close

AstraZeneca - USA

AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialisation of prescription medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. ...
AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialisation of prescription medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. AstraZeneca is one of the world's leading pharmaceutical companies with global healthcare sales of $32.8 billion. In the United States, AstraZeneca is a $13.5 billion dollar healthcare business.
More

Contact

Value chain

  • Research
  • Preclinical
  • Clinical
  • Manufacturing / Production
  • Marketing / Distribution

Activities

  • Preclinical Trials
  • Drug Discovery
  • Models (animal, cellular, ...)

Application Fields

  • Human Health

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
  • Commercial Development
Close

ATLANTIC BONE SCREEN - FRANCE

ATLANTIC BONE SCREEN is a French CRO specializing in the field of bone and joint diseases and also in the field of bone diseases from tumor origin. Our company puts at its customers’ disposal a unique preclinical platform with a wide range of competitive in vitro and in vivo assays as well as histology and imaging services. Atlantic Bone Screen aims to optimize and accelerate the development of ...
ATLANTIC BONE SCREEN is a French CRO specializing in the field of bone and joint diseases and also in the field of bone diseases from tumor origin. Our company puts at its customers’ disposal a unique preclinical platform with a wide range of competitive in vitro and in vivo assays as well as histology and imaging services. Atlantic Bone Screen aims to optimize and accelerate the development of your compounds, allowing you to identify and characterize the therapeutic potential of your drug candidates, nutraceuticals and biomaterials.
More

Contact

Value chain

  • Preclinical

Business Model

  • Service Provider - CRO
  • Service Provider - scientifique

Activities

  • Preclinical Trials
  • Models (animal, cellular, ...)

Application Fields

  • Animal Health
  • Human Health
  • Immunology
  • Infectious Diseases
  • Allergology
  • Genetic / Rare Diseases
  • Nutrition / Food
  • Pediatrics
  • Geriatrics
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Orhpan Diseases
  • Metabolic Diseases
  • Cancer
  • Dermocosmetics
  • CNS related Diseases

Needs and interest

  • Commercial Development
Close

Aurigene Discovery Technologies - INDIA

Aurigene Discovery Technologies Limited is a drug discovery Biotech with expertise in Oncology, Inflammatory disorders, Pain and anti-bacterials. Aurigene's business model provides a unique alternative to Pharma companies to add "early-stage partnering" apart from their internal efforts and in-licensing - thereby adding a strategic dimension to portfolio building. Aurigene's model is val...
Aurigene Discovery Technologies Limited is a drug discovery Biotech with expertise in Oncology, Inflammatory disorders, Pain and anti-bacterials. Aurigene's business model provides a unique alternative to Pharma companies to add "early-stage partnering" apart from their internal efforts and in-licensing - thereby adding a strategic dimension to portfolio building. Aurigene's model is validated through its portfolio of over 20 discovery collaborations with partners spanning Large Pharma, Mid-sized pharma and biotech companies. Aurigene's facilities are fully integrated for Drug Discovery, from Molecular Biology to GLP-Safety studies; spread over 350,000 sft of lab area, Aurigene deploys over 550 scientists at this time. In terms of technology, Aurigene has proven strengths in Structural Biology & peptide-drug discovery. Aurigene's business comprises: 1. Collaborative Drug Discovery and 2. Early-stage licensing
More

Contact

Value chain

  • Research
  • Preclinical

Business Model

  • Product Developer - biopharmaceuticals

Activities

  • Drug Discovery

Application Fields

  • Immunology
  • Infectious Diseases
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Metabolic Diseases
  • Cancer

Needs and interest

  • R&d Partnership
Close

Aurigene Discovery Technologies - INDIA

More

Contact

Value chain

  • Research
  • Preclinical

Business Model

  • Product Developer - biopharmaceuticals

Activities

  • Drug Discovery

Application Fields

  • Immunology
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Metabolic Diseases
  • Cancer

Needs and interest

  • R&d Partnership
Close

AURIGENE DISCOVERY TECHNOLOGIES LIMITED - INDIA

More

Contact

  • Firstname / Lastname :
    SAURABH KAPURE
  • Job title :
    HEAD-BUSINESS DEVELOPMENT
  • Email :
    saurabh_k@aurigene.com
  • Phone :
    918066204390

Value chain

  • Research
  • Preclinical

Business Model

  • Service Provider - CRO

Activities

  • Chemistry
  • Preclinical Trials
  • Drug Discovery

Application Fields

  • Human Health
  • Infectious Diseases
  • Metabolic Diseases
  • Cancer
  • CNS related Diseases

Needs and interest

  • R&d Partnership
Close

Avogadro - FRANCE

AVOGADRO together with AMATSI (175 scientists) offer a wide range of services to its clients in the following fields : •Pharmaceutical development (pre-formulation, formulation, analytical development, stability studies) •Pre-clinical development (bioanalysis, PK, ADME, biopharmaceuticals). •Manufacture, packaging, storage and distribution of clinical batches. •Quality control (raw materia...
AVOGADRO together with AMATSI (175 scientists) offer a wide range of services to its clients in the following fields : •Pharmaceutical development (pre-formulation, formulation, analytical development, stability studies) •Pre-clinical development (bioanalysis, PK, ADME, biopharmaceuticals). •Manufacture, packaging, storage and distribution of clinical batches. •Quality control (raw materials and finished products) Our services are undertaken in a GLP and GMP assured environment (EMA, FDA) maintaining our core values (reactivity, flexibility and communication).
More

Contact

Value chain

  • Preclinical

Business Model

  • Service Provider - CRO
  • Product Developer - pharmaceuticals
  • Product Developer - biopharmaceuticals

Activities

  • Preclinical Trials

Application Fields

  • Animal Health
  • Human Health
Close

AWS Corp - USA

AWS offers more than 15 years of experience in matchmaking European bio/pharma companies with US partners.
AWS offers more than 15 years of experience in matchmaking European bio/pharma companies with US partners.
More

Contact

  • Firstname / Lastname :
    Steve Lanier
  • Job title :
    President
  • Email :
    slanier@awscorp.com
  • Phone :
    2022967385

Value chain

  • Marketing / Distribution

Business Model

  • Other

Activities

  • Other
Close

Azgardabio - USA

Azgardabio is a privately held company focused on the use of mutated of modified viruses whose wild type shows activity against tumor cells. The first target virus effectively eliminates Glioblastoma, Prostate, Colon and other tumor types. The company is at both the manufacturing and preclinical program status, and is seeking regiona development partnerships.
Azgardabio is a privately held company focused on the use of mutated of modified viruses whose wild type shows activity against tumor cells. The first target virus effectively eliminates Glioblastoma, Prostate, Colon and other tumor types. The company is at both the manufacturing and preclinical program status, and is seeking regiona development partnerships.
More

Contact

Value chain

  • Preclinical

Business Model

  • Product Developer - biopharmaceuticals

Activities

  • Biomanufacturing
  • Preclinical Trials

Application Fields

  • Cancer

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
Close

BIO-MODELING SYSTEMS - FRANCE

-BMSYSTEMS is the first and to date the only Integrative Systems Biology Company that succeeded to create in-silico heuristic models validated in-vivo. These CADI*™ outputs led to discoveries, patents, or operational businesses through its innovative business model, in the fields of infectious diseases, neurology, psychiatry, oncology and industrial biotech. -BMSYSTEMS CADI*™ research: - creat...
-BMSYSTEMS is the first and to date the only Integrative Systems Biology Company that succeeded to create in-silico heuristic models validated in-vivo. These CADI*™ outputs led to discoveries, patents, or operational businesses through its innovative business model, in the fields of infectious diseases, neurology, psychiatry, oncology and industrial biotech. -BMSYSTEMS CADI*™ research: - creates new knowledge from raw information through the construction of CADI*™ models and, - generates real & attractive business from this new knowledge through its innovative business model. *CADI™: Computer Assisted Deductive Integration
More

Contact

Value chain

  • Research
  • Preclinical
  • Other

Business Model

  • Service Provider - CRO
  • Service Provider - scientifique
  • Service Provider - non scientifique
  • Product Developer - pharmaceuticals
  • Product Developer - biopharmaceuticals
  • Other

Activities

  • Drug Discovery
  • Bioinformatics / Modeling

Application Fields

  • Human Health
  • Immunology
  • Infectious Diseases
  • Allergology
  • Genetic / Rare Diseases
  • Nutrition / Food
  • Autoimmune Diseases
  • Orhpan Diseases
  • Cancer
  • Dermocosmetics
  • CNS related Diseases

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
Close

Biobide - SPAIN

BIOBIDE is a Biotech Company whose main aim is to accelerate productivity and minimize risks in the Drug Discovery process through a new tailor-made service concept. Our broad experience developing zebrafish standardized and customized assays in a fast and cost-effective manner is based on private and public collaborative projects. Biobide is the unique specialist in zebrafish Technologies and Ser...
BIOBIDE is a Biotech Company whose main aim is to accelerate productivity and minimize risks in the Drug Discovery process through a new tailor-made service concept. Our broad experience developing zebrafish standardized and customized assays in a fast and cost-effective manner is based on private and public collaborative projects. Biobide is the unique specialist in zebrafish Technologies and Services working under a GLP and automation environment providing prompt, clear and relevant information to develop your therapies of interest.

Biobide is your company for tailor Made solutions through zebrafish in Early Drug Discovery and Development, as is the unique specialist in Zebrafish Technologies and Services working under a GLP and automation environment. Biobide has already worked with some of the Top 20 Pharmaceutical Companies and participated in several European projects (FP7, EUREKA,...).
More

Contact

  • Firstname / Lastname :
    Natalia Elizalde
  • Job title :
    Market&Product Development Manager
  • Email :
    elizalde@biobide.es

Value chain

  • Research
  • Preclinical

Business Model

  • Service Provider - CRO
  • Service Provider - scientifique

Activities

  • Drug Discovery
  • Models (animal, cellular, ...)

Application Fields

  • Animal Health
  • Human Health
  • Infectious Diseases
  • Nutrition / Food
  • Inflammatory Diseases
  • Metabolic Diseases
  • Cancer
  • Dermocosmetics
  • CNS related Diseases

Needs and interest

  • R&d Partnership
Close

Biobide - SPAIN

More

Contact

  • Firstname / Lastname :
    Arantza Muriana
  • Job title :
    R+D Management Director
  • Email :
    muriana@biobide.es
  • Phone :
    +34943309360

Value chain

  • Research
  • Preclinical

Business Model

  • Service Provider - CRO
  • Service Provider - scientifique

Activities

  • Preclinical Trials
  • Drug Discovery

Application Fields

  • Human Health
  • Nutrition / Food
  • Metabolic Diseases
  • Cancer
  • CNS related Diseases
  • Other

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
  • Commercial Development
Close

BioFilm Control - FRANCE

BioFolm Control leverages its unique and proprietary biological assays in order to be the first to discover compounds for fighting bacterial biofilms involved in triggering and sustaining severe and common human diseases. Our initial therapeutic targets, each addressing a multi-billion Euro market, are: atopic dermatitis, acne, rhinosinusitis and pressure ulcers. Our initial screening campaign wit...
BioFolm Control leverages its unique and proprietary biological assays in order to be the first to discover compounds for fighting bacterial biofilms involved in triggering and sustaining severe and common human diseases. Our initial therapeutic targets, each addressing a multi-billion Euro market, are: atopic dermatitis, acne, rhinosinusitis and pressure ulcers. Our initial screening campaign with a focus on staphylococci has already identified a first set of active compounds with a promising chemical pattern which we are now pushing into hit-to-lead and preclinical processes.
More

Contact

Value chain

  • Research
  • Preclinical

Business Model

  • Product Developer - pharmaceuticals

Activities

  • Diagnostics / Analysis Methods
  • Drug Discovery

Application Fields

  • Immunology
  • Infectious Diseases
  • Inflammatory Diseases
  • Dermocosmetics

Needs and interest

  • R&d Partnership
Close

BioGenes GmbH - GERMANY

Service provider for development and production of customized ELISA for the areas of R&D, Quality Control, Clinical Trials for biotech, pharma, life science companies
Service provider for development and production of customized ELISA for the areas of R&D, Quality Control, Clinical Trials for biotech, pharma, life science companies
More

Contact

  • Firstname / Lastname :
    Kathrin Guenther
  • Job title :
    Diretor international marketing
  • Email :
    k.guenther@biogenes.de

Value chain

  • Manufacturing / Production

Business Model

  • Service Provider - CRO

Activities

  • Diagnostics / Analysis Methods
  • Biomanufacturing

Application Fields

  • Animal Health
  • Human Health
  • Immunology
  • Infectious Diseases
  • Allergology
  • Genetic / Rare Diseases
  • Nutrition / Food
  • Pediatrics
  • Geriatrics
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Orhpan Diseases
  • Metabolic Diseases
  • Cancer
  • Dermocosmetics
  • CNS related Diseases
  • Other
Close

Bionomics Limited - AUSTRALIA

Bionomics Limited (ASX:BNO, US OTC:BMICY) is fully integrated Australian biotechnology company discovering and developing novel treatments for major unmet needs in CNS disease and cancer. Bionomics' lead product is BNC105, a novel Vascular Disruption Agent (VDA) for cancer, which has recently commenced evaluation in Phase II trials (renal cell carcinoma and mesothelioma) under an US IND. In compar...
Bionomics Limited (ASX:BNO, US OTC:BMICY) is fully integrated Australian biotechnology company discovering and developing novel treatments for major unmet needs in CNS disease and cancer. Bionomics' lead product is BNC105, a novel Vascular Disruption Agent (VDA) for cancer, which has recently commenced evaluation in Phase II trials (renal cell carcinoma and mesothelioma) under an US IND. In comparison to other VDA's in development, BNC105 has the unique properties of a high therapeutic index and the ability to regress tumors when used as a single agent. BNC210 is a novel treatment for anxiety disorders and depression that exhibits efficacy comparable to diazepam, but has none of the side effects of existing anxiety drugs. Phase Ib clinical trials were completed in March 2011, with data showing reduction in panic symptoms and and speeding of recovery following CCK challenge. Additionally, Bionomics has preclinical compound development programs in Autoimmune Disorders/Multiple Sclerosis (targeting the Kv1.3 ion channel), Epilepsy and alpha7 nicotinic acetylcholine receptor (memory).
More

Contact

Value chain

  • Research
  • Preclinical
  • Clinical

Business Model

  • Product Developer - pharmaceuticals

Activities

  • Chemistry
  • Tissue / Cells
  • Drug Discovery
  • Models (animal, cellular, ...)

Application Fields

  • Human Health
  • CNS related Diseases

Needs and interest

  • R&d Partnership
Close

BIopharma Business Development - USA

Biopharmaceutical business development. - Marketing plan - Clinical trials phases II, III and IV - Medical information / Pharmacovigilance - Countries: USA, France, Algeria
Biopharmaceutical business development. - Marketing plan - Clinical trials phases II, III and IV - Medical information / Pharmacovigilance - Countries: USA, France, Algeria
More

Contact

Value chain

  • Research
  • Clinical
  • Marketing / Distribution

Business Model

  • Service Provider - CRO
  • Product Developer - biopharmaceuticals

Activities

  • Protein / Proteomics
  • Vaccine
  • Clinical Trials
  • Medical Device
  • Drug Delivery
  • Nanotechnology

Application Fields

  • Human Health
  • Immunology
  • Infectious Diseases
  • Allergology
  • Genetic / Rare Diseases
  • Pediatrics
  • Geriatrics
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Orhpan Diseases
  • Metabolic Diseases
  • Cancer

Needs and interest

  • Commercial Development
Close

BioSIMS Technologies - FRANCE

BioSIMS is a specialized contract research organisation, which offers solutions for detecting and quantifying biomarkers, proteins and small molecules, by using "SIMS": The most sensitive of all the commonly used analytical techniques.
BioSIMS is a specialized contract research organisation, which offers solutions for detecting and quantifying biomarkers, proteins and small molecules, by using "SIMS": The most sensitive of all the commonly used analytical techniques.
More

Contact

Value chain

  • Research
  • Preclinical

Business Model

  • Service Provider - CRO
  • Service Provider - scientifique

Activities

  • Protein / Proteomics
  • Diagnostics / Analysis Methods

Application Fields

  • Pediatrics
  • Orhpan Diseases
  • Cancer
  • CNS related Diseases

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
  • Commercial Development
Close

Biotech Developpement Conseils - FRANCE

BDC advices biotech and start ups companies of the health sector in their Business Development and Strategic Alliances. BDC assists its clients to create value by trans-national and international, technology-driven, long term partnerships. BDC helps its clients to set business abroad, introduces foreign companies looking for local partners. Our mission is also to identify new technologies or produ...
BDC advices biotech and start ups companies of the health sector in their Business Development and Strategic Alliances. BDC assists its clients to create value by trans-national and international, technology-driven, long term partnerships. BDC helps its clients to set business abroad, introduces foreign companies looking for local partners. Our mission is also to identify new technologies or products in Europe, Japan and Israel.
More

Contact

Value chain

  • Research
  • Preclinical
  • Clinical
  • Manufacturing / Production
  • Other

Business Model

  • Other

Activities

  • Vaccine
  • Diagnostics / Analysis Methods
  • Preclinical Trials
  • Drug Discovery
  • Medical Device
  • Cell Therapy

Application Fields

  • Animal Health
  • Human Health
  • Immunology
  • Infectious Diseases
  • Allergology
  • Genetic / Rare Diseases
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Orhpan Diseases
  • Cancer
  • Dermocosmetics
  • CNS related Diseases
Close

Biotech Développement Conseils - FRANCE

More

Contact

Value chain

  • Research
  • Preclinical
  • Manufacturing / Production
  • Marketing / Distribution
  • Other

Business Model

  • Other

Activities

  • Protein / Proteomics
  • Vaccine
  • Tissue / Cells
  • Lab Equipment
  • Diagnostics / Analysis Methods
  • Biomanufacturing
  • Preclinical Trials
  • Drug Discovery
  • Medical Device
  • Drug Delivery
  • Instrumentation
  • Cell Therapy
  • Models (animal, cellular, ...)

Application Fields

  • Animal Health
  • Human Health
  • Immunology
  • Infectious Diseases
  • Allergology
  • Nutrition / Food
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Orhpan Diseases
  • Cancer
  • Dermocosmetics
  • CNS related Diseases
Close

Biotech Vendor Services - USA

Founded in 2003, BVS provides effective and cost-saving vendor management services for biotech, pharmaceutical, hospital and academic research and manufacturing companies and institutes. We help drug delivery, clinical, research and development, and manufacturing departments of all sizes manage their suppliers by setting up customized vendor product shows, technical seminars, symposiums, and event...
Founded in 2003, BVS provides effective and cost-saving vendor management services for biotech, pharmaceutical, hospital and academic research and manufacturing companies and institutes. We help drug delivery, clinical, research and development, and manufacturing departments of all sizes manage their suppliers by setting up customized vendor product shows, technical seminars, symposiums, and events. BVS is a FREE service for biotech, pharmaceutical and academic research organizations, who host events at their facility. BVS is sponsored by biotech product manufacturers and service companies.
More

Contact

  • Firstname / Lastname :
    Pamela Gardner
  • Job title :
    President and CEO
  • Email :
    pam.gardner@bvsweb.com
  • Phone :
    858-349-8375

Value chain

  • Research
  • Preclinical
  • Clinical
  • Manufacturing / Production
  • Marketing / Distribution
  • Other

Business Model

  • Service Provider - scientifique

Activities

  • Other

Application Fields

  • Other
Close

Boehringer Ingelheim Pharmaceuticals Inc - USA

Boehringer Ingelheim is a group of companies dedicated to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine. It is one of the world's 20 leading pharmaceutical companies.

Boehringer Ingelheim is a group of companies dedicated to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine. It is one of the world's 20 leading pharmaceutical companies.

More

Contact

Activities

  • Biomanufacturing
  • Drug Discovery
  • Medical Device
  • Drug Delivery
  • Nanotechnology
Close

Boehringer Ingelheim Pharmaceuticals, Inc. - USA

More

Contact

Activities

  • Drug Discovery
Close

Burrill & Company - USA

Burrill & Company is a life science venture capital and investment bank firm.
Burrill & Company is a life science venture capital and investment bank firm.
More

Contact

  • Firstname / Lastname :
    Michael Keyoung
  • Job title :
    Managing Director
  • Email :
    mkeyoung@b-c.com
  • Phone :
    415-591-5400

Business Model

  • Other

Activities

  • Other
Close

Campanelli Companies - USA

Established in 1947, Campanelli is a full-service commercial real estate development and construction company with extensive experience in the industrial, Research & Development, high tech, office, medical office, warehouse/distribution and retail markets. To date, Campanelli has developed over 18 million square feet of commercial real estate property in New England and the Eastern Seaboard. T...
Established in 1947, Campanelli is a full-service commercial real estate development and construction company with extensive experience in the industrial, Research & Development, high tech, office, medical office, warehouse/distribution and retail markets. To date, Campanelli has developed over 18 million square feet of commercial real estate property in New England and the Eastern Seaboard. The company’s signature capabilities include land development, design and build, redevelopment and value-added acquisitions.
More

Contact

  • Firstname / Lastname :
    Peter Brown
  • Job title :
    Director of Business Development
  • Email :
    pbrown@campanelli.com
  • Phone :
    617-633-4422

Value chain

  • Other

Business Model

  • Other

Activities

  • Other

Application Fields

  • Other

Needs and interest

  • Commercial Development
Close

CARLINA Technologies - FRANCE

CARLINA Technologies is a biopharmaceutical company specialized in the micro and nano encapsulation of therapeutics. We provide R&D formulation development services with out-licensing and partnership opprtunities.
CARLINA Technologies is a biopharmaceutical company specialized in the micro and nano encapsulation of therapeutics. We provide R&D formulation development services with out-licensing and partnership opprtunities.
More

Contact

  • Firstname / Lastname :
    Olivier Meyer
  • Job title :
    President & CEO
  • Email :
    omeyer@carlinatech.com
  • Phone :
    +33(0)2 49 71 03 37

Value chain

  • Research
  • Preclinical
  • Clinical
  • Manufacturing / Production

Business Model

  • Service Provider - CRO
  • Product Developer - pharmaceuticals

Activities

  • Drug Delivery
  • Nanotechnology

Application Fields

  • Human Health
  • Cancer

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
Close

CATO BioVentures - USA

Cato BioVentures is the venture capital affiliate of Cato Research Ltd., a global contract research and development organization (CRO). For over 20 years, Cato BioVentures and Cato Research have partnered with entrepeneurs, academic institutions, and a broad base of biotech and pharmaceutical companies to advance a robust portfolio of sucessful product development programs. Through strategic CRO s...
Cato BioVentures is the venture capital affiliate of Cato Research Ltd., a global contract research and development organization (CRO). For over 20 years, Cato BioVentures and Cato Research have partnered with entrepeneurs, academic institutions, and a broad base of biotech and pharmaceutical companies to advance a robust portfolio of sucessful product development programs. Through strategic CRO service agreements with Cato Research, we have invested our CRO Service Capital™ in innovative therapeutics, medical devices and stem cell technologies that improve Pharma's Research and Development productivity. If strategic outsourcing for development and regulatory and clinical support is a core component of a company's business plan, then our investment model can make a positive difference in the company's overall success.
More

Contact

  • Firstname / Lastname :
    Lynda Sutton
  • Job title :
    Principal
  • Email :
    lsutton@cato.com
  • Phone :
    919-361-2286

Value chain

  • Preclinical
  • Clinical

Business Model

  • Service Provider - CRO
  • Other

Activities

  • Gene / Genomics
  • Protein / Proteomics
  • Chemistry
  • Vaccine
  • Tissue / Cells
  • Diagnostics / Analysis Methods
  • Clinical Trials
  • Medical Device
  • Drug Delivery
  • Cell Therapy
  • Nanotechnology

Application Fields

  • Human Health
  • Immunology
  • Infectious Diseases
  • Genetic / Rare Diseases
  • Pediatrics
  • Geriatrics
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Orhpan Diseases
  • Metabolic Diseases
  • Cancer
  • CNS related Diseases

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
  • Commercial Development
Close

CATO BioVentures - USA

More

Contact

  • Firstname / Lastname :
    Allen Cato
  • Job title :
    Principal
  • Email :
    acato@cato.com
  • Phone :
    919-361-2286

Value chain

  • Research
  • Preclinical
  • Clinical

Business Model

  • Service Provider - CRO
  • Other

Activities

  • Gene / Genomics
  • Protein / Proteomics
  • Chemistry
  • Vaccine
  • Tissue / Cells
  • Diagnostics / Analysis Methods
  • Clinical Trials
  • Drug Discovery
  • Medical Device
  • Drug Delivery
  • Cell Therapy
  • Models (animal, cellular, ...)
  • Nanotechnology

Application Fields

  • Human Health
  • Immunology
  • Infectious Diseases
  • Genetic / Rare Diseases
  • Pediatrics
  • Geriatrics
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Orhpan Diseases
  • Metabolic Diseases
  • Cancer
  • CNS related Diseases

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
  • Commercial Development
Close

CATO Research - USA

Cato Research is a contract research organization (CRO) that provides integrated services to pharmaceutical, biotechnology, and medical device companies. We specialize in complex development programs requiring innovative regulatory and clinical strategies, and we have experience implementing and conducting successful clinical trials and development programs. As a midsize CRO, Cato Research offers ...
Cato Research is a contract research organization (CRO) that provides integrated services to pharmaceutical, biotechnology, and medical device companies. We specialize in complex development programs requiring innovative regulatory and clinical strategies, and we have experience implementing and conducting successful clinical trials and development programs. As a midsize CRO, Cato Research offers a complete range of services with personalized attention and flexibity. The relationships we create with our sponsors produce positive, tangible results.
More

Contact

  • Firstname / Lastname :
    Jack Snyder
  • Job title :
    Clinical Research Physician
  • Email :
    jsnyder@cato.com
  • Phone :
    301-309-8242

Value chain

  • Research
  • Preclinical
  • Clinical

Business Model

  • Service Provider - CRO

Activities

  • Gene / Genomics
  • Protein / Proteomics
  • Chemistry
  • Vaccine
  • Tissue / Cells
  • Diagnostics / Analysis Methods
  • Clinical Trials
  • Medical Device
  • Drug Delivery
  • Cell Therapy
  • Nanotechnology

Application Fields

  • Human Health
  • Immunology
  • Infectious Diseases
  • Genetic / Rare Diseases
  • Pediatrics
  • Geriatrics
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Orhpan Diseases
  • Metabolic Diseases
  • Cancer
  • CNS related Diseases

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
  • Commercial Development
Close

CATO Research - USA

More

Contact

  • Firstname / Lastname :
    Elizabeth Rach
  • Job title :
    Scientist
  • Email :
    erach@cato.com
  • Phone :
    301-309-8242

Value chain

  • Research
  • Preclinical
  • Clinical

Business Model

  • Service Provider - CRO

Activities

  • Gene / Genomics
  • Protein / Proteomics
  • Chemistry
  • Vaccine
  • Tissue / Cells
  • Diagnostics / Analysis Methods
  • Clinical Trials
  • Medical Device
  • Drug Delivery
  • Cell Therapy
  • Nanotechnology

Application Fields

  • Human Health
  • Immunology
  • Infectious Diseases
  • Genetic / Rare Diseases
  • Pediatrics
  • Geriatrics
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Orhpan Diseases
  • Metabolic Diseases
  • Cancer
  • Dermocosmetics
  • CNS related Diseases

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
  • Commercial Development
Close

CATO Research - USA

More

Contact

  • Firstname / Lastname :
    Nicole Corrado
  • Job title :
    Project Coordinator
  • Email :
    ncorrado@cato.com
  • Phone :
    301-309-8242

Value chain

  • Research
  • Preclinical
  • Clinical

Business Model

  • Service Provider - CRO

Activities

  • Gene / Genomics
  • Protein / Proteomics
  • Chemistry
  • Vaccine
  • Tissue / Cells
  • Diagnostics / Analysis Methods
  • Clinical Trials
  • Medical Device
  • Drug Delivery
  • Cell Therapy
  • Nanotechnology

Application Fields

  • Human Health
  • Immunology
  • Infectious Diseases
  • Genetic / Rare Diseases
  • Pediatrics
  • Geriatrics
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Orhpan Diseases
  • Metabolic Diseases
  • Cancer
  • Dermocosmetics
  • CNS related Diseases

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
  • Commercial Development
Close

Cellectis bioresearch Inc. - USA

Cellectis is a French biotechnology company specialized in an innovative approach to genome engineering, called rational genome engineering. Founded on a true technological breakthrough, Cellectis’ approach allows precise engineering of the genome and the rewriting of DNA sequences in all living organisms. Cellectis bioresearch (CBR) develops and commercializes R&D kits to generate isogenic ...
Cellectis is a French biotechnology company specialized in an innovative approach to genome engineering, called rational genome engineering. Founded on a true technological breakthrough, Cellectis’ approach allows precise engineering of the genome and the rewriting of DNA sequences in all living organisms. Cellectis bioresearch (CBR) develops and commercializes R&D kits to generate isogenic stable cell lines.
More

Contact

Value chain

  • Research

Business Model

  • Service Provider - scientifique
  • Product Developer - biopharmaceuticals

Activities

  • Gene / Genomics
  • Tissue / Cells
  • Biomanufacturing
  • Models (animal, cellular, ...)

Application Fields

  • Animal Health
  • Human Health
  • Immunology
  • Infectious Diseases
  • Allergology
  • Genetic / Rare Diseases
  • Nutrition / Food
  • Pediatrics
  • Geriatrics
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Orhpan Diseases
  • Metabolic Diseases
  • Cancer
  • Dermocosmetics
  • CNS related Diseases

Needs and interest

  • Commercial Development
Close

Cellzome - USA

Cellzome is a world leader in chemoproteomics, transforming the sciences of epigenetics and signal transduction into novel drug candidates in inflammatory diseases and oncology.
Cellzome is a world leader in chemoproteomics, transforming the sciences of epigenetics and signal transduction into novel drug candidates in inflammatory diseases and oncology.
More

Contact

Value chain

  • Research

Business Model

  • Product Developer - pharmaceuticals

Activities

  • Protein / Proteomics
  • Chemistry
  • Drug Discovery

Application Fields

  • Human Health
  • Immunology
  • Infectious Diseases
  • Genetic / Rare Diseases
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Orhpan Diseases
  • Metabolic Diseases
  • Cancer
  • CNS related Diseases

Needs and interest

  • R&d Partnership
Close

CG Pharmaceuticals, Inc. - USA

"CrystalGenomics, Inc. is a clinical stage drug R&D biopharmaceutical company headquartered in Seoul, Korea with a US presence for multi-national clinical management (CG Pharmaceuticals, Inc.) in Emeryville, California and publicly traded in KOSDAQ exchange, Korea. Our business model is to discover and develop novel therapeutics in the areas of inflammation, oncology, and infectious disea...
"CrystalGenomics, Inc. is a clinical stage drug R&D biopharmaceutical company headquartered in Seoul, Korea with a US presence for multi-national clinical management (CG Pharmaceuticals, Inc.) in Emeryville, California and publicly traded in KOSDAQ exchange, Korea. Our business model is to discover and develop novel therapeutics in the areas of inflammation, oncology, and infectious disease upto clinical proof-of-concept and then to partner for further development. We currently have three clinical stage programs and several earlier stage programs in preclinical development. CG100649 is the lead developmental candidate which is a novel and next generation NSAID with a tissue specific pharmacological activity for potentially improved cardiovascular, gastrointestinal, and renal safety profiles over existing NSAIDs. CG100649 has completed a Phase IIa clinical trial in Europe and currently in Phase IIb development. Additionally, our novel HDAC inhibitor, CG200745 for cancer is in Phase I development and the novel antibiotic candidate CG400549 for MRSA is Phase IIa ready. We are actively pursuing License-Out opportunities of our candidates for worldwide or regional territories, as well as R&D collaboration or JV partnerships for utilizing our structural chemoproteiomics-based platform technology for novel lead generation and medicinal chemistry expertise. Our discovery capabilities has been validated thru past cover page publication on the Nature magazine for determination of the PDE5 structure, and a recent R&D collaboration announcement with AstraZeneca for novel anti-infectives. We are also looking to License-In late clinical stage or already marketed external programs in oncology and/or inflammation. We are open to consider other disease areas if the drug program shows clear differentiations from existing products and competing programs in development and territories of interest to us are Asian territories including Korea and China."
More

Contact

  • Firstname / Lastname :
    Joong Myung Cho
  • Job title :
    President & CEO
  • Email :
    jmcho@cgxinc.com

Business Model

  • Product Developer - pharmaceuticals

Activities

  • Protein / Proteomics
  • Clinical Trials
  • Drug Discovery

Application Fields

  • Human Health
  • Infectious Diseases
  • Inflammatory Diseases
  • Cancer
  • CNS related Diseases

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
Close

CG Pharmaceuticals, Inc. - USA

More

Contact

Activities

  • Protein / Proteomics
  • Clinical Trials
  • Drug Discovery
Close

CHELATEC - FRANCE

OUR MISSION: TO HELP IN THE SELECTION OF YOUR CANDIDATE MOLECULES Chelatec is an independent company providing customized service in the specific fields of radiolabeling and preclinical research. Our mission is to assist the pharmaceutical and biotechnology industry in the identification and selection process of drug candidates using the radioactive tracer. The broad expertise of our multidiscipli...
OUR MISSION: TO HELP IN THE SELECTION OF YOUR CANDIDATE MOLECULES Chelatec is an independent company providing customized service in the specific fields of radiolabeling and preclinical research. Our mission is to assist the pharmaceutical and biotechnology industry in the identification and selection process of drug candidates using the radioactive tracer. The broad expertise of our multidisciplinary team and the quality of our technical resources guarantee you optimum support for subcontracted projects. We offer a unique environment of laboratories accredited in both the handling of radionuclides and animal experimentation conducted on rodents.
More

Contact

  • Firstname / Lastname :
    Jean-Francois GESTIN
  • Job title :
    Founder & BD
  • Email :
    jfgestin@chelatec.fr
  • Phone :
    33(0)251861959

Value chain

  • Research
  • Preclinical
  • Clinical

Business Model

  • Service Provider - CRO
  • Service Provider - scientifique

Activities

  • Preclinical Trials

Application Fields

  • Human Health
  • Immunology
  • Cancer
  • CNS related Diseases
  • Other

Needs and interest

  • R&d Partnership
  • Commercial Development
Close

Chesapeake PERL - USA

Chesapeake PERL has been in business for over 10 years. During that time we have successfully expressed and recovered over 120 proteins. We have unique capabilities and expertise to produce difficult to produce proteins some of which have never been successfully produced is other expression systems.
Chesapeake PERL has been in business for over 10 years. During that time we have successfully expressed and recovered over 120 proteins. We have unique capabilities and expertise to produce difficult to produce proteins some of which have never been successfully produced is other expression systems.
More

Contact

  • Firstname / Lastname :
    Robert Balcerzak
  • Job title :
    President
  • Email :
    bbalcerzak@c-perl.com
  • Phone :
    301 317-9300 x103

Value chain

  • Research
  • Preclinical
  • Manufacturing / Production

Business Model

  • Service Provider - CMO
  • Product Developer - biopharmaceuticals

Activities

  • Protein / Proteomics
  • Vaccine
  • Biomanufacturing

Application Fields

  • Animal Health
  • Human Health
  • Infectious Diseases
  • Genetic / Rare Diseases
  • Inflammatory Diseases
  • Orhpan Diseases
  • Cancer
  • Other

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
  • Commercial Development
Close

Chikujee Therapeutics - USA

Develop multifunctional therapeutics in Oncology, Cardiovascular and CNS diseases- Invitro and in vivo diagnostics, targeted therapeutics and biomarker monitoring.
Develop multifunctional therapeutics in Oncology, Cardiovascular and CNS diseases- Invitro and in vivo diagnostics, targeted therapeutics and biomarker monitoring.
More

Contact

  • Firstname / Lastname :
    Arkesh Mehta
  • Job title :
    CEO
  • Email :
    jenny@at-gc.com
  • Phone :
    3015405474

Value chain

  • Research
  • Preclinical
  • Clinical
  • Manufacturing / Production
  • Marketing / Distribution

Business Model

  • Product Developer - biopharmaceuticals

Activities

  • Imagery
  • Diagnostics / Analysis Methods
  • Biomanufacturing
  • Drug Discovery
  • Drug Delivery
  • Nanotechnology

Application Fields

  • Human Health
  • Infectious Diseases
  • Orhpan Diseases
  • Metabolic Diseases
  • CNS related Diseases

Needs and interest

  • R&d Partnership
  • Commercial Development
Close

Ciloa - FRANCE

Ciloa is a start-up company with a proprietary technology that provides fully native transmembrane proteins (GPCR, kinase receptors, ion channels, adhesion molecules, viral envelope proteins) on natural nanovesicles called exosomes. This product allows an easier way to reach your goals in drug screening, monoclonal antibody development, immunotherapy, diagnostic, and vaccine development. Ciloa tai...
Ciloa is a start-up company with a proprietary technology that provides fully native transmembrane proteins (GPCR, kinase receptors, ion channels, adhesion molecules, viral envelope proteins) on natural nanovesicles called exosomes. This product allows an easier way to reach your goals in drug screening, monoclonal antibody development, immunotherapy, diagnostic, and vaccine development. Ciloa tailors exosomes to express your transmembrane proteins - any type, with single or multi-transmembrane domains - at high concentrations and in their fully native conformation. This means that, except for an added exosome signal peptide, your protein on exosomes is exactly the same as its wild-type on cells: • No mutation of either ectodomain(s) or transmembrane helice(s). • Your protein presents all of its natural post-translational modifications such as: glycosylation, multimerization, cleavage, etc. • Your protein is naturally inserted in a natural phospholipid environment. Exosomes with your membrane protein are easy to store and easy to handle, as they are non-live, non-infectious particles with a volume 10-7 smaller than that of a cell. Thus, you have an easy way to handle native membrane proteins in suspension, in homogenous, characterized and reliable batches.
More

Contact

Value chain

  • Research

Business Model

  • Service Provider - scientifique

Activities

  • Protein / Proteomics
  • Vaccine
  • Biomanufacturing
  • Drug Discovery

Application Fields

  • Animal Health
  • Human Health
  • Immunology
  • Infectious Diseases
  • Allergology
  • Genetic / Rare Diseases
  • Inflammatory Diseases
  • Orhpan Diseases
  • Metabolic Diseases
  • Cancer
  • CNS related Diseases

Needs and interest

  • R&d Partnership
Close

CM-CIC Capital Innovation - FRANCE

We invest in technological companies with the exception of drug development.
We invest in technological companies with the exception of drug development.
More

Contact

Business Model

  • Other

Activities

  • Imagery
  • Diagnostics / Analysis Methods
  • Medical Device
  • Nanotechnology

Application Fields

  • Immunology
  • Infectious Diseases
  • Nutrition / Food
  • Cancer
Close

COEXEL - FRANCE

help grow small companies in the initial stages of their international development
help grow small companies in the initial stages of their international development
More

Contact

Activities

  • Other
Close

COLCOM - FRANCE

Colcom is specialised in nanotechnologies for biological applications (DendriGraft of Lysines or DGL) which present a large range of biological applications (health, diagnostic, biomaterials, environment…). Our business activity is based on 3 parts : - Commercialization of DGL for research or industrial actors; from mg to kg and over. - Chemical modifications of DGL (at the core or on the surfac...
Colcom is specialised in nanotechnologies for biological applications (DendriGraft of Lysines or DGL) which present a large range of biological applications (health, diagnostic, biomaterials, environment…). Our business activity is based on 3 parts : - Commercialization of DGL for research or industrial actors; from mg to kg and over. - Chemical modifications of DGL (at the core or on the surface) to adapt DGL for our partners’ applications. - Development of biomaterials based on organic polymers grafted with native or functionnalized DGL (beads, lab-on-chip, elisa plates, fibers,…). Some examples of recent publications (2010) on this subject: - Arginine end-functionalized poly(L-lysine) dendrigrafts for the stabilization and controlled release of insulin. - New Nanosized Biocompatible MR Contrast Agents Based on Lysine-Dendri-Graft Macromolecules. - A leptin derived 30-amino-acid peptide modified pegylated poly-L-lysine dendrigraft for brain targeted gene delivery. - Evaluation and mechanism studies of PEGylated dendrigraft poly-L-lysines as novel gene delivery vectors. - Dendrigraft Poly-L-lysine: A Non-Immunogenic Synthetic Carrier for Antibody Production. - Nanostructured Assemblies for Dental Application. Some of our references : BIO-RAD, Merck, Air Liquide, CNES, Altis, MIT Cambridge, NIH - National Cancer Institute, Vanderbilt University, Purdue University, Fudan University of Shanghai, Tyndall National Institute, Leibniz Institute,... COLCOM has an exclusive know-how in chemistry and is mainly interested in collaborative research with industrial and academic partners. Fields of interest: antibodies production, biomarkers characterization, preclinical drug, transport of macromolecules across biological barriers, gene transfection, drug delivery, fluorescent molecule encapsulation, cell culture, biological traces detection, water filtration, in vitro diagnostic.
More

Contact

Value chain

  • Research

Business Model

  • Service Provider - scientifique
  • Product Developer - pharmaceuticals
  • Product Developer - biopharmaceuticals

Activities

  • Chemistry
  • Nanotechnology

Application Fields

  • Human Health
  • Immunology
  • Infectious Diseases
  • Metabolic Diseases
  • Cancer
  • Dermocosmetics
  • CNS related Diseases

Needs and interest

  • R&d Partnership
Close

Cool Springs Life Sciences Center - USA

The Cool Springs Life Sciences Center is a 15-acre, 260,000 square foot life-sciences focused research and development campus, planned to provide dedicated space for well-equipped laboratory research, product development and manufacturing facilities for medical device, biotechnology, pharmaceutical and other life science-oriented companies and their support services. Prospective tenants include al...
The Cool Springs Life Sciences Center is a 15-acre, 260,000 square foot life-sciences focused research and development campus, planned to provide dedicated space for well-equipped laboratory research, product development and manufacturing facilities for medical device, biotechnology, pharmaceutical and other life science-oriented companies and their support services. Prospective tenants include all stages of business, from small start-ups within Vanderbilt University's research programs to emerging venture capital-funded companies in late-stage product development, to fully-integrated life sciences companies. The range of potential research activities in this facility is as diverse as biomedical research itself and includes pharmaceutical and medical device development activities utilizing organic chemistry, biochemistry, molecular and cellular biology, tissue culture work, histology, nanotechnology, biomedical engineering, tissue engineering, etc. The scope of manufacturing work could range from non-technical production to high-tech cGMP microbiological clean room operations. CSLSC tenants will be able to build-out their space to fit the unique needs of their business.The Cool Springs Life Sciences Center is projected to create 600 new jobs, nearly 300 of which will be on-site. The 10-year regional economic impact of the CSLSC is estimated at $766 million.
More

Contact

Activities

  • Other
Close

Cornell Center for Technology Enterprise and Commercialization - USA

The Cornell Center for Technology Enterprise & Commercialization (CCTEC) is Cornell University's technology transfer office. We manage technologies and plant varieties for Cornell University at the main campus in Ithaca, the Weill Cornell Medical College campus in New York City, and the New York State Agricultural Experiment Station in Geneva. Our goal is to support Cornell's land-grant missio...
The Cornell Center for Technology Enterprise & Commercialization (CCTEC) is Cornell University's technology transfer office. We manage technologies and plant varieties for Cornell University at the main campus in Ithaca, the Weill Cornell Medical College campus in New York City, and the New York State Agricultural Experiment Station in Geneva. Our goal is to support Cornell's land-grant mission and to promote public good by connecting Cornell technology to industry and business development efforts.
More

Contact

Value chain

  • Research

Activities

  • Chemistry
Close

CytImmune Sciences, Inc. - USA

CytImmune is a clinical stage nanomedicine company with a core focus on the discovery, development and commercialization of multifunctional, tumor-targeted cancer therapies. Based on a research and development strategy to harness the unique properties of gold nanoparticles, cytotoxic agents, and biology of tumors, CytImmune is developing a pipeline of proprietary drug candidates by binding potent ...
CytImmune is a clinical stage nanomedicine company with a core focus on the discovery, development and commercialization of multifunctional, tumor-targeted cancer therapies. Based on a research and development strategy to harness the unique properties of gold nanoparticles, cytotoxic agents, and biology of tumors, CytImmune is developing a pipeline of proprietary drug candidates by binding potent anti-cancer agents – whose toxicity profiles currently prevent or severely limit clinical use – to its patented tumor-targeting platform nanotechnology.
More

Contact

  • Firstname / Lastname :
    Mitchell Marder
  • Job title :
    Executive Vice President
  • Email :
    mmarder@cytimmune.com
  • Phone :
    202 415-4928

Value chain

  • Research
  • Preclinical
  • Clinical
  • Manufacturing / Production
  • Marketing / Distribution

Business Model

  • Product Developer - biopharmaceuticals

Activities

  • Clinical Trials
  • Preclinical Trials
  • Drug Discovery
  • Drug Delivery
  • Nanotechnology

Application Fields

  • Inflammatory Diseases
  • Autoimmune Diseases
  • Cancer

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
  • Commercial Development
Close

Da Volterra - FRANCE

DA VOLTERRA is a privately-held biotech company located in Paris, France, focused on developing unique drug products to contain the amplification and dissemination of antibiotic resistance in man and animals, and ultimately prevent multi-resistant infections. Antimicrobial Resistance has now joined the front rank of global health concerns, as illustrated by the WHO selecting it as the topic of the...
DA VOLTERRA is a privately-held biotech company located in Paris, France, focused on developing unique drug products to contain the amplification and dissemination of antibiotic resistance in man and animals, and ultimately prevent multi-resistant infections. Antimicrobial Resistance has now joined the front rank of global health concerns, as illustrated by the WHO selecting it as the topic of the “World Health Day” on April 7, 2011. We have the ambitious mission at DA VOLTERRA to contribute to “safeguard antibiotics for future generations”, through the development of three innovative pharmaceutical strategies applicable to human and animal health. Expert in understanding how the commensal flora colonisation by resistant bacteria in mammals often precedes infection and leads to dissemination, DA VOLTERRA opens new avenues to control resistance transmission and therefore reduce multi-resistant infections. Based on novel drug delivery strategies targeting the lower intestine, DA VOLTERRA’s proprietary products aim to prevent the intestinal flora from being a reservoir of resistance to antibiotics (see product description). We expect to bring both strong individual and community benefits with our products. DA VOLTERRA’s corporate strategy is to develop its product portfolio up to phase II in close collaboration with the top clinical experts in the anti-infectious field worldwide, and to partner its products for further clinical developments and commercialisation. DA VOLTERRA will as well pursue its efforts to mobilize all institutions and authorities to the need for such breakthrough developments in order to tackle the daunting challenge of bacterial resistance. “You can fool all the microbes for some time; You can fool some of the microbes all the time; But you cannot fool all the microbes all the time” JAPI, 2010
More

Contact

  • Firstname / Lastname :
    Florence Séjourné
  • Job title :
    CEO
  • Email :
    contact@davolterra.com
  • Phone :
    +33 158393220

Value chain

  • Research
  • Preclinical
  • Clinical

Business Model

  • Product Developer - pharmaceuticals

Activities

  • Clinical Trials
  • Preclinical Trials
  • Drug Delivery

Application Fields

  • Animal Health
  • Human Health
  • Infectious Diseases

Needs and interest

  • R&d Partnership
Close

Da Volterra - FRANCE

More

Contact

  • Firstname / Lastname :
    Pierre-Alain Bandinelli
  • Job title :
    Business development manager
  • Email :
    contact@davolterra.com

Value chain

  • Research
  • Preclinical
  • Clinical

Business Model

  • Product Developer - pharmaceuticals

Activities

  • Clinical Trials
  • Preclinical Trials
  • Drug Delivery
Close

Domain Therapeutics FRANCE

Domain Therapeutics is a French biopharmaceutical company focused on drug discovery and early development of G-Protein Coupled Receptor drugs. Domain discovers and develops GPCR ligands until preclinical candidate stage and then looks for partners for further development.
Domain Therapeutics is a French biopharmaceutical company focused on drug discovery and early development of G-Protein Coupled Receptor drugs. Domain discovers and develops GPCR ligands until preclinical candidate stage and then looks for partners for further development.
More

Contact

Value chain

  • Research
  • Preclinical

Business Model

  • Product Developer - biopharmaceuticals

Activities

  • Drug Discovery

Application Fields

  • Human Health
  • Metabolic Diseases
  • CNS related Diseases

Needs and interest

  • R&d Partnership
Close

Dr. Reddy's Laboratories Ltd - USA

Company main activity in Generic API's and Biosimilars development and manufacturing with a division, Custom Pharmaceutical services, dedicated to services for the innovators. CPS offers his 3 R&D centers and expertise in API manufacturing for the development and manufacturing of NCE's and API's from clinical phases to commercial request as well as formulation development of drug products.
Company main activity in Generic API's and Biosimilars development and manufacturing with a division, Custom Pharmaceutical services, dedicated to services for the innovators. CPS offers his 3 R&D centers and expertise in API manufacturing for the development and manufacturing of NCE's and API's from clinical phases to commercial request as well as formulation development of drug products.
More

Contact

Business Model

  • Service Provider - CMO
  • Product Developer - pharmaceuticals
  • Product Developer - biopharmaceuticals

Activities

  • Chemistry
  • Biomanufacturing
  • Drug Delivery

Application Fields

  • Animal Health
  • Human Health
  • Inflammatory Diseases
  • Metabolic Diseases
  • Cancer
Close

DSML Executive Search Inc - USA

Executive Search company specializing in helping European companies (especially French) find the right talent for their US operations. Experience in the pharmaceutical, biotech and medical device industries.
Executive Search company specializing in helping European companies (especially French) find the right talent for their US operations. Experience in the pharmaceutical, biotech and medical device industries.
More

Contact

Business Model

  • Service Provider - non scientifique
Close

Durect Corporation - USA

DURECT Corporation is a specialty pharmaceutical company focused on the development of pharmaceutical systems based on its proprietary drug delivery platform technologies. These platform technologies include the Depot Delivery System (a patented and versatile depot injectable useful for proteins, peptides and small molecule delivery), the ORADUR® sustained release oral gel-cap technology (an oral...
DURECT Corporation is a specialty pharmaceutical company focused on the development of pharmaceutical systems based on its proprietary drug delivery platform technologies. These platform technologies include the Depot Delivery System (a patented and versatile depot injectable useful for proteins, peptides and small molecule delivery), the ORADUR® sustained release oral gel-cap technology (an oral sustained release technology with several potential abuse deterrent properties), the TRANSDUR® transdermal patch technology, the DURIN™ Biodegradable Implant (drug-loaded implant system) and the MICRODUR™ Biodegradable Microparticulates (microspheres injectable system). DURECT also partners with pharmaceutical and biotechnology companies to develop and commercialize proprietary and enhanced pharmaceutical products based on its technologies. DURECT has five disclosed on-going development programs of which four are in collaboration with pharmaceutical partners. DURECT's strategy is to capitalize on the wealth of opportunities afforded by our proprietary platform technologies in three ways: To internally develop promising products based on our technologies; To partner some of our product opportunities with development and/or commercialization partners at appropriate stages along the development timelines; and To make our technologies, along with our pre-clinical and clinical development expertise available to partners with the desire to develop proprietary extended or controlled release formulations of a wide range of molecules.
More

Contact

Business Model

  • Product Developer - pharmaceuticals
  • Product Developer - biopharmaceuticals

Activities

  • Drug Delivery

Needs and interest

  • R&d Partnership
Close

DURECT Corporation - USA

More

Contact

  • Firstname / Lastname :
    James Matriano
  • Job title :
    Sr. Director, Project Feasiblity Mgmnt, Principal Scientist
  • Email :
    jim.matriano@durect.com
  • Phone :
    011-408-777-3553

Value chain

  • Research
  • Preclinical
  • Clinical

Business Model

  • Product Developer - pharmaceuticals
  • Product Developer - biopharmaceuticals

Activities

  • Drug Delivery

Application Fields

  • Animal Health
  • Human Health
  • Immunology
  • Infectious Diseases
  • Genetic / Rare Diseases
  • Pediatrics
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Orhpan Diseases
  • Metabolic Diseases
  • Cancer
  • CNS related Diseases

Needs and interest

  • R&d Partnership
Close

Emergent BioSolutions - USA

Emergent BioSolutions protects and enhances life by developing and manufacturing vaccines and therapeutics that are supplied to healthcare providers and purchasers for use in preventing and treating disease. Emergent’s marketed and investigational products target infectious diseases, oncology and autoimmune disorders.
Emergent BioSolutions protects and enhances life by developing and manufacturing vaccines and therapeutics that are supplied to healthcare providers and purchasers for use in preventing and treating disease. Emergent’s marketed and investigational products target infectious diseases, oncology and autoimmune disorders.
More

Contact

  • Firstname / Lastname :
    Laurence Lemiale
  • Job title :
    Director, BioDefense Vaccines
  • Email :
    lemialel@ebsi.com
  • Phone :
    301 944 0134

Value chain

  • Clinical

Business Model

  • Product Developer - biopharmaceuticals

Activities

  • Vaccine
Close

Empire Genomics - USA

Today, we are the leading supplier of molecular diagnostics for customization and production of FISH probes, aGCH assays and other genomic technologies. We currently work with leading Academic labs, Reference labs, Pharma, CRO’s and Biotech companies around the world.
Today, we are the leading supplier of molecular diagnostics for customization and production of FISH probes, aGCH assays and other genomic technologies. We currently work with leading Academic labs, Reference labs, Pharma, CRO’s and Biotech companies around the world.
More

Contact

Value chain

  • Manufacturing / Production

Business Model

  • Service Provider - CRO
  • Service Provider - scientifique
  • Product Developer - pharmaceuticals
  • Product Developer - biopharmaceuticals

Activities

  • Gene / Genomics
  • Clinical Trials
  • Medical Device

Application Fields

  • Human Health
  • Genetic / Rare Diseases
  • Pediatrics
  • Inflammatory Diseases
  • Orhpan Diseases
  • Cancer
  • CNS related Diseases

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
  • Commercial Development
Close

EnGeneIC - AUSTRALIA

EnGeneIC’s mission is to change the perception of cancer from life threatening to curable. We are a privately held Australian company with patented technology for targeting tumors, overcoming drug resistance and minimizing the toxicity of cancer therapies. EnGeneIC has published in Nature Biotechnology and Cancer Cell and now seeks partners to progress our phase I/IIa clinical trial product towa...
EnGeneIC’s mission is to change the perception of cancer from life threatening to curable. We are a privately held Australian company with patented technology for targeting tumors, overcoming drug resistance and minimizing the toxicity of cancer therapies. EnGeneIC has published in Nature Biotechnology and Cancer Cell and now seeks partners to progress our phase I/IIa clinical trial product towards its commercial potential.
More

Contact

  • Firstname / Lastname :
    Lisa Rodgers
  • Job title :
    Business Development Manager
  • Email :
    lrodgers@engeneic.com
  • Phone :
    +61282035035

Value chain

  • Research
  • Clinical

Business Model

  • Product Developer - pharmaceuticals
  • Product Developer - biopharmaceuticals

Activities

  • Clinical Trials
  • Drug Delivery
  • Other
  • Nanotechnology

Application Fields

  • Cancer

Needs and interest

  • R&d Partnership
Close

Ensemble Therapeutics Corp. - USA

A Revolution in Chemistry. A New Class of Drugs. Ensemble is the first company to successfully and reliably exploit synthetic macrocycle drugs, called Ensemblins™. With their distinctive macrocyclic ring structure, Ensemblins have unique properties to address difficult-to-address drug targets that are known to play key roles in disease processes, yet are currently undruggable with conventional s...
A Revolution in Chemistry. A New Class of Drugs. Ensemble is the first company to successfully and reliably exploit synthetic macrocycle drugs, called Ensemblins™. With their distinctive macrocyclic ring structure, Ensemblins have unique properties to address difficult-to-address drug targets that are known to play key roles in disease processes, yet are currently undruggable with conventional small molecule drugs. With their unique chemical and biological properties, Ensemblins are a new class of drugs in the emerging therapeutic space between small molecules and biologics. Ensemble's leadership capabilities in developing macrocycle drugs are based on the company's proprietary, DNA-programmed chemistry drug discovery platform. The company has a pipeline of proprietary and partnered Ensemblin drug candidates to treat a broad range of diseases, including inflammation, oncology and diabetes.
More

Contact

  • Firstname / Lastname :
    Ted Hibben
  • Job title :
    SVP Corporate Development
  • Email :
    thibben@ensembletx.com
  • Phone :
    617 492-6977

Value chain

  • Research
  • Preclinical

Business Model

  • Product Developer - pharmaceuticals

Activities

  • Chemistry
  • Drug Discovery

Application Fields

  • Immunology
  • Infectious Diseases
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Metabolic Diseases
  • Cancer
  • CNS related Diseases

Needs and interest

  • R&d Partnership
Close

Ernst & Young - FRANCE

Audit firm proposing audit and consulting services dedicated in Biotechnology
Audit firm proposing audit and consulting services dedicated in Biotechnology
More

Contact

Activities

  • Other
Close

Ernst&Young Paris - FRANCE

More

Contact

Business Model

  • Service Provider - non scientifique

Activities

  • Other
Close

ERYTECH Pharma - FRANCE

ERYTECH Pharma (Lyon, Philadelphia) is a specialty pharma developing new high value medicinal products for unmet clinical needs in the field of oncology, hematology and immunology. ERYTECH Pharma success is based on four major advantages: - A first product close to the market - A huge proprietary R&D platform offering large possibility of new products or new applications - The most appropriate...
ERYTECH Pharma (Lyon, Philadelphia) is a specialty pharma developing new high value medicinal products for unmet clinical needs in the field of oncology, hematology and immunology. ERYTECH Pharma success is based on four major advantages: - A first product close to the market - A huge proprietary R&D platform offering large possibility of new products or new applications - The most appropriate technology in the field of depletion of amino acids, of immune modulation and of oxygenation - An industrial and very efficient process ERYTECH Pharma’s business model consists both of developing and selling new innovative medicinal products and of partnering with pharma/biotech companies. ERYTECH Pharma will adress a one billion $ market with its in in house products and through business development deals. The ambition of the company is to become rapidly a world leader in the specialty pharma field using Red Blood Cells as vehicles. ERYTECH Pharma looks forward discussing BD, license and corporate deal to accelerate its development
More

Contact

  • Firstname / Lastname :
    Pierre-Olivier GOINEAU
  • Job title :
    CEO
  • Email :
    contact@erytech.com
  • Phone :
    0033478744438

Value chain

  • Research
  • Clinical
  • Manufacturing / Production
  • Marketing / Distribution

Business Model

  • Product Developer - pharmaceuticals
  • Product Developer - biopharmaceuticals

Activities

  • Gene / Genomics
  • Vaccine
  • Clinical Trials
  • Drug Discovery
  • Drug Delivery
  • Cell Therapy

Application Fields

  • Immunology
  • Genetic / Rare Diseases
  • Autoimmune Diseases
  • Orhpan Diseases
  • Cancer

Needs and interest

  • R&d Partnership
  • Commercial Development
Close

Eurofins OPTIMED - FRANCE

French company founded in 1990, EUROFINS OPTIMED provides services for Early Drug Development (First into Human and First into Patient studies, PK/PD studies, Proof of concept, etc .). EUROFINS OPTIMED has its own facilities on 2 sites with a full capacity of 100 beds including a hospital based unit. Thanks to its position within the Lyon Sud Hospital, Eurofins Optimed has access to various type o...
French company founded in 1990, EUROFINS OPTIMED provides services for Early Drug Development (First into Human and First into Patient studies, PK/PD studies, Proof of concept, etc .). EUROFINS OPTIMED has its own facilities on 2 sites with a full capacity of 100 beds including a hospital based unit. Thanks to its position within the Lyon Sud Hospital, Eurofins Optimed has access to various type of patients and a large network of experts. In addition to its services in pharmacology, Eurofins Optimed offers all services needed to achieve your study : regulatory services, medical writing, monitoring, data management and statistics.
More

Contact

  • Firstname / Lastname :
    Yves DONAZZOLO
  • Job title :
    President & Medical Director
  • Email :
    corine.cussey@optimed.fr
  • Phone :
    +33 4 38 37 27 47

Business Model

  • Service Provider - CRO

Activities

  • Clinical Trials

Application Fields

  • Human Health
  • Immunology
  • Infectious Diseases
  • Allergology
  • Genetic / Rare Diseases
  • Nutrition / Food
  • Pediatrics
  • Geriatrics
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Orhpan Diseases
  • Metabolic Diseases
  • Cancer
  • Dermocosmetics
  • CNS related Diseases

Needs and interest

  • Commercial Development
Close

Eveon - FRANCE

Eveon is a french Medtech dedicated to design and industrialisation of injection medical devices. Eveon presents the first completely automatic, patient independent and safe injection medical device, designed for subcutaneous, intradermal and intramuscular administration of drugs. WHAT DIFFERENTIATES EVEON SELF ADMINISTRATION DEVICES FROM TRADITIONAL SYRINGES, PENS AND AUTOINJECTORS? Eveon fully a...
Eveon is a french Medtech dedicated to design and industrialisation of injection medical devices. Eveon presents the first completely automatic, patient independent and safe injection medical device, designed for subcutaneous, intradermal and intramuscular administration of drugs. WHAT DIFFERENTIATES EVEON SELF ADMINISTRATION DEVICES FROM TRADITIONAL SYRINGES, PENS AND AUTOINJECTORS? Eveon fully automatic, micropump-based system adapts to any primary container, vials, cartridges or PFS. All injection parameters are programmable and customizable according to your needs to inject the right dose at the right place: DOSE : a very accurate dose is delivered with precision of µl to eliminate overdosage TIME: controlled injection time guaranties drug integrity and is considerably reduced compare to manual injection (1ml, 30cp, 27G 1/2, in less than 10s) DEPTH: integrated skin sensors allows depth control for efficient ID, SC, IM injection ALARM: integrated alarm reminds the patient when it's time for injection SAFETY: the needle is never accessible, before, during and after injection. The needle trigger only when the device is in contact with the skin and retracts automatically after injection. AUTOMATIC REHYDRATION OF LYOPHILIZED DRUG Eveon Intuity®Lyo is a 2 steps reconstitution and injection system. It features: CUSTOMIZED MIXING options perfectly adapted to reconstitution and injection of biologics INTUITIVE design ANTI FOAMING PRECISE and ACCURATE dosage ECOFRIENDLY HIGHLY VISCOUS DRUGS INJECTION The fully automatic, plunger-free micropump based system allows fast injection of highly viscous drugs (1-100cp) with a slight pressure. Perfectly adapted to biologics (therapeutic proteins, monoclonal antibodies, the device ensure drug integrity while reducing the overall injection time by 5 compare to manual injection. EVEON OFFER Because each molecule requires specific care, EVEON offers development of customized injection medical devices from feasibility studies, co-development, up to manufacturing of clinical products
More

Contact

  • Firstname / Lastname :
    Valérie Roux-Jallet
  • Email :
    vrj@eveon.eu

Value chain

  • Clinical
  • Manufacturing / Production
  • Marketing / Distribution

Business Model

  • Product Developer - other health

Activities

  • Medical Device
  • Drug Delivery

Application Fields

  • Animal Health
  • Immunology
  • Infectious Diseases
  • Allergology
  • Genetic / Rare Diseases
  • Pediatrics
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Metabolic Diseases
  • Cancer
  • CNS related Diseases

Needs and interest

  • Commercial Development
Close

Evolva SA - SWITZERLAND

We seek to build a high growth, and sustainably profitable, company that is focused on the discovery and development of innovative products for the pharmaceutical and the consumer healthcare and nutrition sectors. We are maximising our technology platform to discover innovative products, rather that commodities, leveraging both our technological and corporate strengths. Innovative products can ste...
We seek to build a high growth, and sustainably profitable, company that is focused on the discovery and development of innovative products for the pharmaceutical and the consumer healthcare and nutrition sectors. We are maximising our technology platform to discover innovative products, rather that commodities, leveraging both our technological and corporate strengths. Innovative products can stem from novel compounds (novel chemical entities) or from novel production methods (biosynthesis or fermentation) but have as a common theme that they provide patients or consumers with medical or wellness benefits that existing products do not provide.
More

Contact

  • Firstname / Lastname :
    Pascal Longchamp
  • Job title :
    Chief Business Officer
  • Email :
    pascall@evolva.com
  • Phone :
    41 61 485 2000

Value chain

  • Preclinical
  • Clinical

Business Model

  • Product Developer - pharmaceuticals
  • Product Developer - biopharmaceuticals
  • Product Developer - other health

Activities

  • Drug Discovery

Application Fields

  • Animal Health
  • Human Health
  • Immunology
  • Infectious Diseases
  • Genetic / Rare Diseases
  • Nutrition / Food
  • Metabolic Diseases
  • Cancer
Close

FLAMEL Technologies - FRANCE

FLAMEL Technologies is a world leader in advanced delivery technologies for protein, peptide and small molecule drugs.
FLAMEL Technologies is a world leader in advanced delivery technologies for protein, peptide and small molecule drugs.
More

Contact

  • Firstname / Lastname :
    Gregoire Franoux
  • Job title :
    Director New Business Development
  • Email :
    franoux@flamel.com

Value chain

  • Preclinical
  • Clinical
  • Manufacturing / Production

Business Model

  • Product Developer - pharmaceuticals
  • Product Developer - biopharmaceuticals

Activities

  • Vaccine
  • Clinical Trials
  • Preclinical Trials
  • Drug Delivery
  • Nanotechnology

Application Fields

  • Animal Health
  • Human Health
  • Immunology
  • Infectious Diseases
  • Pediatrics
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Orhpan Diseases
  • Metabolic Diseases
  • Cancer

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
  • Commercial Development
Close

Foley & Lardner LLP - USA

Intellectual Property concerning biotech/chemical innovations.
Intellectual Property concerning biotech/chemical innovations.
More

Contact

Business Model

  • Other

Activities

  • Gene / Genomics
Close

FORMULA PHARMAINC - USA

Formula Pharmaceuticals is a privately-held, clinical stage biopharmaceutical company.Our Mission is to develop drug candidates which target large markets characterized by significant unmet medical needs, while providing investors with rapid time-to-value returns.We maximize the clinical opportunity and commercial value of promising drug candidates through excellence in drug development and strate...
Formula Pharmaceuticals is a privately-held, clinical stage biopharmaceutical company.Our Mission is to develop drug candidates which target large markets characterized by significant unmet medical needs, while providing investors with rapid time-to-value returns.We maximize the clinical opportunity and commercial value of promising drug candidates through excellence in drug development and strategic partnering.
More

Contact

Value chain

  • Clinical

Business Model

  • Product Developer - biopharmaceuticals

Activities

  • Vaccine

Application Fields

  • Human Health
  • Orhpan Diseases
  • Cancer

Needs and interest

  • R&d Partnership
Close

Foundation Venture Capital Group, LLC - USA

Foundation Venture Capital Group (FVCG), LLC, established in March 2006, invests in intellectual property developed by faculty at the University of Medicine and Dentistry of New Jersey. The company was initially funded by its affiliate, New Jersey Health Foundation. Because FVCG directly invests in the development of new start-ups that most likely would not have been formed without outside support...
Foundation Venture Capital Group (FVCG), LLC, established in March 2006, invests in intellectual property developed by faculty at the University of Medicine and Dentistry of New Jersey. The company was initially funded by its affiliate, New Jersey Health Foundation. Because FVCG directly invests in the development of new start-ups that most likely would not have been formed without outside support, it brings vital help to these companies to fund emerging medical breakthroughs in research and technology. To date, FVCG has seven start-up companies in its portfolio in the areas of life sciences and medicine including diagnostics. Once a company is established with seed funding, FVCG seeks to work with other traditional venture capital companies to help advance these technologies. For more information, visit FVCG’s website: http://www.foundationventure.com/ or contact Dr. Reza Razavi: rrazavi@njhf.org or at 908-315-5868. Current investments include: •Affineti Biologics, developing plaque-reducing dental hygiene products; • Actinobac Biomed Inc.,developing a therapeutic agent targeting blood cells for the treatment of hematological malignancies; • CellXplore, Inc., engaged in the development of biomarker-based in vitro diagnostic assays for cancer; • Celvive, Inc.,working to develop technology to treat patients with chronic spinal cord injuries with their own adult stem cells; • Durin Technologies, working to develop a blood test to diagnose Alzheimer’s disease; • Longevica Pharmaceuticals, Inc., developing a chemoprotective agent that may keep normal cells healthy during cancer treatments (FVCG’s equity interest in Longevica was recently sold to Rostock International, LTD, a subsidiary of a Moscow (Russia) based global investment firm); • Snowdon Pharmaceuticals, a drug discovery company focused on several major therapeutic areas
More

Contact

  • Firstname / Lastname :
    Reza Razavi
  • Job title :
    Director of New Ventures and Strategic Initiatives
  • Email :
    rrazavi@njhf.org

Value chain

  • Other

Business Model

  • Other

Activities

  • Diagnostics / Analysis Methods
  • Drug Discovery
  • Cell Therapy

Application Fields

  • Infectious Diseases
  • Autoimmune Diseases
  • Cancer
  • CNS related Diseases

Needs and interest

  • R&d Partnership
  • Commercial Development
Close

Frontier BioSciences, Inc. - CHINA

Frontier BioSciences, Inc., is a preclinical CRO in Chengdu, China, providing a full range of research services to pharmaceutical, biotechnology, and institutional researchers worldwide, from proof-of-concept and discovery, to GLP toxicology studies, designed for supporting submissions to China SFDA and U.S. FDA. Frontier’s in-house capabilities include safety and efficacy studies, PK/TK, Animal...
Frontier BioSciences, Inc., is a preclinical CRO in Chengdu, China, providing a full range of research services to pharmaceutical, biotechnology, and institutional researchers worldwide, from proof-of-concept and discovery, to GLP toxicology studies, designed for supporting submissions to China SFDA and U.S. FDA. Frontier’s in-house capabilities include safety and efficacy studies, PK/TK, Animal Models (Acute Radiation Syndrome, Ocular studies for AMD), General Toxicology, Developmental & Reproductive Toxicology, Safety Pharmacology, and Genetic Toxicology, supported by bioanalytical, clinical pathology, and histopathology services. The state-of-the art toxicology facilities encompass a total of 300,000 sq. ft. and are equipped with the latest advanced technology, and are operated by highly-trained and experienced staff with international CRO experience. Employing the best resources across a wide spectrum of scientific and regulatory expertise, Frontier would be your ideal research arm in accelerating the development of your drug.
More

Contact

  • Firstname / Lastname :
    Beth Wong
  • Job title :
    Vice President, Marketing & Business Development
  • Email :
    bwong@frontierbsi.com
  • Phone :
    3015155560

Value chain

  • Preclinical

Business Model

  • Service Provider - CRO

Activities

  • Preclinical Trials
  • Drug Discovery
  • Models (animal, cellular, ...)

Needs and interest

  • R&d Partnership
Close

Fusionview LLC - USA

FusionView LLC is a business development organization based out of Cambridge, MA, serving life sciences, energy and other high tech industries in US and international markets. FusionView works with Fortune 50 corporations, small and startup organizations and government delivering business development and marketing services with an emphasis on market entry implementation.
FusionView LLC is a business development organization based out of Cambridge, MA, serving life sciences, energy and other high tech industries in US and international markets. FusionView works with Fortune 50 corporations, small and startup organizations and government delivering business development and marketing services with an emphasis on market entry implementation.
More

Contact

  • Firstname / Lastname :
    Horacio Caperan
  • Job title :
    Managing Director
  • Email :
    hcaepran@fusionview.com
  • Phone :
    6173954298

Value chain

  • Preclinical
  • Clinical
  • Marketing / Distribution

Business Model

  • Service Provider - non scientifique

Activities

  • Vaccine
  • Drug Delivery
  • Models (animal, cellular, ...)
  • Nanotechnology

Application Fields

  • Animal Health
  • Human Health
  • Nutrition / Food

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
  • Commercial Development
Close

genOway - FRANCE

genOway designs and develops accurate discovery and preclinical rodent models for biopharmaceutical companies. More than 65 biotechnology companies and 6 of the Top10-pharmaceutical companies entrust genOway for the development of reliable and highly physiological in vivo models for target validation, drug screening, efficacy and safety testing. With more than 750 models generated, genOway has gat...
genOway designs and develops accurate discovery and preclinical rodent models for biopharmaceutical companies. More than 65 biotechnology companies and 6 of the Top10-pharmaceutical companies entrust genOway for the development of reliable and highly physiological in vivo models for target validation, drug screening, efficacy and safety testing. With more than 750 models generated, genOway has gathered a recognized expertise in the design, the creation and the management of accurate custom-made discovery and preclinical mouse models. genOway proposes a panel of proprietary technologies enabling the development of highly physiological in vivo models for target validation (kinase dead, RNAi, functional Knock-out, inducible systems), drug efficacy AND safety testing from the same mouse model (access to a Knock-out and a humanized models from the same line, etc.). The company provides an outstanding consulting activity for a thorough assessment of the risks and the performances of each project, while securing timelines by detecting and avoiding troublesome steps in the development process.
More

Contact

  • Firstname / Lastname :
    Kader Thiam
  • Job title :
    VP Transgenic Technologies
  • Email :
    info@genoway.com

Value chain

  • Preclinical

Business Model

  • Service Provider - scientifique

Activities

  • Models (animal, cellular, ...)

Application Fields

  • Human Health
  • Immunology
  • Infectious Diseases
  • Allergology
  • Genetic / Rare Diseases
  • Pediatrics
  • Geriatrics
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Metabolic Diseases
  • Cancer
  • CNS related Diseases
Close

GenScript - USA

GenScript is a fully biology focused/orientated CRO and are the largest biology CRO (>1000 employees) focusing on early drug discovery. GenScript are a stable, profitable company with strong VC financial backing from KPCB and will undergo major expansion later in 2011 with the opening of the new 325,000 sq.ft. Nanjing BioCenter. The GenScript team has the critical mass and high throughput capa...
GenScript is a fully biology focused/orientated CRO and are the largest biology CRO (>1000 employees) focusing on early drug discovery. GenScript are a stable, profitable company with strong VC financial backing from KPCB and will undergo major expansion later in 2011 with the opening of the new 325,000 sq.ft. Nanjing BioCenter. The GenScript team has the critical mass and high throughput capacity to fully serve and support pharmas bio-reagent generation requirements. We have strong upstream molecular biology reagent generation support with the largest global synthetic gene capacity of over 3.5 million bp/month. GenScript’s protein service group have a throughput of over 150 projects/month, with high capacity E.coli, Insect, Mammalian production platforms. We also possess strong integrated down-stream assay development and screening capacity. This allows protein reagent testing/validated in accordance with industry plate-based pharmacology standards including HTS formatting and optimization. Functional activity of expressed and purified material can be determined with accuracy and precision across a myriad of validated assay formats. GenScript can also integrate down-stream structure biology support from crystalization to x-ray data collection and analysis. Our independent, dedicated QC team ensures quality at every point along the production path and we have well established FTE-based models for optimal client communication, project flexibility and efficiency, streamlined operations with faster turnaround times, and maximized ROI for the client.
More

Contact

  • Firstname / Lastname :
    Brian Manning
  • Job title :
    Director, Business Development
  • Email :
    brianm@genscript.com

Value chain

  • Preclinical
  • Manufacturing / Production
  • Other

Business Model

  • Service Provider - CRO
  • Service Provider - scientifique
  • Laboratory Equipment Supplier

Activities

  • Gene / Genomics
  • Protein / Proteomics
  • Vaccine
  • Tissue / Cells
  • Imagery
  • Lab Equipment
  • Drug Discovery
  • Instrumentation
  • Models (animal, cellular, ...)
  • Biobank
  • Bioinformatics / Modeling

Application Fields

  • Animal Health
  • Human Health
  • Immunology
  • Infectious Diseases
  • Allergology
  • Nutrition / Food
  • Pediatrics
  • Geriatrics
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Orhpan Diseases
  • Metabolic Diseases
  • Cancer
  • Dermocosmetics
  • CNS related Diseases

Needs and interest

  • R&d Partnership
Close

Greater Memphis Chamber - USA

The broad-based collection of bioscience industries in the Memphis region employ close to 40,000 workers across more than 300 establishments, representing over six percent of the private employment in the region. This concentration of bioscience industry activity stands more than 30 percent higher than the national average. Memphis’ diverse network of institutions, organizations, incubators, cli...
The broad-based collection of bioscience industries in the Memphis region employ close to 40,000 workers across more than 300 establishments, representing over six percent of the private employment in the region. This concentration of bioscience industry activity stands more than 30 percent higher than the national average. Memphis’ diverse network of institutions, organizations, incubators, clinics and bioscience firms is known for its research and clinical excellence, its depth of skilled technicians and internationally-recognized scientists and its commitment to deepening and broadening the bioscience training available locally. Memphis offers bioscience firms and researchers: An established base of leading biomedical firms & clinical expertise. An extensive support network & opportunities for collaboration. The optimal infrastructure for collaboration, commercialization and getting goods to market. A favorable business climate.
More

Contact

  • Firstname / Lastname :
    Leigh Anne Downes
  • Job title :
    Director Life Science Business Development
  • Email :
    ldownes@memphischamber.com
  • Phone :
    901-543-3540

Value chain

  • Other

Business Model

  • Other

Activities

  • Other
Close

Grifols Engineering S.A. - SPAIN

Grifols Engineering is a company specialized in biotech and sterile manufacturing processes. Grifols Engineering offers consultancy and engineering services and also machinery development for the biotech industry (Ultrafiltration units, Filtration Skids, fermentors, CIP's, etc...) We have the know-how to design projects and specific machinery which comply with the European health authorities and t...
Grifols Engineering is a company specialized in biotech and sterile manufacturing processes. Grifols Engineering offers consultancy and engineering services and also machinery development for the biotech industry (Ultrafiltration units, Filtration Skids, fermentors, CIP's, etc...) We have the know-how to design projects and specific machinery which comply with the European health authorities and the US FDA
More

Contact

  • Firstname / Lastname :
    Oriol Argemi
  • Job title :
    Business Development Manager
  • Email :
    oriol.argemi@grifols.com
  • Phone :
    0034935710042

Value chain

  • Other

Business Model

  • Product Developer - pharmaceuticals
  • Product Developer - biopharmaceuticals

Activities

  • Biomanufacturing

Application Fields

  • Human Health

Needs and interest

  • Commercial Development
Close

Hadasit research services & development LTD - ISRAEL

medical researce services and development
medical researce services and development
More

Contact

Activities

  • Clinical Trials
Close

Harmonic Pharma - FRANCE

Company's core business is directed towards repurposing clinical or approved drugs in new therapeutic areas. The company offers an innovative solution, developed in 2011, which exploits spherical harmonic based representations of molecular entities for drug repositioning, and which currently draws on experimental in vitro/in vivo validations in four main therapeutic areas : Alzheimer disease, Infe...
Company's core business is directed towards repurposing clinical or approved drugs in new therapeutic areas. The company offers an innovative solution, developed in 2011, which exploits spherical harmonic based representations of molecular entities for drug repositioning, and which currently draws on experimental in vitro/in vivo validations in four main therapeutic areas : Alzheimer disease, Infectious diseases, Diabetes associated diseases, and Cancer.
More

Contact

Value chain

  • Research

Business Model

  • Service Provider - CRO
  • Service Provider - scientifique

Activities

  • Drug Discovery
  • Other

Application Fields

  • Infectious Diseases
  • Metabolic Diseases
  • Cancer
  • CNS related Diseases

Needs and interest

  • R&d Partnership
  • Commercial Development
Close

HELIOS BIOSCIENCES - FRANCE

Helios BioSciences is an independent biotechnology company focused on the characterization of therapeutic targets and biomarkers. Since 2002, the company has developed an outstanding platform of modeling based on a new and patented technology. The technology is designed to address multifactorial diseases and to help industrials in ranking putative targets and combinations of putative targets. The ...
Helios BioSciences is an independent biotechnology company focused on the characterization of therapeutic targets and biomarkers. Since 2002, the company has developed an outstanding platform of modeling based on a new and patented technology. The technology is designed to address multifactorial diseases and to help industrials in ranking putative targets and combinations of putative targets. The technology is also designed to help industrials in defining the causality of biomarkers and defining biomarkers useful in the stratification of patients. Dynamic models of immuno-stimulation (Immunodyn) and neuro-degenerative disease (Neuraptodyn) have been built. With Immunodyn, six putative immuno- supressive therapeutic targets have been selected and experimentally validated. With Neuraptodyn, a couple of putative therapeutic targets have been characterized and are in the course of experimental validation. Our technology is used by pharmas and cosmectic companies. We offer a variety of opportunities to access to our technology and are very flexible. For instance, we can: • Select or prioritize therapeutic targets after having built a dedicated dynamic model. • Build and deliver dynamic models dedicated to your therapeutic questions. Prioritization of therapeutic targets and/or biomarkers evaluations can be conducted internally
More

Contact

Value chain

  • Research

Business Model

  • Service Provider - CRO
  • Service Provider - scientifique

Activities

  • Gene / Genomics
  • Drug Discovery
  • Bioinformatics / Modeling

Application Fields

  • Immunology
  • Allergology
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Cancer
  • Dermocosmetics
  • CNS related Diseases

Needs and interest

  • R&d Partnership
  • Commercial Development
Close

Hemarina - FRANCE

Hemarina is a biotechnology company developing a new generation of oxygen-carrier for therapeutical and industrial applications
Hemarina is a biotechnology company developing a new generation of oxygen-carrier for therapeutical and industrial applications
More

Contact

Value chain

  • Research

Business Model

  • Product Developer - biopharmaceuticals

Activities

  • Protein / Proteomics
  • Tissue / Cells
  • Medical Device

Application Fields

  • Animal Health
  • Human Health
  • Dermocosmetics

Needs and interest

  • R&d Partnership
  • Commercial Development
Close

IGR&D - FRANCE

Technology transfer office of the Institut Gustave Roussy comprehensive cancer center in France Villejuif
Technology transfer office of the Institut Gustave Roussy comprehensive cancer center in France Villejuif
More

Contact

  • Firstname / Lastname :
    Isabelle Pelletier-Bressac
  • Job title :
    Manager
  • Email :
    rechdev@igr.fr

Value chain

  • Research
  • Preclinical

Activities

  • Preclinical Trials
  • Models (animal, cellular, ...)
  • Biobank

Application Fields

  • Cancer

Needs and interest

  • R&d Partnership
Close

ImaBiotech - FRANCE

ImaBiotech offers unique services with unique molecular imaging techniques
ImaBiotech offers unique services with unique molecular imaging techniques
More

Contact

Value chain

  • Research
  • Preclinical

Business Model

  • Service Provider - CRO
  • Service Provider - scientifique

Activities

  • Protein / Proteomics
  • Tissue / Cells
  • Imagery
  • Preclinical Trials
  • Drug Discovery

Application Fields

  • Animal Health
  • Human Health
  • Immunology
  • Infectious Diseases
  • Allergology
  • Genetic / Rare Diseases
  • Nutrition / Food
  • Pediatrics
  • Inflammatory Diseases
  • Orhpan Diseases
  • Metabolic Diseases
  • Cancer
  • CNS related Diseases

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
Close

ImmunID Technologies - FRANCE

ImmunID is a molecular diagnostics company that uses the immune repertoire diversity as a dynamic biomarker. Our team is dedicated to bringing solutions for the assessment of the efficacy and safety of immunomodulators during clinical trials and for patient stratification, in the areas of Oncology and Infectious Diseases. ImmunID recently introduced the innovative concept of divpenia® (www.divpen...
ImmunID is a molecular diagnostics company that uses the immune repertoire diversity as a dynamic biomarker. Our team is dedicated to bringing solutions for the assessment of the efficacy and safety of immunomodulators during clinical trials and for patient stratification, in the areas of Oncology and Infectious Diseases. ImmunID recently introduced the innovative concept of divpenia® (www.divpenia.com), a clinical state of reduced T & B lymphocytes immune diversity that correlates with a higher risk of infection & mortality and a reduced treatment efficiency. Depending on the indication, divpenia® can be used as a biomarker for early diagnosis, prognosis, response to treatment monitoring (efficiency and safety) & prediction and for patient stratification. ImmunID is currently conducting trials for the clinical validation of divpenia® in Lymphoma, Leukemia and metastatic Breast Cancer. We are also working for several biotech and pharma companies in additional indications, including HIV, HCV, and Transplant.
More

Contact

  • Firstname / Lastname :
    Isabelle Tanneau
  • Job title :
    Scientific Sales Manager - North America
  • Email :
    itanneau@immunid.com

Business Model

  • Other

Activities

  • Diagnostics / Analysis Methods
  • Clinical Trials

Application Fields

  • Immunology
  • Infectious Diseases
  • Cancer

Needs and interest

  • R&d Partnership
Close

ImmunID Technologies - FRANCE

More

Contact

  • Firstname / Lastname :
    Nadia Plantier
  • Job title :
    Director, External Collaborations and Business Development
  • Email :
    nplantier@immunid.com

Value chain

  • Research
  • Preclinical
  • Clinical
  • Manufacturing / Production
  • Marketing / Distribution

Business Model

  • Service Provider - scientifique

Activities

  • Diagnostics / Analysis Methods
  • Clinical Trials

Application Fields

  • Immunology
  • Infectious Diseases
  • Cancer

Needs and interest

  • R&d Partnership
Close

ImmunID Technologies - FRANCE

More

Contact

Value chain

  • Research
  • Preclinical
  • Clinical

Activities

  • Diagnostics / Analysis Methods
  • Clinical Trials

Application Fields

  • Immunology
  • Infectious Diseases
  • Cancer

Needs and interest

  • R&d Partnership
Close

ImmunoGenes AG - SWITZERLAND

ImmunoGenes is a biopharmaceutical company specialized in the generation of transgenic animals for the production of polyclonal and monoclonal antibodies. Antibody production is time consuming and has a tendency to generate low yields all of which costs antibody manufacturers time and money. ImmunoGenes’ solution is a genetic modification that leads to the overexpression of a particular receptor...
ImmunoGenes is a biopharmaceutical company specialized in the generation of transgenic animals for the production of polyclonal and monoclonal antibodies. Antibody production is time consuming and has a tendency to generate low yields all of which costs antibody manufacturers time and money. ImmunoGenes’ solution is a genetic modification that leads to the overexpression of a particular receptor (FcRn). This receptor overexpression, in turn, makes these animals ideal for the production of high antibody yields with very low levels of degradation. Using such animals, sufficient quantities of polyclonal antibodies can be harvested far faster than using standard techniques. FcRn overexpression not only extends the IgG half-life, but also enhances the expansion of antigen-specific B cells and plasma cells, thus offering major advantages in monoclonal antibody production where the goal is to generate a large antigen-specific B-cell pool from the spleen to form hybridomas against weakly immunogenic proteins and peptides.
More

Contact

Value chain

  • Research
  • Preclinical

Business Model

  • Product Developer - pharmaceuticals
  • Product Developer - biopharmaceuticals

Activities

  • Vaccine
  • Drug Discovery
  • Models (animal, cellular, ...)

Application Fields

  • Immunology
  • Infectious Diseases
  • Autoimmune Diseases
  • Cancer

Needs and interest

  • R&d Partnership
Close

IN-CELL-ART - FRANCE

IN CELL ART, which is headquartered in Nantes (France) is a biopharmaceutical company specializing in the preclinical and pharmaceutical development of nanocarriers for macromolecular drugs. Its founder and research team, which includes a Nobel Laureate, have designed new classes of vectors that are organized on a nanometric scale, which enables them to cross the cell barrier efficiently and safel...
IN CELL ART, which is headquartered in Nantes (France) is a biopharmaceutical company specializing in the preclinical and pharmaceutical development of nanocarriers for macromolecular drugs. Its founder and research team, which includes a Nobel Laureate, have designed new classes of vectors that are organized on a nanometric scale, which enables them to cross the cell barrier efficiently and safely. IN CELL ART offers a range of reagents and biotechnology development services: -ICANtibodies®: In the absence of recombinant antigen, ICANtibodies® allows, from an in silico DNA antigenic sequence, the production of the most ambitious functional antibodies against any natively expressed nuclear, cytoplasmic, secreted or membrane proteins. ICANtibodies® has allowed, in less than 2 years, the production of more than 100 different functional antibodies (Sanofi-Aventis, Merial, TCL Pharma, Geneuro, InnavirVax, Cancer Research UK, Institute of Neurology of London etc. ...) -ICAFectin® transfection reagents: ICAFectin® transfection reagents are innovative breakthrough synthetic vectors for in vitro nucleic acid delivery. They are becoming the reagents of choice for efficient DNA and siRNA transfections as demonstrated by their increasing use in numerous studies published in high impact factor journals including Journal of Biological Chemistry, Nucleic Acids Research, PLOS ONE, PLOS Pathogen, Human Gene Therapy, Journal of Neurochemistry, Experimental Cell Research, Neoplasia
More

Contact

Value chain

  • Research
  • Preclinical
  • Manufacturing / Production

Business Model

  • Service Provider - CRO
  • Product Developer - biopharmaceuticals

Activities

  • Vaccine
  • Diagnostics / Analysis Methods
  • Drug Delivery
  • Nanotechnology

Application Fields

  • Human Health
  • Immunology
  • Infectious Diseases
  • Genetic / Rare Diseases
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Metabolic Diseases
  • Cancer

Needs and interest

  • Commercial Alliance - Comarketing
  • Commercial Development
Close

IN-CELL-ART - FRANCE

More

Contact

Activities

  • Vaccine
  • Diagnostics / Analysis Methods
  • Drug Discovery
  • Drug Delivery
  • Nanotechnology
Close

Indicia Biotechnology - FRANCE

Indicia Biotechnology is positioning itself as a specialist in immunotechnology and biochemistry. The company provides R&D contract services to biopharmaceutical & diagnostic companies to support their research and development of bioanalytical methods. Our services: 1- Customized solutions for Immunomonitoring, Immunogenicity risk assessment and Biomarker identification 2- Development...

Indicia Biotechnology is positioning itself as a specialist in immunotechnology and biochemistry. The company provides R&D contract services to biopharmaceutical & diagnostic companies to support their research and development of bioanalytical methods. Our services: 1- Customized solutions for Immunomonitoring, Immunogenicity risk assessment and Biomarker identification 2- Development of tailored-made immunoassays (companion diagnostic tests, assay for biomarkers, QC methods...) 3- Development of polyclonal and monoclonal antibodies 4- OEM Manufacturing of diagnostic reagents, API, cell culture media...

Indicia Biotechnology, as a unique CRO, has been offering for more than ten years a wide panel of services in proteomic, ranging from immunoassay development to sample analysis. The company offers span the entire drug development process. In particular, Indicia addresses unmet needs in biomarker identification, characterization, and immunogenicity assessment. Indicia Biotechnology gives access to its expertise on cutting edge technologies as well as conventional ones: - Erenna from Singulex® that allows biomarker quantification at the femtogram level, - xMAPTM from Luminex® (multiplexed assay), - Lateral flow test (immunochromatography), - ELISA, - Development and production of customized polyclonal and monoclonal antibodies and related services. Through its partnering with Singulex Inc., Indicia Biotechnology provides technical solutions for protein quantification at a level that has never been reached so far. This ultrasensitive immunoassay permits the measurement of proteins at the femtogram level in various biological fluids. Indicia Biotechnology proposes not only custom assay developments, but also sample testing. The Erenna system proposes a menu of 50 proteins involved in five therapeutic domains (inflammatory, oncology, metabolic, neurology, cardiology). Indicia Biotechnology is an ISO 9001/ISO 13485 certified company and meet GMP guidelines.

More

Contact

  • Firstname / Lastname :
    Stéphane Legastelois
  • Job title :
    President and CEO
  • Email :
    slegastelois@indicia.fr
  • Phone :
    +33(0)472391492

Value chain

  • Research
  • Preclinical
  • Clinical
  • Manufacturing / Production

Business Model

  • Service Provider - CRO
  • Service Provider - scientifique
  • Product Developer - biopharmaceuticals
  • Product Developer - other health

Activities

  • Protein / Proteomics
  • Diagnostics / Analysis Methods

Application Fields

  • Immunology

Needs and interest

  • R&d Partnership
  • Commercial Development
Close

InGen BioSciences - FRANCE

The InGen BioSciences Group is a private integrated In Vitro Diagnostics (IVD) company with headquarters in France developing and marketing innovative diagnostic kits for clinical use, especially in the areas of infectious diseases and immunology. The company's competence and expertise range from product inception to commercialization, including regulatory affairs. Its current customers are hospit...
The InGen BioSciences Group is a private integrated In Vitro Diagnostics (IVD) company with headquarters in France developing and marketing innovative diagnostic kits for clinical use, especially in the areas of infectious diseases and immunology. The company's competence and expertise range from product inception to commercialization, including regulatory affairs. Its current customers are hospitals, private laboratories, blood transfusion services and research laboratories. Revenues reached EUR 21M in 2010. The group is situated in the Paris metropolitan area and employs 65 people.
More

Contact

Activities

  • Protein / Proteomics
  • Diagnostics / Analysis Methods
Close

InGen BioSciences - FRANCE

More

Contact

Activities

  • Protein / Proteomics
  • Diagnostics / Analysis Methods
Close

InGen BioSciences - FRANCE

More

Contact

Activities

  • Protein / Proteomics
  • Diagnostics / Analysis Methods
Close

Inno Bio Ventures Sdn Bhd - MALAYSIA

Inno Biologics is a globally operating Contract Manufacturer for monoclonal antibodies and therapeutic proteins with state-of-the-art cGMP Manufacturing Facility. Our multiproduct mammalian cell culture facility has been designed in compliance with both EMEA and US FDA guidelines. The single train cGMP facility houses 200L and 1,000L production bioreactors, associated inoculums suite and prim...

Inno Biologics is a globally operating Contract Manufacturer for monoclonal antibodies and therapeutic proteins with state-of-the-art cGMP Manufacturing Facility. Our multiproduct mammalian cell culture facility has been designed in compliance with both EMEA and US FDA guidelines. The single train cGMP facility houses 200L and 1,000L production bioreactors, associated inoculums suite and primary recovery equipment for efficient cell removal and concentration. Following initial cell removal and product concentration, purification is performed in pre and post viral purification suites. We are proud to offer highly flexible purification systems to allow a wide variety of chromatographic techniques to be applied. Our exceptional combination of upstream and downstream processing areas and technologies have been designed to provide maximum flexibility and capacity to meet the needs of clients requiring biomanufacturing services in all phases of clinical trials all according to the Good Manufacturing Practices (GMPs) guidelines.

More

Contact

Value chain

  • Manufacturing / Production

Business Model

  • Service Provider - CMO

Activities

  • Biomanufacturing
  • Preclinical Trials

Application Fields

  • Human Health
Close

Inno Bio Ventures Sdn Bhd - MALAYSIA

More

Contact

  • Firstname / Lastname :
    Sakinah Jamil
  • Job title :
    Manager Business Development
  • Email :
    sakinahjamil@gmail.com
  • Phone :
    +60 320813000

Value chain

  • Manufacturing / Production

Business Model

  • Service Provider - CRO
  • Service Provider - CMO

Activities

  • Biomanufacturing
Close

Innovation & International Relationship - FRANCE

Strategic Consulting
Strategic Consulting
More

Contact

Value chain

  • Other

Business Model

  • Other

Activities

  • Vaccine
  • Imagery
  • Medical Device

Application Fields

  • Human Health

Needs and interest

  • R&d Partnership
Close

Institut Merieux - FRANCE

Institut Mérieux is committing its experience in industrial biology to serve medicine and public health across the globe. To fight against infectious diseases and cancers, it imagines and develops new approaches in the fields of diagnostics, immunotherapy, food safety and nutrition.. Its three bio-industrial companies: bioMérieux, Transgene and Mérieux NutriSciences, working closely with its en...
Institut Mérieux is committing its experience in industrial biology to serve medicine and public health across the globe. To fight against infectious diseases and cancers, it imagines and develops new approaches in the fields of diagnostics, immunotherapy, food safety and nutrition.. Its three bio-industrial companies: bioMérieux, Transgene and Mérieux NutriSciences, working closely with its entities devoted to innovation, such as ABL Inc and Mérieux Développement, have enabled major advances in medicine and public health. Throughout the world, it aims to make these solutions accessible to the greatest number of people. It has in particular created IMAccess, a company devoted to diagnostics for developing countries and working biology without borders.
More

Contact

Value chain

  • Research
  • Preclinical
  • Clinical
  • Manufacturing / Production

Business Model

  • Product Developer - biopharmaceuticals
  • Product Developer - other health

Activities

  • Gene / Genomics
  • Protein / Proteomics
  • Chemistry
  • Vaccine
  • Lab Equipment
  • Diagnostics / Analysis Methods
  • Biomanufacturing
  • Drug Discovery
  • Medical Device
  • Instrumentation
  • Bioinformatics / Modeling
  • Nanotechnology

Application Fields

  • Human Health
  • Immunology
  • Infectious Diseases
  • Nutrition / Food
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Cancer

Needs and interest

  • R&d Partnership
Close

Ipsen Group - FRANCE

Ipsen is a global biopharmaceutical group, with sales exceeding €1.1 billion in 2010. The Group has total worldwide staff of more than 4,400 employees, of which more than 900 contribute to the discovery and development of innovative drugs for patient care. Ipsen’s development strategy is based on fast growing specialty care drugs in oncology, endocrinology, neurology and hematology and on prim...
Ipsen is a global biopharmaceutical group, with sales exceeding €1.1 billion in 2010. The Group has total worldwide staff of more than 4,400 employees, of which more than 900 contribute to the discovery and development of innovative drugs for patient care. Ipsen’s development strategy is based on fast growing specialty care drugs in oncology, endocrinology, neurology and hematology and on primary care drugs. This strategy is supported by an active policy of partnerships. Ipsen’s research & development (R&D) centers and its peptide & protein engineering platform give the Group a strong competitive edge. In 2010, R&D expenditure totaled more than €220 million, above 20% of Group sales. Ipsen’s shares are traded on segment A of Euronext Paris (stock code: IPN, ISIN code: FR0010259150) and eligible to the “Service de Règlement Différé” (“SRD”). The Group is part of the SBF 120 index. Ipsen has implemented a Sponsored Level I American Depositary Receipt (ADR) program, which trade on the overthe- counter market in the United States under the symbol IPSEY. For more information on Ipsen, visit www.ipsen.com.
More

Contact

Value chain

  • Marketing / Distribution

Business Model

  • Product Developer - biopharmaceuticals

Activities

  • Protein / Proteomics
  • Biomanufacturing

Application Fields

  • Human Health
  • Cancer
  • CNS related Diseases

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
  • Commercial Development
Close

Katten Muchin Rosenman - USA

Legal services associated with the commercialization and protection of biotechnology innovations.
Legal services associated with the commercialization and protection of biotechnology innovations.
More

Contact

Business Model

  • Service Provider - scientifique
  • Service Provider - non scientifique

Activities

  • Gene / Genomics
  • Protein / Proteomics
  • Vaccine
  • Tissue / Cells
  • Biomanufacturing
  • Drug Discovery
  • Drug Delivery
  • Cell Therapy
  • Models (animal, cellular, ...)
  • Biobank
  • Bioinformatics / Modeling

Application Fields

  • Animal Health
  • Human Health
  • Immunology
  • Infectious Diseases
  • Allergology
  • Genetic / Rare Diseases
  • Nutrition / Food
  • Pediatrics
  • Geriatrics
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Orhpan Diseases
  • Metabolic Diseases
  • Cancer
  • CNS related Diseases

Needs and interest

  • Commercial Alliance - Comarketing
Close

Keyrus Biopharma - FRANCE

Founded in 1998 Keyrus Biopharma, a European Clinical Research Organization, shares its experience pharmaceuticals company. With more than 170 employees skilled in various therapeutic area, we are able to provide you with a full range of services fulfilling your clinical trials needs.

As a Contract Research Organisation (CRO) and major player in clinical research, Keyrus Biopharm...

Founded in 1998 Keyrus Biopharma, a European Clinical Research Organization, shares its experience pharmaceuticals company. With more than 170 employees skilled in various therapeutic area, we are able to provide you with a full range of services fulfilling your clinical trials needs.

As a Contract Research Organisation (CRO) and major player in clinical research, Keyrus Biopharma has been assisting the pharmaceutical industry for over 10 years in the development of their drugs. Today, Keyrus Biopharma provides expertise and consultancy in all clinical research areas on the basis of this experience and has adapted to the requirements of new environments / areas such as nutrition, biotechnology, cosmetology and medical devices.

More

Contact

Value chain

  • Clinical

Business Model

  • Service Provider - CRO

Activities

  • Clinical Trials

Application Fields

  • Human Health
  • Immunology
  • Infectious Diseases
  • Allergology
  • Genetic / Rare Diseases
  • Nutrition / Food
  • Inflammatory Diseases
  • Metabolic Diseases
  • Cancer
  • Dermocosmetics
  • CNS related Diseases

Needs and interest

  • Commercial Development
Close

keyrus biopharma - FRANCE

More

Contact

Value chain

  • Clinical

Business Model

  • Service Provider - CRO

Activities

  • Vaccine
  • Tissue / Cells
  • Clinical Trials
  • Medical Device
  • Cell Therapy

Application Fields

  • Animal Health
  • Human Health
  • Immunology
  • Infectious Diseases
  • Allergology
  • Genetic / Rare Diseases
  • Nutrition / Food
  • Pediatrics
  • Geriatrics
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Orhpan Diseases
  • Metabolic Diseases
  • Cancer
  • Dermocosmetics
  • CNS related Diseases
Close

Koronis Pharmaceuticals Inc - USA

Antivirals based on disruptive innovation with lead compound for the treatment of HIV
Antivirals based on disruptive innovation with lead compound for the treatment of HIV
More

Contact

Value chain

  • Clinical

Business Model

  • Product Developer - pharmaceuticals

Activities

  • Clinical Trials

Application Fields

  • Infectious Diseases

Needs and interest

  • R&d Partnership
Close

Laboratoire S.Lasnier - FRANCE

Research and development specialized in neurosciences. Licensed a new medicine for Alzheimer disease.
Research and development specialized in neurosciences. Licensed a new medicine for Alzheimer disease.
More

Contact

Value chain

  • Research
  • Preclinical
  • Clinical

Business Model

  • Product Developer - biopharmaceuticals

Activities

  • Clinical Trials
  • Drug Discovery

Application Fields

  • CNS related Diseases

Needs and interest

  • R&d Partnership
Close

Lowe Hauptman Ham & Berner, LLP - USA

Legal services related to US patents
Legal services related to US patents
More

Contact

  • Firstname / Lastname :
    Sean Passino
  • Job title :
    Director
  • Email :
    spassino@ipfirm.com
  • Phone :
    703-684-1111

Value chain

  • Other

Business Model

  • Service Provider - non scientifique

Activities

  • Gene / Genomics
  • Chemistry
  • Nanotechnology
Close

Lykera Biotech - SPAIN

Lykera is a privately held biotech company based in Barcelona, Spain. The Company is developing biologics for the treatment of cancer by targeting not only the tumour cells but also the stromal cells and tumour angiogenesis. Lykera’s vision stands for bringing innovative therapies for cancer treatment based on a global view of cancer.
Lykera is a privately held biotech company based in Barcelona, Spain. The Company is developing biologics for the treatment of cancer by targeting not only the tumour cells but also the stromal cells and tumour angiogenesis. Lykera’s vision stands for bringing innovative therapies for cancer treatment based on a global view of cancer.
More

Contact

Value chain

  • Research

Business Model

  • Product Developer - pharmaceuticals
  • Product Developer - biopharmaceuticals

Activities

  • Tissue / Cells
  • Diagnostics / Analysis Methods
  • Preclinical Trials
  • Drug Discovery
  • Drug Delivery
  • Models (animal, cellular, ...)

Application Fields

  • Cancer

Needs and interest

  • R&d Partnership
Close

MassGlobal Partners - USA

MassGlobal Partners helps companies, organizations and governments innovate and grow by facilitating and advancing international collaborations in life science, technology and other innovation-driven sectors.We believe that successful commercial application of new technology is a global enterprise. As such, companies and organizations need to think and act globally - even from early stages of deve...
MassGlobal Partners helps companies, organizations and governments innovate and grow by facilitating and advancing international collaborations in life science, technology and other innovation-driven sectors.We believe that successful commercial application of new technology is a global enterprise. As such, companies and organizations need to think and act globally - even from early stages of development - and need to establish global networks with other organizations, researchers, collaborators etc. in order to successfully accelerate their growth. MassGlobal offers individualized programs including: cluster development, benchmarking, feasibility studies, training for US market entry, partnering, identifying financing sources, market intelligence and more. Our clients include regional governmental organizations, individual companies and as well as trade organizations and technology parks.
More

Contact

Value chain

  • Marketing / Distribution

Business Model

  • Service Provider - scientifique
  • Service Provider - non scientifique

Activities

  • Other

Application Fields

  • Animal Health
  • Human Health

Needs and interest

  • Commercial Alliance - Comarketing
  • Commercial Development
Close

MEDINCELL - FRANCE

Medincell is a leading biopharmaceutical company that offers innovative technologies in Drug Delivery. Medincell core business consists in designing long acting formulations of drugs, allowing only one administration of active pharmaceutical ingredients with a therapeutic effect ranging from a couple of days to many months.
Medincell is a leading biopharmaceutical company that offers innovative technologies in Drug Delivery. Medincell core business consists in designing long acting formulations of drugs, allowing only one administration of active pharmaceutical ingredients with a therapeutic effect ranging from a couple of days to many months.
More

Contact

Value chain

  • Research
  • Preclinical

Business Model

  • Product Developer - pharmaceuticals
  • Product Developer - biopharmaceuticals
  • Product Developer - other health

Activities

  • Drug Delivery

Application Fields

  • Human Health
  • Immunology
  • Infectious Diseases
  • Allergology
  • Pediatrics
  • Geriatrics
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Orhpan Diseases
  • Metabolic Diseases
  • Cancer
  • CNS related Diseases

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
  • Commercial Development
Close

MEDIT US - USA

MEDIT SA provides an innovative software approach to address the Chemo-Proteomic challenge. Combining experimental biostructural data and MEDIT cheminformatics in smart protocols opens applications for 1-Allosteric site detection, 2-Functional annotation, 3-Binding site characterization and selectivity assessment, 4-Target druggability, 5-Off target identification, 6-Drug repurposing , 7-Scaffold ...
MEDIT SA provides an innovative software approach to address the Chemo-Proteomic challenge. Combining experimental biostructural data and MEDIT cheminformatics in smart protocols opens applications for 1-Allosteric site detection, 2-Functional annotation, 3-Binding site characterization and selectivity assessment, 4-Target druggability, 5-Off target identification, 6-Drug repurposing , 7-Scaffold hopping, 8-Bioisosterism replacement, 9-Fragment binding prediction, 10-Fragment-based drug design, 11-Protein-protein interactions.
More

Contact

  • Firstname / Lastname :
    Stephane Richard
  • Job title :
    VP Business Development
  • Email :
    srichard@medit.fr
  • Phone :
    +18583426807

Business Model

  • Product Developer - biopharmaceuticals

Activities

  • Drug Discovery
  • Bioinformatics / Modeling

Application Fields

  • Human Health
  • Infectious Diseases
  • Genetic / Rare Diseases
  • Inflammatory Diseases
  • Orhpan Diseases
  • Metabolic Diseases
  • Cancer

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
  • Commercial Development
Close

MilleGen - FRANCE

Millegen is expert in discovery and genetic engineering of therapeutic antibodies. MilleGen's antibody platform allows the generation of fully human monoclonal antibodies and lead optimization using a powerful Directed Molecular Evolution technology. Our specificity is to have a proprietary library comprising several billion different fully human antibodies with an original diversity. Our efficien...
Millegen is expert in discovery and genetic engineering of therapeutic antibodies. MilleGen's antibody platform allows the generation of fully human monoclonal antibodies and lead optimization using a powerful Directed Molecular Evolution technology. Our specificity is to have a proprietary library comprising several billion different fully human antibodies with an original diversity. Our efficiency was proven through several successful projects with industrial partners. MilleGen has built a pipeline of therapeutic antibodies. We are looking to associate human antibody candidates to original targets to develop with you a targeted therapy.
More

Contact

  • Firstname / Lastname :
    Anne DEFLISQUE
  • Job title :
    Business development manager
  • Email :
    anne.deflisque@millegen.com
  • Phone :
    +33 (0)5 61 28 73 74

Value chain

  • Research
  • Preclinical

Business Model

  • Service Provider - CRO
  • Product Developer - biopharmaceuticals

Activities

  • Drug Discovery

Application Fields

  • Human Health
  • Cancer
Close

Millegen SA - FRANCE

More

Contact

Value chain

  • Research

Business Model

  • Product Developer - biopharmaceuticals

Activities

  • Drug Discovery

Application Fields

  • Human Health
  • Cancer

Needs and interest

  • R&d Partnership
Close

Molecular Profiles Ltd. - UNITED KINGDOM

At Molecular Profiles, we provide pharmaceutical development services and consulting expertise to pharmaceutical companies worldwide. With trusted expertise in formulation development, clinical trial manufacturing, advanced analytical techniques and solid state characterization, we offer fast, flexible services customized to your needs.
At Molecular Profiles, we provide pharmaceutical development services and consulting expertise to pharmaceutical companies worldwide. With trusted expertise in formulation development, clinical trial manufacturing, advanced analytical techniques and solid state characterization, we offer fast, flexible services customized to your needs.
More

Contact

Value chain

  • Research

Business Model

  • Service Provider - CRO

Activities

  • Drug Delivery

Application Fields

  • Human Health
  • Immunology
  • Infectious Diseases
  • Pediatrics
  • Inflammatory Diseases
  • Orhpan Diseases
  • Cancer
  • CNS related Diseases

Needs and interest

  • Commercial Development
Close

Molecular Profiles Ltd. - UNITED KINGDOM

More

Contact

Value chain

  • Research

Business Model

  • Service Provider - CRO

Activities

  • Drug Delivery
Close

nanovector srl - ITALY

NANOVECTOR is a research company, with specific expertise in Microemulsions (µEs) and in Solid Lipid Nanoparticles (SLNs) obtained by proprietary method from warm µEs. Company’s core business is to exploit its lipid colloidal carriers for drug delivery in Pharmaceutics and Diagnostics. Recent results in Ophthalmology for delivery to the back of the eye Novel application in Nutracuetics
NANOVECTOR is a research company, with specific expertise in Microemulsions (µEs) and in Solid Lipid Nanoparticles (SLNs) obtained by proprietary method from warm µEs. Company’s core business is to exploit its lipid colloidal carriers for drug delivery in Pharmaceutics and Diagnostics. Recent results in Ophthalmology for delivery to the back of the eye Novel application in Nutracuetics
More

Contact

Value chain

  • Research
  • Manufacturing / Production

Business Model

  • Service Provider - scientifique
  • Product Developer - pharmaceuticals
  • Product Developer - other health

Activities

  • Drug Delivery
  • Nanotechnology

Application Fields

  • Nutrition / Food
  • Inflammatory Diseases
  • Orhpan Diseases
  • Cancer
  • Dermocosmetics
  • CNS related Diseases

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
  • Commercial Development
Close

NaugaNeedles - USA

NaugaNeedles
NaugaNeedles
More

Contact

Value chain

  • Research
  • Manufacturing / Production

Business Model

  • Laboratory Equipment Supplier

Activities

  • Lab Equipment
  • Nanotechnology
Close

NETRIS Pharma - FRANCE

NETRIS Pharma is a biotech company pioneer in the characterization and development of drug candidates targeting the Dependence Receptors pathway. The therapeutic area of the company is oncology. The therapeutic approaches are based on cellular mechanisms identified by a world-renowned research group and have not yet been explored by the pharmaceutical industry. NETRIS Pharma evaluates and optimize...
NETRIS Pharma is a biotech company pioneer in the characterization and development of drug candidates targeting the Dependence Receptors pathway. The therapeutic area of the company is oncology. The therapeutic approaches are based on cellular mechanisms identified by a world-renowned research group and have not yet been explored by the pharmaceutical industry. NETRIS Pharma evaluates and optimizes several drug candidates in both in vitro and in vivo models, integrating early pharmacokinetic and toxicological aspects. The company proposes licensing and collaborative agreements to the pharmaceutical industry looking for innovative targets in the field of cancer therapy. NETRIS Pharma has several drug candidates that target different pairs “dependence receptor/ligand” in its pipeline. These candidates are at various stages of development: from animal proof of concept to preclinical development.
More

Contact

Value chain

  • Research
  • Preclinical

Business Model

  • Product Developer - pharmaceuticals

Activities

  • Drug Discovery
  • Models (animal, cellular, ...)

Application Fields

  • Cancer

Needs and interest

  • R&d Partnership
  • Commercial Development
Close

Noble Life Sciences - USA

Noble Life Sciences provides a continuum of preclinical research services, including a proven process for the selection and validation of biomarkers, preclinical experimental design and testing, cellular- and animal-based disease models as well as a best-in-class vivarium -- to support therapeutic and diagnostic discoveries for personalized medicine.
Noble Life Sciences provides a continuum of preclinical research services, including a proven process for the selection and validation of biomarkers, preclinical experimental design and testing, cellular- and animal-based disease models as well as a best-in-class vivarium -- to support therapeutic and diagnostic discoveries for personalized medicine.
More

Contact

  • Firstname / Lastname :
    Tom Ng
  • Job title :
    Director of Business Development
  • Email :
    tng@noblelifesci.com
  • Phone :
    3018060127

Value chain

  • Research
  • Preclinical

Business Model

  • Service Provider - CRO

Activities

  • Gene / Genomics
  • Chemistry
  • Tissue / Cells
  • Diagnostics / Analysis Methods
  • Preclinical Trials
  • Models (animal, cellular, ...)
  • Biobank
  • Bioinformatics / Modeling

Application Fields

  • Human Health
  • Infectious Diseases
  • Cancer
Close

Noble Life Sciences - USA

More

Contact

Value chain

  • Research
  • Preclinical

Business Model

  • Service Provider - CRO

Activities

  • Gene / Genomics
  • Chemistry
  • Tissue / Cells
  • Diagnostics / Analysis Methods
  • Models (animal, cellular, ...)
  • Biobank

Application Fields

  • Human Health
  • Infectious Diseases
  • Cancer
Close

Novalix - FRANCE

NovAliX is focusing on the development of enabling chemistry and biophysical technologies to support the pharmaceutical industry’s outsourcing needs from discovery to manufacturing. With proprietary unique SPR technology, X-ray protein crystallography, supramolecular mass spectrometry and chemistry NovAliX offers comprehensive integrated services for small molecule drug discovery. With advanced ...
NovAliX is focusing on the development of enabling chemistry and biophysical technologies to support the pharmaceutical industry’s outsourcing needs from discovery to manufacturing. With proprietary unique SPR technology, X-ray protein crystallography, supramolecular mass spectrometry and chemistry NovAliX offers comprehensive integrated services for small molecule drug discovery. With advanced NMR technologies, NovAliX provides fine characterization of biologics, thorough analysis of APIs and polymorphism studies to support pharmaceutical development and manufacturing teams. NovAliX Group, a team of 120 scientists, is located in state-of-the-art laboratory facilities in Strasbourg-Illkirch (France) and Heidelberg (Germany).
More

Contact

Value chain

  • Research
  • Preclinical

Business Model

  • Service Provider - CRO

Activities

  • Chemistry
  • Drug Discovery

Needs and interest

  • Commercial Development
Close

Novartis Institutes for Biomedical Research - USA

The Novartis Institutes for BioMedical Research (NIBR) is the pharmaceutical research arm of Novartis, responsible for innovative therapeutic discovery and development up to clinical proof of concept. Disease areas of interest include autoimmunity, transplantation and inflammation, cardiovascular and metabolism, infectious diseases, musculoskeletal diseases, neuroscience, oncology, ophthalmology, ...
The Novartis Institutes for BioMedical Research (NIBR) is the pharmaceutical research arm of Novartis, responsible for innovative therapeutic discovery and development up to clinical proof of concept. Disease areas of interest include autoimmunity, transplantation and inflammation, cardiovascular and metabolism, infectious diseases, musculoskeletal diseases, neuroscience, oncology, ophthalmology, and respiratory diseases. We seek to partner with academics and biotechs to (1) access novel drug discovery technologies, (2) collaborate on drug discovery programs, and (3) in-license therapeutic products that have not yet shown proof-of-concept. Particular interest is focused on areas of unmet medical need where partnering has the potential to set new directions and jumpstart our efforts.
More

Contact

Value chain

  • Preclinical

Activities

  • Protein / Proteomics
  • Diagnostics / Analysis Methods
  • Drug Discovery
  • Cell Therapy
  • Biobank
Close

Oncomedics - FRANCE

Oncomedics collect human cancer tumor from patients to obtain cancer primary culture as models for cancer research, drug screening, biomarker validation, and individualized diagnotics. This innovative technique is called Oncogramme and is useful to evaluate experimental drug efficiency on a panel of tumoral cell from distinct patient. Oncogramme allow to explore the heterogeneity of patients in on...
Oncomedics collect human cancer tumor from patients to obtain cancer primary culture as models for cancer research, drug screening, biomarker validation, and individualized diagnotics. This innovative technique is called Oncogramme and is useful to evaluate experimental drug efficiency on a panel of tumoral cell from distinct patient. Oncogramme allow to explore the heterogeneity of patients in oncology. Moreover, specific marker can be searched on our ex vivo models. Correlation between new drug candidate and companion biomarker can be addressed with oncogram at pre-clinical stage.
More

Contact

  • Firstname / Lastname :
    Christophe Lautrette
  • Job title :
    CEO
  • Email :
    contact@oncomedics.com
  • Phone :
    +33 (0)5 55 33 85 25

Value chain

  • Research
  • Preclinical
  • Clinical

Business Model

  • Service Provider - CRO
  • Product Developer - biopharmaceuticals

Activities

  • Tissue / Cells
  • Imagery
  • Diagnostics / Analysis Methods
  • Preclinical Trials
  • Models (animal, cellular, ...)
  • Biobank

Application Fields

  • Cancer

Needs and interest

  • R&d Partnership
Close

Only for children pharmaceuticals - FRANCE

Only for children pharmaceuticals develop and commercialise orphan medicines for children.
Only for children pharmaceuticals develop and commercialise orphan medicines for children.
More

Contact

Activities

  • Clinical Trials
  • Preclinical Trials
  • Other

Application Fields

  • Infectious Diseases
  • Genetic / Rare Diseases
  • Pediatrics
  • Autoimmune Diseases
  • Orhpan Diseases
  • Cancer

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
  • Commercial Development
Close

Ontario Genomics Institute - CANADA

The Ontario Genomics Institute (OGI) is a private, not-for-profit corporation focused on using world-class research to create strategic genomics resources and accelerate Ontario’s development of a globally-competitive life sciences sector.
The Ontario Genomics Institute (OGI) is a private, not-for-profit corporation focused on using world-class research to create strategic genomics resources and accelerate Ontario’s development of a globally-competitive life sciences sector.
More

Contact

Activities

  • Gene / Genomics
Close

Oramed - ISRAEL

Oramed Pharmaceuticals is a technology pioneer in the field of oral delivery solutions for drugs and vaccines presently delivered via injection. Oramed is seeking to revolutionize the treatment of diabetes through its patented flagship product, an orally ingestible insulin capsule currently in Phase 2 clinical trials. Established in 2006, Oramed's technology is based on over 25 years of research p...
Oramed Pharmaceuticals is a technology pioneer in the field of oral delivery solutions for drugs and vaccines presently delivered via injection. Oramed is seeking to revolutionize the treatment of diabetes through its patented flagship product, an orally ingestible insulin capsule currently in Phase 2 clinical trials. Established in 2006, Oramed's technology is based on over 25 years of research performed by top research scientists at Jerusalem's Hadassah Medical Center. The Company's corporate and R&D headquarters are based in Jerusalem.
More

Contact

  • Firstname / Lastname :
    Nadav Kidron
  • Job title :
    CEO
  • Email :
    tara@oramed.com

Value chain

  • Research
  • Preclinical
  • Clinical

Activities

  • Drug Delivery

Application Fields

  • Metabolic Diseases

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
Close

OROXCELL - FRANCE

Oroxcell is a well recognized CRO offering a unique one-stop-shopping platform to assess skin and oral absorption, Distribution, Metabolism, Elimination, Toxicity profile and physicochemical characteristics of compounds issued life sciences industry. Oroxcell is actively involved in setting up unique predictive alternative technologies to animal use for toxicity assessment : cardiotoxicity, skin c...
Oroxcell is a well recognized CRO offering a unique one-stop-shopping platform to assess skin and oral absorption, Distribution, Metabolism, Elimination, Toxicity profile and physicochemical characteristics of compounds issued life sciences industry. Oroxcell is actively involved in setting up unique predictive alternative technologies to animal use for toxicity assessment : cardiotoxicity, skin corrosion, skin irritation, corneal irritation…. Oroxcell has cutting-edge equipment and high analytical and screening capabilities. Oroxcell is GLP compliant.
More

Contact

Value chain

  • Research
  • Preclinical

Business Model

  • Service Provider - CRO
  • Product Developer - pharmaceuticals

Activities

  • Diagnostics / Analysis Methods
  • Drug Discovery
  • Models (animal, cellular, ...)

Application Fields

  • Animal Health
  • Human Health
  • Nutrition / Food
  • Pediatrics
  • Dermocosmetics
  • CNS related Diseases

Needs and interest

  • R&d Partnership
  • Commercial Development
Close

OROXCELL - FRANCE

More

Contact

Business Model

  • Service Provider - CRO
  • Product Developer - pharmaceuticals

Activities

  • Diagnostics / Analysis Methods
  • Drug Discovery
  • Models (animal, cellular, ...)

Application Fields

  • Animal Health
  • Human Health
  • Nutrition / Food
  • Pediatrics
  • Dermocosmetics
  • CNS related Diseases

Needs and interest

  • R&d Partnership
  • Commercial Development
Close

OWL Genomics - SPAIN

OWL Genomics is a biotechnology company founded in 2002 whose primary objective is to develop new diagnosis and treatment solutions for complex disease scenarios. Since 2005 the company has focused its efforts on the application of LC-MS based metabolomics technology to biomarker discovery in the pharmaceutical (toxicity and drug efficacy) and human health (disease diagnosis / prognosis) sectors. ...
OWL Genomics is a biotechnology company founded in 2002 whose primary objective is to develop new diagnosis and treatment solutions for complex disease scenarios. Since 2005 the company has focused its efforts on the application of LC-MS based metabolomics technology to biomarker discovery in the pharmaceutical (toxicity and drug efficacy) and human health (disease diagnosis / prognosis) sectors.
More

Contact

  • Firstname / Lastname :
    Teresa Porto
  • Job title :
    Business Development Manager
  • Email :
    teresaporto@ya.com
  • Phone :
    0034 94 4318540

Value chain

  • Clinical
  • Manufacturing / Production

Business Model

  • Service Provider - CRO
  • Product Developer - other health

Activities

  • Other

Application Fields

  • Human Health
  • Metabolic Diseases
  • CNS related Diseases

Needs and interest

  • Commercial Alliance - Comarketing
Close

ParinGenix, Inc. - USA

We are developing a new chemical entity, in phase II clinical trials for pediatric protein losing enteropathy and for pancreatic cancer.
We are developing a new chemical entity, in phase II clinical trials for pediatric protein losing enteropathy and for pancreatic cancer.
More

Contact

  • Firstname / Lastname :
    Stephen Marcus
  • Job title :
    President and CEO
  • Email :
    smarcus@paringenix.com
  • Phone :
    954-315-3660

Value chain

  • Clinical

Business Model

  • Product Developer - pharmaceuticals

Activities

  • Clinical Trials

Application Fields

  • Human Health

Needs and interest

  • R&d Partnership
Close

Pfizer, Inc. - USA

Pharmaceutical Company
Pharmaceutical Company
More

Contact

Value chain

  • Research
  • Preclinical
  • Clinical

Business Model

  • Product Developer - pharmaceuticals
  • Product Developer - biopharmaceuticals
  • Product Developer - other health

Activities

  • Gene / Genomics
  • Protein / Proteomics
  • Chemistry
  • Vaccine
  • Imagery
  • Diagnostics / Analysis Methods
  • Drug Discovery
  • Drug Delivery
  • Models (animal, cellular, ...)
  • Biobank
  • Nanotechnology

Application Fields

  • Human Health
  • Immunology
  • Infectious Diseases
  • Genetic / Rare Diseases
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Orhpan Diseases
  • Metabolic Diseases
  • Cancer
  • CNS related Diseases

Needs and interest

  • R&d Partnership
Close

Phage Consultants - POLAND

THE COMPANY PHAGE CONSULTANTS was created to help companies, which production is based on bacterial activities, to fight with and prevent from bacteriophage infection. Phage infections may be very destructive in bioprocesses for a company's productivity. Based on our research we propose different ways of assistance - from personnel training, through consulting and process optimization in aspect of...
THE COMPANY PHAGE CONSULTANTS was created to help companies, which production is based on bacterial activities, to fight with and prevent from bacteriophage infection. Phage infections may be very destructive in bioprocesses for a company's productivity. Based on our research we propose different ways of assistance - from personnel training, through consulting and process optimization in aspect of phage growth limitation, to assistance in projecting new facilities. All people involved in Phage Consultants activities are experts in the field of bacteriophage biology with special emphasis on bacteriophages in bioprocesses. Now, on the basis of our broad experience, we also offer an assistance in eradication and prevention of other types of contaminations in all types of bioprocesses. Due to frequent inquiries, we introduced a contract research service in all aspects of bacteriophage use in various fields of biotechnology, medicine, food and crop protection etc. Our extensive expertise in phage biology research help us deliver to you high quality results in relatively short time and in competitive price. Our another activity is contract phage manufacturing and phage purification service.
More

Contact

Value chain

  • Research
  • Manufacturing / Production
  • Other

Business Model

  • Service Provider - CRO
  • Service Provider - CMO
  • Service Provider - scientifique

Activities

  • Biomanufacturing

Application Fields

  • Other

Needs and interest

  • R&d Partnership
Close

Phage Consultants - POLAND

More

Contact

Activities

  • Biomanufacturing
Close

Pharm-Olam International - USA

Pharm-Olam is a privately-held full service CRO that over the last 15 years has grown throughout Europe, Russia, Africa, Asia, Latin America and North America. With our Corporate HQ in Houston, Texas and a European HQ in Ascot, UK, we have a total of 27 offices in 23 countries around the world. Pharm-Olam has one of the largest geographic presences for a company its size, combining the advantages ...
Pharm-Olam is a privately-held full service CRO that over the last 15 years has grown throughout Europe, Russia, Africa, Asia, Latin America and North America. With our Corporate HQ in Houston, Texas and a European HQ in Ascot, UK, we have a total of 27 offices in 23 countries around the world. Pharm-Olam has one of the largest geographic presences for a company its size, combining the advantages of senior executive communications, relationship management, and responsiveness of a small company culture with global resources and experience. We continue to offer flexible full service trial solutions from Virtual Biotech to Preferred Providerships with corporate Pharma. Coupled with our trouble shooting skills, refined from our busy ‘Rescue Trial’ work from other CROs large and small, we offer a mature, proven operation and look forward to working together with you on your next challenge.
More

Contact

  • Firstname / Lastname :
    Steve Bliss
  • Job title :
    Director, Business Development
  • Email :
    steve.bliss@pharm-olam.com
  • Phone :
    973-879-0403

Value chain

  • Clinical

Business Model

  • Service Provider - CRO

Activities

  • Clinical Trials

Application Fields

  • Human Health
  • Immunology
  • Infectious Diseases
  • Allergology
  • Genetic / Rare Diseases
  • Pediatrics
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Orhpan Diseases
  • Metabolic Diseases
  • Cancer
  • Dermocosmetics
  • CNS related Diseases

Needs and interest

  • R&d Partnership
Close

Pharm-Olam International - USA

Pharm-Olam is a CRO with business in USA, Europe, Estern Europe, Russia India as well as South Africa and Latin America that has been in the business of clinical research since 1994.
Pharm-Olam is a CRO with business in USA, Europe, Estern Europe, Russia India as well as South Africa and Latin America that has been in the business of clinical research since 1994.
More

Contact

  • Firstname / Lastname :
    Jorge Fiuza
  • Job title :
    Senior Director Global Operations
  • Email :
    jorge.fiuza@pharm-olam.com
  • Phone :
    7135597910

Value chain

  • Research

Business Model

  • Service Provider - CRO

Activities

  • Clinical Trials

Application Fields

  • Infectious Diseases
  • Allergology
  • Metabolic Diseases
  • Cancer

Needs and interest

  • Commercial Development
Close

PHENOPRO SAS - FRANCE

PhenoPro is an early preclinical CRO - before registration process - dedicated to mouse phenotyping protocols including: - characterization and validation of mutant mouse models - in vivo preclinical drug screening * target validation / identification * efficacy / risks evaluation
PhenoPro is an early preclinical CRO - before registration process - dedicated to mouse phenotyping protocols including: - characterization and validation of mutant mouse models - in vivo preclinical drug screening * target validation / identification * efficacy / risks evaluation
More

Contact

  • Firstname / Lastname :
    Tania SORG
  • Job title :
    Head of Scientific Operations
  • Email :
    tsorg@igbmc.fr

Value chain

  • Research
  • Preclinical

Business Model

  • Service Provider - CRO
  • Service Provider - scientifique

Activities

  • Gene / Genomics
  • Preclinical Trials
  • Models (animal, cellular, ...)
  • Other

Application Fields

  • Genetic / Rare Diseases
  • Nutrition / Food
  • Metabolic Diseases
  • CNS related Diseases
  • Other
Close

Picometrics - FRANCE

Picometrics manufacture and commercialize analytical instrumentation based on quantitative detection of traces by Laser Induced Fluorescence (LIF).

Picometrics manufacture and commercialize analytical instrumentation based on quantitative detection of traces by Laser Induced Fluorescence (LIF).

More

Contact

Business Model

  • Laboratory Equipment Supplier

Activities

  • Lab Equipment
  • Diagnostics / Analysis Methods
  • Instrumentation
  • Nanotechnology

Needs and interest

  • R&d Partnership
Close

Pluristem - ISRAEL

Pluristem Therapeutics Inc. (NasdaqCM: PSTI; TASE: PLTR) is a biotechnology company developing and manufacturing standardized cell therapies derived from the human placenta. Pluristem’s PLX (PLacental eXpanded) cell products are expanded using the company’s proprietary patented technology. PLX cells serve as a biologically-controlled drug delivery platform capable of secreting various cytokine...
Pluristem Therapeutics Inc. (NasdaqCM: PSTI; TASE: PLTR) is a biotechnology company developing and manufacturing standardized cell therapies derived from the human placenta. Pluristem’s PLX (PLacental eXpanded) cell products are expanded using the company’s proprietary patented technology. PLX cells serve as a biologically-controlled drug delivery platform capable of secreting various cytokines and other soluble factors in response to environmental signals. These cells are readily available and require no tissue matching prior to administration.
More

Contact

Value chain

  • Manufacturing / Production

Activities

  • Tissue / Cells

Application Fields

  • Immunology
  • Inflammatory Diseases
  • Autoimmune Diseases
  • CNS related Diseases
Close

Pluristem - ISRAEL

More

Contact

Value chain

  • Manufacturing / Production

Business Model

  • Product Developer - biopharmaceuticals

Activities

  • Tissue / Cells
Close

Pluristem - ISRAEL

More

Contact

Value chain

  • Manufacturing / Production

Business Model

  • Product Developer - biopharmaceuticals

Activities

  • Tissue / Cells
  • Cell Therapy
Close

Point A Consulting - USA

My consultancy specializes in strategic planning for research parks and technology incubators; clients are universities, municipalities, regions and private real estate developers. Focus includes "soft landing" opportunities for international businesses seeking to establish a presence across borders.
My consultancy specializes in strategic planning for research parks and technology incubators; clients are universities, municipalities, regions and private real estate developers. Focus includes "soft landing" opportunities for international businesses seeking to establish a presence across borders.
More

Contact

Value chain

  • Other

Business Model

  • Service Provider - non scientifique

Activities

  • Other

Application Fields

  • Other

Needs and interest

  • Commercial Alliance - Comarketing
  • Commercial Development
Close

Polyplus-transfection - FRANCE

Polyplus-transfection SA is a biotechnology company that develops, markets and sells innovative solutions for the in vivo, in vitro and ex vivo delivery of nucleic acids in research, bio-production and therapeutics. Located close to Strasbourg (France), Polyplus-transfection supplies its proprietary range of catalogue reagents for the transfection of genes, oligonucleotides and siRNA in vitro and ...
Polyplus-transfection SA is a biotechnology company that develops, markets and sells innovative solutions for the in vivo, in vitro and ex vivo delivery of nucleic acids in research, bio-production and therapeutics. Located close to Strasbourg (France), Polyplus-transfection supplies its proprietary range of catalogue reagents for the transfection of genes, oligonucleotides and siRNA in vitro and in vivo through a worldwide distributor network. In addition, Polyplus-transfection cGMP transfection reagents are involved into a growing number of clinical trials worldwide. The company holds a broad portfolio of patents and licenses in the fields of nucleic acid delivery and modified oligonucleotides. Polyplus-transfection is the worldwide exclusive licensee of PEI and derivates for stable and transient transfection of eucaryotic cells. Polyplus-transfection is Private Equity owned company and completed a new funding round in December 2010. The company plans to use the new capital to upscale its research & development resources, specifically in the area of new compound development for siRNA delivery.
More

Contact

Value chain

  • Research
  • Preclinical

Business Model

  • Product Developer - pharmaceuticals

Activities

  • Biomanufacturing
  • Nanotechnology

Application Fields

  • Cancer

Needs and interest

  • R&d Partnership
Close

Polyplus-transfection - FRANCE

More

Contact

Value chain

  • Research
  • Preclinical

Business Model

  • Product Developer - biopharmaceuticals

Activities

  • Biomanufacturing
  • Nanotechnology

Application Fields

  • Cancer

Needs and interest

  • R&d Partnership
Close

Polyplus-transfection - FRANCE

More

Contact

Value chain

  • Research
  • Preclinical

Business Model

  • Product Developer - biopharmaceuticals

Activities

  • Biomanufacturing
  • Nanotechnology

Application Fields

  • Cancer

Needs and interest

  • R&d Partnership
Close

Porsolt - FRANCE

Porsolt has been delivering the highest quality research to the pharmaceutical and biotech industries for over 25 years. Throughout our history, our primary focus and core expertise has been in vivo disease models. The scientific experience of our dedicated team, many with backgrounds in drug discovery, enables us to be both proactive and reactive to the needs of our clients; new model development...
Porsolt has been delivering the highest quality research to the pharmaceutical and biotech industries for over 25 years. Throughout our history, our primary focus and core expertise has been in vivo disease models. The scientific experience of our dedicated team, many with backgrounds in drug discovery, enables us to be both proactive and reactive to the needs of our clients; new model development is very much client-driven. Personalized contact with designated project managers for each client ensures continuity and consistency within each project, facilitating scientific discussions and interaction. We provide a wide range of preclinical in vivo pathophysiological models across a variety of disease areas including CNS, cardiovascular, and metabolic disorders, pain and inflammation. Our safety pharmacology programs, which can performed to GLP, cover all in vivo and in vitro components of the safety battery, as well as assessment of drug dependence and abuse liability in both rodents and non-human primates. We also provide PK services, including dog and non-human primate CSF sampling.
More

Contact

Value chain

  • Preclinical

Business Model

  • Service Provider - CRO

Activities

  • Lab Equipment
  • Drug Discovery
  • Models (animal, cellular, ...)

Application Fields

  • Inflammatory Diseases
  • Metabolic Diseases
  • CNS related Diseases
  • Other

Needs and interest

  • Commercial Development
Close

Porsolt - FRANCE

More

Contact

Value chain

  • Research
  • Preclinical

Business Model

  • Service Provider - CRO

Activities

  • Preclinical Trials
  • Models (animal, cellular, ...)
Close

Precision Antibody/A&G Pharmaceutical Inc - USA

A&G Pharmaceutical Inc is a theranostic company with diagnostic and therapeutic antibodies against breast cancer and lung cancer. Precision Antibody is a service arm of A&G that developes high content high affinity monoclonal antibodies in about 50 days
A&G Pharmaceutical Inc is a theranostic company with diagnostic and therapeutic antibodies against breast cancer and lung cancer. Precision Antibody is a service arm of A&G that developes high content high affinity monoclonal antibodies in about 50 days
More

Contact

Business Model

  • Service Provider - CRO
  • Service Provider - scientifique
  • Product Developer - biopharmaceuticals

Activities

  • Tissue / Cells
  • Diagnostics / Analysis Methods
  • Biomanufacturing
  • Drug Discovery
  • Other

Application Fields

  • Human Health
  • Immunology
  • Autoimmune Diseases
  • Cancer
  • CNS related Diseases

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
Close

Prestwick Chemical - FRANCE

Prestwick Chemical is a very successful drug discovery company operating under a dual model: 1) it's drug discovery services have generated 6 compounds in the clinics, including 1 in phase III; 2) Its collaborative research has resulted in late 2010 in the first licensing out deal. In addition, our renowned Prestwick Chemical Library has become a standard for the whole industry
Prestwick Chemical is a very successful drug discovery company operating under a dual model: 1) it's drug discovery services have generated 6 compounds in the clinics, including 1 in phase III; 2) Its collaborative research has resulted in late 2010 in the first licensing out deal. In addition, our renowned Prestwick Chemical Library has become a standard for the whole industry
More

Contact

Value chain

  • Research

Business Model

  • Service Provider - CRO
  • Service Provider - scientifique
  • Product Developer - pharmaceuticals

Activities

  • Chemistry
  • Drug Discovery

Application Fields

  • Animal Health
  • Human Health
  • Infectious Diseases
  • Genetic / Rare Diseases
  • Autoimmune Diseases
  • Orhpan Diseases
  • Metabolic Diseases
  • Cancer
  • Dermocosmetics
  • CNS related Diseases

Needs and interest

  • R&d Partnership
Close

PX Therapeutics / AcCInov - FRANCE

PX'Therapeutics is a biotechnology company dedicated to the development of biotherapeutics from early stage research up to GMP (Good Manufacturing Practices) production of clinical grade material
PX'Therapeutics is a biotechnology company dedicated to the development of biotherapeutics from early stage research up to GMP (Good Manufacturing Practices) production of clinical grade material
More

Contact

Value chain

  • Research
  • Preclinical
  • Clinical
  • Manufacturing / Production

Business Model

  • Service Provider - CMO

Activities

  • Protein / Proteomics
  • Vaccine
  • Biomanufacturing

Application Fields

  • Animal Health
  • Human Health
  • Immunology
  • Infectious Diseases
  • Allergology
  • Genetic / Rare Diseases
  • Pediatrics
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Orhpan Diseases
  • Metabolic Diseases
  • Cancer
  • CNS related Diseases

Needs and interest

  • R&d Partnership
  • Commercial Development
Close

PX'Cell Therapy / PX'Therapeutics - FRANCE

PX’Therapeutics is a world-class, contract biomanufacturing company offering process development of recombinant proteins, antibodies and cGMP manufacturing services to a wide range of companies from small start-ups to international biotechnology and pharmaceutical companies. The new division “PX’Cell Therapy” specializes in the development and manufacture of specific proteins required for ...
PX’Therapeutics is a world-class, contract biomanufacturing company offering process development of recombinant proteins, antibodies and cGMP manufacturing services to a wide range of companies from small start-ups to international biotechnology and pharmaceutical companies. The new division “PX’Cell Therapy” specializes in the development and manufacture of specific proteins required for the isolation, expansion or differentiation of therapeutic cells. We provide clients with a range of products and associated services in the field of immunotherapy, starting today with an MHC Class I multimers at pharmaceutical or research-grade as well as custom-made production services. 
More

Contact

Activities

  • Biomanufacturing
  • Cell Therapy
Close

QuantiBact - DENMARK

diagnostics
diagnostics
More

Contact

Business Model

  • Product Developer - other health

Activities

  • Diagnostics / Analysis Methods

Application Fields

  • Infectious Diseases
  • Genetic / Rare Diseases
  • Cancer

Needs and interest

  • R&d Partnership
Close

Quinten - FRANCE

Enabled by its extremely powerful bioinformatics technology, Quinten detects profiles that are undetected with other sophisticated analytical approaches, and within a few weeks delivers concrete and strategic insights & recommendations that have been proven to save time, enhance product performance, and mitigate risks in drug development programs.
Enabled by its extremely powerful bioinformatics technology, Quinten detects profiles that are undetected with other sophisticated analytical approaches, and within a few weeks delivers concrete and strategic insights & recommendations that have been proven to save time, enhance product performance, and mitigate risks in drug development programs.
More

Contact

Value chain

  • Research
  • Preclinical
  • Clinical
  • Other

Business Model

  • Service Provider - scientifique

Activities

  • Gene / Genomics
  • Chemistry
  • Diagnostics / Analysis Methods
  • Clinical Trials
  • Drug Discovery
  • Bioinformatics / Modeling

Application Fields

  • Human Health
  • Immunology
  • Infectious Diseases
  • Allergology
  • Genetic / Rare Diseases
  • Nutrition / Food
  • Pediatrics
  • Geriatrics
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Orhpan Diseases
  • Metabolic Diseases
  • Cancer
  • Dermocosmetics
  • CNS related Diseases

Needs and interest

  • R&d Partnership
  • Commercial Development
Close

RecipharmCobra Biologics - UNITED KINGDOM

RecipharmCobra Biologics (formerly Cobra Biomanufacturing) is a part of the Recipharm group, a full service Contact Development and Manufacturing Organisation (CDMO) operating several production facilities across Europe. Recipharm offers a comprehensive service including cell line development, process and analytical development, GMP manufacture including formulation development, fill/finish in var...
RecipharmCobra Biologics (formerly Cobra Biomanufacturing) is a part of the Recipharm group, a full service Contact Development and Manufacturing Organisation (CDMO) operating several production facilities across Europe. Recipharm offers a comprehensive service including cell line development, process and analytical development, GMP manufacture including formulation development, fill/finish in various formats and release to clinic for antibodies, recombinant proteins, viruses and DNA.
More

Contact

Value chain

  • Preclinical
  • Clinical
  • Manufacturing / Production

Business Model

  • Service Provider - CMO

Activities

  • Vaccine
  • Biomanufacturing
  • Cell Therapy

Application Fields

  • Human Health
  • Immunology
  • Infectious Diseases
  • Genetic / Rare Diseases
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Orhpan Diseases
  • Cancer

Needs and interest

  • R&d Partnership
  • Commercial Development
Close

RELIANCE CLINICAL RESEARCH SERVICES - INDIA

Full service CRO based in India with Phase I-IV services across 14 therapy domains
Full service CRO based in India with Phase I-IV services across 14 therapy domains
More

Contact

Value chain

  • Preclinical
  • Clinical

Business Model

  • Service Provider - CRO

Activities

  • Clinical Trials
  • Preclinical Trials

Application Fields

  • Human Health
  • Immunology
  • Infectious Diseases
  • Inflammatory Diseases
  • Metabolic Diseases
  • Cancer
  • CNS related Diseases
Close

Research & Development - FRANCE

Sanofi is a diversified global healthcare leader, focused on patients’ needs Group strategy is based on three key principles in order to deliver long-term sustainable growth: increasing innovation in Research & Development, seizing external growth opportunities, adapt to future challenges and opportunities. A global healthcare leader A diversified offering of medicines, consumer healthcare p...
Sanofi is a diversified global healthcare leader, focused on patients’ needs Group strategy is based on three key principles in order to deliver long-term sustainable growth: increasing innovation in Research & Development, seizing external growth opportunities, adapt to future challenges and opportunities. A global healthcare leader A diversified offering of medicines, consumer healthcare products, generics and animal health A world leader in human vaccines A broad and balanced presence on both traditional and emerging markets
More

Contact

Value chain

  • Research
  • Preclinical
  • Clinical
  • Manufacturing / Production
  • Marketing / Distribution

Business Model

  • Product Developer - pharmaceuticals
  • Product Developer - biopharmaceuticals

Activities

  • Gene / Genomics
  • Protein / Proteomics
  • Chemistry
  • Vaccine
  • Clinical Trials
  • Preclinical Trials
  • Drug Discovery
  • Medical Device
  • Drug Delivery

Application Fields

  • Animal Health
  • Human Health
  • Immunology
  • Infectious Diseases
  • Allergology
  • Genetic / Rare Diseases
  • Nutrition / Food
  • Pediatrics
  • Geriatrics
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Orhpan Diseases
  • Metabolic Diseases
  • Cancer
  • Dermocosmetics
  • CNS related Diseases

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
  • Commercial Development
Close

Rhenovia Pharma - FRANCE

Rhenovia is a leading biotech company in biosimulation with a unique service offering for pharma and biotech companies to accelerate, reduce the costs and improve the success rate of their Drug Development for neurodegenerative and psychiatric diseases. It uses breakthrough technology of modeling the cellular and molecular signaling cascades of neuronal transmission and simulating functional elect...
Rhenovia is a leading biotech company in biosimulation with a unique service offering for pharma and biotech companies to accelerate, reduce the costs and improve the success rate of their Drug Development for neurodegenerative and psychiatric diseases. It uses breakthrough technology of modeling the cellular and molecular signaling cascades of neuronal transmission and simulating functional electrophysiological and biochemical measures for testing drug effects under pathological conditions, and develops a rate controlled patch that allows appropriate administration of drug combinations.
More

Contact

Value chain

  • Research

Business Model

  • Service Provider - CRO

Activities

  • Drug Discovery
  • Drug Delivery
  • Bioinformatics / Modeling
  • Nanotechnology

Application Fields

  • Nutrition / Food
  • Orhpan Diseases
  • CNS related Diseases

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
  • Commercial Development
Close

RNL Life Science - USA

RNL Bio is a Korea-based public company that is dedicated to the commercialization of stem cell-based therapeutics. RNL Bio is a pioneer in the use of adipose and other tissue-derived stem cells for the treatment of indications of unmet clinical need. RNL Bio is licensing to us rights and intellectual property to commercialize several applications of their harvest and therapy applications of stem ...
RNL Bio is a Korea-based public company that is dedicated to the commercialization of stem cell-based therapeutics. RNL Bio is a pioneer in the use of adipose and other tissue-derived stem cells for the treatment of indications of unmet clinical need. RNL Bio is licensing to us rights and intellectual property to commercialize several applications of their harvest and therapy applications of stem cells. RNL Bio is a leader in the harvest and growth of stem cells derived from Adipose tissue. Adipose is body fat composed of lipoblasts. The main role of lipoblasts is to store energy in the form of fat, although it also cushions and insulates the body. RNL Bio’s research has been guided by its proprietary understanding of the isolation, expansion and administration of stem cells. Through this innovation, a large number of adult stem cells can be efficiently and rapidly obtained for therapeutic use. Some of the advantages of using adipose as a source material for stem cell therapies are that adipose has a greater abundance of stem cells and it requires a simpler processing method, which involves a quick and simple liposuction (5 to 10 ml) rather than a more extensive liposuction or a painful iliac puncture. RNL Bio has standardized the stem cell expansion technology specifically for autologous adipose tissue-derived stem cells, which is the process by which the original material is cultivated in a culture medium to grow stem cells. These newly grown stem cells are called Expanded Stem Cells. Each time the original cells are “grown” is called an Expansion Cycle. Expanded stem cells were shown to have the same property and characteristics in vitro during and up to 12 passages of expansion cycles. Furthermore, no cytotoxicity and tumorigenecity was found in the studies.
More

Contact

  • Firstname / Lastname :
    Jin Han Hong
  • Job title :
    President
  • Email :
    hongjh@rnl.co.kr
  • Phone :
    3019560921

Value chain

  • Research

Business Model

  • Product Developer - biopharmaceuticals

Activities

  • Diagnostics / Analysis Methods
  • Cell Therapy

Application Fields

  • Human Health
  • Inflammatory Diseases
  • Autoimmune Diseases

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
  • Commercial Development
Close

Rowpar Pharmaceuticals, Inc. - USA

Rowpar Pharmaceuticals develops, makes, markets and licenses innovative oral care products targeted as adjuncts in the treatment of oral and systemic diseases. It's CloSYS brand of oral care products are distributed by leading dental professionals throughout North America and Australia and sold through major drug and grocery retailers. It's Dentists' Choice brand of oral care products are distribu...
Rowpar Pharmaceuticals develops, makes, markets and licenses innovative oral care products targeted as adjuncts in the treatment of oral and systemic diseases. It's CloSYS brand of oral care products are distributed by leading dental professionals throughout North America and Australia and sold through major drug and grocery retailers. It's Dentists' Choice brand of oral care products are distributed in Africa and Asia.
More

Contact

  • Firstname / Lastname :
    James Ratcliff
  • Job title :
    Chairman and CEO
  • Email :
    jratcliff@rowpar.com
  • Phone :
    1-480-948-6997

Value chain

  • Research
  • Manufacturing / Production
  • Marketing / Distribution

Business Model

  • Product Developer - pharmaceuticals
  • Product Developer - other health

Activities

  • Chemistry
  • Preclinical Trials
  • Drug Discovery
  • Drug Delivery

Application Fields

  • Human Health
  • Infectious Diseases
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Metabolic Diseases
  • Cancer

Needs and interest

  • Commercial Alliance - Comarketing
  • Commercial Development
Close

sanofi - FRANCE

Sanofi : Pharmaceutical company
Sanofi : Pharmaceutical company
More

Contact

Business Model

  • Product Developer - pharmaceuticals
  • Product Developer - biopharmaceuticals

Activities

  • Gene / Genomics
  • Protein / Proteomics
  • Chemistry
  • Vaccine
  • Clinical Trials
  • Drug Discovery
  • Drug Delivery
  • Cell Therapy
  • Models (animal, cellular, ...)
  • Biobank
  • Bioinformatics / Modeling
Close

Sanofi - USA

Sanofi is a global healthcare leader Focused on patients’ needs, Sanofi offers a range of essential healthcare assets, including a broad-based product portfolio and a presence worldwide
Sanofi is a global healthcare leader Focused on patients’ needs, Sanofi offers a range of essential healthcare assets, including a broad-based product portfolio and a presence worldwide
More

Contact

  • Firstname / Lastname :
    Frederic Badey
  • Job title :
    Sr Director, International Public Affairs Coordination
  • Email :
    frederic.badey@sanofi.com

Activities

  • Vaccine
  • Drug Discovery
Close

sanofi pasteur - FRANCE

One of the largest vaccines manufacturer in the world

Sanofi Pasteur, the vaccines division of sanofi-aventis Group, provides more than 1 billion doses of vaccine each year, making it possible to immunize more than 500 million people across the globe. A world leader in the vaccine industry, Sanofi Pasteur offers the broadest range of vaccines protecting against 20 infectious dise...

One of the largest vaccines manufacturer in the world

Sanofi Pasteur, the vaccines division of sanofi-aventis Group, provides more than 1 billion doses of vaccine each year, making it possible to immunize more than 500 million people across the globe. A world leader in the vaccine industry, Sanofi Pasteur offers the broadest range of vaccines protecting against 20 infectious diseases. The company's heritage, to create vaccines that protect life, dates back more than a century. Sanofi Pasteur is the largest company entirely dedicated to vaccines. Every day, the company invests more than EUR 1 million in research and development

More

Contact

Value chain

  • Research

Business Model

  • Product Developer - pharmaceuticals

Activities

  • Vaccine

Application Fields

  • Human Health

Needs and interest

  • R&d Partnership
Close

sanofi pasteur - FRANCE

More

Contact

Value chain

  • Preclinical
  • Clinical
  • Manufacturing / Production
  • Marketing / Distribution

Business Model

  • Product Developer - other health

Activities

  • Vaccine

Application Fields

  • Human Health
  • Infectious Diseases

Needs and interest

  • R&d Partnership
Close

sanofi pasteur - USA

More

Contact

Value chain

  • Research
  • Preclinical
  • Clinical
  • Manufacturing / Production
  • Marketing / Distribution

Activities

  • Gene / Genomics
  • Tissue / Cells
  • Biomanufacturing
  • Preclinical Trials

Application Fields

  • Animal Health
  • Immunology
  • Infectious Diseases
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Cancer

Needs and interest

  • R&d Partnership
Close

Sanofi-aventis - FRANCE

Pharmaceutical Industry
Pharmaceutical Industry
More

Contact

Value chain

  • Research

Business Model

  • Product Developer - pharmaceuticals

Activities

  • Drug Discovery

Application Fields

  • Human Health
  • Infectious Diseases

Needs and interest

  • R&d Partnership
Close

Sanofi-aventis - USA

Sanofi is a diversified global healthcare company
Sanofi is a diversified global healthcare company
More

Contact

Value chain

  • Research
  • Preclinical
  • Clinical

Activities

  • Diagnostics / Analysis Methods
  • Clinical Trials
  • Drug Discovery
  • Drug Delivery
  • Cell Therapy
  • Models (animal, cellular, ...)

Application Fields

  • Human Health
  • CNS related Diseases

Needs and interest

  • R&d Partnership
Close

SCiSOURCE - USA

SCiSOURCE assists companies with Business Development and Sales Development internationally.
SCiSOURCE assists companies with Business Development and Sales Development internationally.
More

Contact

Value chain

  • Marketing / Distribution

Business Model

  • Service Provider - non scientifique

Activities

  • Gene / Genomics
  • Protein / Proteomics
  • Tissue / Cells
  • Lab Equipment
  • Diagnostics / Analysis Methods
  • Biomanufacturing
  • Medical Device
  • Instrumentation
  • Other

Application Fields

  • Human Health
  • Immunology
  • Infectious Diseases
  • Genetic / Rare Diseases
  • Nutrition / Food
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Orhpan Diseases
  • Metabolic Diseases
  • Cancer
  • CNS related Diseases

Needs and interest

  • Commercial Alliance - Comarketing
  • Commercial Development
Close

Scout Diagnostics - USA

Immunoassay for Alzheimer's
Immunoassay for Alzheimer's
More

Contact

Value chain

  • Research

Activities

  • Medical Device

Application Fields

  • CNS related Diseases

Needs and interest

  • Commercial Development
Close

SEPPIC Inc - USA

SEPPIC, a wholly owned subsidiary of the Air Liquide Group, designs and supplies innovative specialty chemical products for the pharmaceutical, nutrition, and vaccine markets. It is a recognized leader for polymers, surfactants, emulsion technologies, and more. SEPPIC offer scientific expertise in the fields of chemistry, formulation and objectification.
SEPPIC, a wholly owned subsidiary of the Air Liquide Group, designs and supplies innovative specialty chemical products for the pharmaceutical, nutrition, and vaccine markets. It is a recognized leader for polymers, surfactants, emulsion technologies, and more. SEPPIC offer scientific expertise in the fields of chemistry, formulation and objectification.
More

Contact

Value chain

  • Manufacturing / Production

Business Model

  • Product Developer - pharmaceuticals

Activities

  • Vaccine
  • Drug Delivery

Application Fields

  • Animal Health
  • Human Health
  • Immunology
  • Infectious Diseases
  • Allergology
  • Genetic / Rare Diseases
  • Nutrition / Food
  • Pediatrics
  • Geriatrics
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Orhpan Diseases
  • Cancer
  • Dermocosmetics

Needs and interest

  • R&d Partnership
  • Commercial Development
Close

SIOGEN Biotech - MALAYSIA

SIOGEN Biotech, a world leader in the production of Silane based nanoparticles, manufactures GMP Siosomes® as flexible vesicles for the delivery of drugs, other compounds and substances. It is applying this nanoparticle technology to reduce side effects and increase efficacy of existing and developmental drugs that is the future of smart drug delivery systems. SIOGEN has a special encapsulation t...
SIOGEN Biotech, a world leader in the production of Silane based nanoparticles, manufactures GMP Siosomes® as flexible vesicles for the delivery of drugs, other compounds and substances. It is applying this nanoparticle technology to reduce side effects and increase efficacy of existing and developmental drugs that is the future of smart drug delivery systems. SIOGEN has a special encapsulation technology that can enhance drug delivery and tissue targeting. The Company is a privately financed technology company, headquartered in Kuala Lumpur, Malaysia, with manufacturing facilities in Germany and a research centre in the UK. The company is already revenue making, achieve its first sales in 2009 and is currently negotiating drug deals with several top ten Pharmaceuticals.
More

Contact

  • Firstname / Lastname :
    Shermal Perera
  • Job title :
    Managing Director
  • Email :
    shermal@siogen.com
  • Phone :
    +60126871826

Value chain

  • Research
  • Preclinical
  • Manufacturing / Production

Business Model

  • Service Provider - scientifique
  • Product Developer - pharmaceuticals
  • Product Developer - biopharmaceuticals
  • Product Developer - other health

Activities

  • Drug Delivery
  • Nanotechnology

Application Fields

  • Animal Health
  • Human Health
  • Immunology
  • Infectious Diseases
  • Genetic / Rare Diseases
  • Autoimmune Diseases
  • Cancer
  • Dermocosmetics
  • CNS related Diseases

Needs and interest

  • R&d Partnership
  • Commercial Development
Close

Splicos - FRANCE

SPLICOS: the innovative pharmacology of alternative splicing Recent discoveries have shown that modifications of RNA alternative splicing play a critical role in the alteration of key biological mechanisms implicated in various diseases, opening a brand new field for the search of new treatments for diseases with high medical needs. Based on breakthrough proprietary discoveries and innovative scre...
SPLICOS: the innovative pharmacology of alternative splicing Recent discoveries have shown that modifications of RNA alternative splicing play a critical role in the alteration of key biological mechanisms implicated in various diseases, opening a brand new field for the search of new treatments for diseases with high medical needs. Based on breakthrough proprietary discoveries and innovative screening technologies, SPLICOS is developing a novel class of small molecules targeting RNA alternative splicing in the field of HIV-AIDS, oncology (metastatic invasion) SPLICOS is a cutting hedge company entirely focused on preclinical R&D in the field of RNA alternative splicing from discovery to in vivo validation of the NCEs on appropriate animal models. With three ongoing projects generating very promising results, such as a novel class of molecule in HIV showing excellent in vitro and in vivo efficacy, SPLICOS is actively looking for industrial partners to advance these projects to the clinical development stage.
More

Contact

Value chain

  • Research
  • Preclinical

Business Model

  • Product Developer - pharmaceuticals
  • Product Developer - biopharmaceuticals

Activities

  • Drug Discovery

Application Fields

  • Infectious Diseases
  • Cancer

Needs and interest

  • R&d Partnership
Close

SYNTHELIS - FRANCE

Synthelis is a young start-up company providing a solution to a well known challenge in terms of biotechnological production, namely the development, characterization and production of customized membrane proteins and associated service offerings. The technology at the heart of the Synthelis offering originates from the University Joseph Fourier’s and the company started its life in commercial t...
Synthelis is a young start-up company providing a solution to a well known challenge in terms of biotechnological production, namely the development, characterization and production of customized membrane proteins and associated service offerings. The technology at the heart of the Synthelis offering originates from the University Joseph Fourier’s and the company started its life in commercial terms as a Business Unit of Floralis (the UJF’s technology transfer subsidiary) in 2008 before recently spinning off as a company. The company is also working on its own R&D programs with a view to developing innovative therapeutic and vaccine approaches. Synthelis intends to develop therapeutic proteoliposomes until stage I clinical trial and to then out-license these products to pharmaceutical companies capable of further developing these biopharmaceuticals. Synthelis is already working with a variety of big pharma clients, proof in itself of the quality and the potential that they see in the company’s offering. Synthelis has won three important awards for innovation including the Credit Agricole Innovation Award organized by the Grenoble School for Management, followed by the Emergence category of the national OSEO award for new businesses in 2009 and a second OSEO prize in the “Creation-Development” category in 2010.
More

Contact

Value chain

  • Research
  • Preclinical

Business Model

  • Service Provider - CMO

Activities

  • Protein / Proteomics
  • Vaccine
  • Biomanufacturing
  • Drug Discovery

Application Fields

  • Human Health
  • Inflammatory Diseases
  • Cancer
  • CNS related Diseases

Needs and interest

  • R&d Partnership
  • Commercial Development
Close

The Research Volunteer - USA

Clinical trials recruitment
Clinical trials recruitment
More

Contact

Value chain

  • Clinical
  • Marketing / Distribution

Business Model

  • Service Provider - non scientifique

Activities

  • Clinical Trials

Application Fields

  • Human Health
  • Pediatrics

Needs and interest

  • Commercial Alliance - Comarketing
  • Commercial Development
Close

The Scheye Group Ltd. - USA

The Scheye Group Ltd provides global advisory services to academic medical centres and the biotechnology sector. We help identify strategic partners for collaborations/alliances/research consortia formation to bring products from bench to commercialisation and achieve win-win solutions.
The Scheye Group Ltd provides global advisory services to academic medical centres and the biotechnology sector. We help identify strategic partners for collaborations/alliances/research consortia formation to bring products from bench to commercialisation and achieve win-win solutions.
More

Contact

  • Firstname / Lastname :
    Elaine Scheye
  • Job title :
    President
  • Email :
    escheye@gmail.com
  • Phone :
    +1 312 836 1129 cell, +1 773 989 9315

Value chain

  • Research
  • Preclinical
  • Clinical
  • Marketing / Distribution

Business Model

  • Service Provider - scientifique
  • Service Provider - non scientifique

Activities

  • Vaccine
  • Clinical Trials
  • Preclinical Trials

Application Fields

  • Human Health
  • Genetic / Rare Diseases
  • Pediatrics
  • Inflammatory Diseases
  • Orhpan Diseases
  • Metabolic Diseases
  • Cancer
  • CNS related Diseases

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
  • Commercial Development
Close

The Stanton Group, Inc. - USA

The Stanton Group, Inc. is a commercial real estate company founded in December 1986 by Debra C. Viol, CPM, President and CEO. At its founding, Viol recognized a need in the Nashville market for a locally owned professional property management firm that could cater to the needs of the real estate investment community. Since its inception, The Stanton Group, Inc. (SGI) has grown to manage over a mi...
The Stanton Group, Inc. is a commercial real estate company founded in December 1986 by Debra C. Viol, CPM, President and CEO. At its founding, Viol recognized a need in the Nashville market for a locally owned professional property management firm that could cater to the needs of the real estate investment community. Since its inception, The Stanton Group, Inc. (SGI) has grown to manage over a million square feet of commercial property which includes a portfolio of office buildings, state of the art medical offices, warehouses and retail centers. Not only does SGI provide service in management, acquisition and development of real estate portfolios, but we also manage several notable commercial associations and oversee multi-property portfolios for local investment groups.
More

Contact

Activities

  • Other
Close

Theralpha - FRANCE

Theralpha SAS is a product development-oriented company, focusing on preclinical and clinical development of new pain therapeutics. Theralpha drug candidates originate from worldwide exclusive licenses from IPMC (Institut de Pharmacologie Moleculaire, CNRS, Sophia Antipolis, France) based on research made by Professor Michel Lazdunski and his team who have pioneered the discovery of peptides found...
Theralpha SAS is a product development-oriented company, focusing on preclinical and clinical development of new pain therapeutics. Theralpha drug candidates originate from worldwide exclusive licenses from IPMC (Institut de Pharmacologie Moleculaire, CNRS, Sophia Antipolis, France) based on research made by Professor Michel Lazdunski and his team who have pioneered the discovery of peptides found in animal venoms that selectively inhibit Acid Sensing Ion Channels (ASICs) which are directly implicated in pain signal transmission. Theralpha is also developing an analgesic venom derived peptide generated at Protherapeutics, a National University of Singapore (NUS) spin-off, and licensed worldwide to Theralpha.
More

Contact

Value chain

  • Research
  • Preclinical
  • Clinical

Business Model

  • Product Developer - biopharmaceuticals

Activities

  • Other

Application Fields

  • Human Health
  • Pediatrics
  • Inflammatory Diseases
  • CNS related Diseases
  • Other
Close

Theranostics Health, Inc. - USA

Theranostics Health is a proteomics-based diagnostics company that provides research services to drug development companies and is developing diagnostic tests to enable personalized cancer therapies tailored to each patient’s tumor. Our technologies are of particular use for companies developing Molecular Targeted Therapies allow insights into the phospho-activation status of drug targets and re...
Theranostics Health is a proteomics-based diagnostics company that provides research services to drug development companies and is developing diagnostic tests to enable personalized cancer therapies tailored to each patient’s tumor. Our technologies are of particular use for companies developing Molecular Targeted Therapies allow insights into the phospho-activation status of drug targets and receptors, their downstream pathways, and potential survival or adaptive mechanisms within targeted cell populations.
More

Contact

  • Firstname / Lastname :
    Corinne Ramos
  • Job title :
    Executive Director of Clinical Research
  • Email :
    cramos@theranosticshealth.com
  • Phone :
    301-251-4443

Value chain

  • Research

Business Model

  • Service Provider - scientifique

Activities

  • Protein / Proteomics
  • Diagnostics / Analysis Methods

Application Fields

  • Immunology
  • Inflammatory Diseases
  • Cancer

Needs and interest

  • R&d Partnership
Close

Tocagen Inc - USA

Tocagen Inc. is a US based, clinical stage, biopharmaceutical company with a focus in oncology. Tocagen is initially pursuing treatments for patients with advanced cancer for whom we believe no adequate treatment currently exists.
Tocagen Inc. is a US based, clinical stage, biopharmaceutical company with a focus in oncology. Tocagen is initially pursuing treatments for patients with advanced cancer for whom we believe no adequate treatment currently exists.
More

Contact

Value chain

  • Research
  • Preclinical
  • Clinical
  • Manufacturing / Production
  • Marketing / Distribution

Business Model

  • Product Developer - biopharmaceuticals

Activities

  • Gene / Genomics
  • Vaccine
  • Imagery
  • Diagnostics / Analysis Methods
  • Biomanufacturing
  • Preclinical Trials
  • Drug Discovery
  • Medical Device
  • Drug Delivery
  • Models (animal, cellular, ...)

Application Fields

  • Animal Health
  • Immunology
  • Infectious Diseases
  • Genetic / Rare Diseases
  • Inflammatory Diseases
  • Orhpan Diseases
  • Cancer
  • CNS related Diseases

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
  • Commercial Development
Close

Triana Life Sciences - USA

With offices in Paris, NYC, Philadelphia and San Jose (CA), Triana Life Sciences assists biotech, pharma and medical device companies with expansion between the US, EU and Israel.  Our services and assistance range from analysis and strategic planing to market entry and commercialization.  Some of our commercialization operations include: securing partnerships, licensing agreements and dist...

With offices in Paris, NYC, Philadelphia and San Jose (CA), Triana Life Sciences assists biotech, pharma and medical device companies with expansion between the US, EU and Israel.  Our services and assistance range from analysis and strategic planing to market entry and commercialization.  Some of our commercialization operations include: securing partnerships, licensing agreements and distribution and commercialization channels.

More

Contact

  • Firstname / Lastname :
    Antonio Pinto
  • Job title :
    Business Development
  • Email :
    apinto@trianagroup.com
  • Phone :
    (646) 417-8136 x 706

Value chain

  • Other

Business Model

  • Service Provider - scientifique
  • Service Provider - non scientifique

Activities

  • Other

Application Fields

  • Animal Health
  • Human Health
  • Immunology
  • Infectious Diseases
  • Allergology
  • Genetic / Rare Diseases
  • Nutrition / Food
  • Pediatrics
  • Geriatrics
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Orhpan Diseases
  • Metabolic Diseases
  • Cancer
  • Dermocosmetics
Close

TriStar Technology Group, LLC - USA

TriStar is based in Rockville, MD with archived human tissue repositories (>2.5 million samples) and scientific personnel located in Hamburg (Germany), Catania (Italy) and Madrid (Spain). Our large-scale (>4100 donor) Multi-Tumor and Normal arrays provide valuable information on target expression in over 120 cancers and 76 human normal tissues. Cancer specific prognosis arrays (1500 – 2800...
TriStar is based in Rockville, MD with archived human tissue repositories (>2.5 million samples) and scientific personnel located in Hamburg (Germany), Catania (Italy) and Madrid (Spain). Our large-scale (>4100 donor) Multi-Tumor and Normal arrays provide valuable information on target expression in over 120 cancers and 76 human normal tissues. Cancer specific prognosis arrays (1500 – 2800 donors per tumor type) relate target expression/amplification to histological sub-types, 5-year outcome data (prognosis, progression, treatment & response) and molecular markers. TriStar’s business model encompasses fee-for-service projects as well as providing standard and custom arrays to customers in Europe, Japan & USA. TriStar offers in-vitro as well as in-vivo assays for the screening of small molecule compounds and therapeutic antibodies on Human Cancer Stem Cells (CSCs) of Breast, Colon, Lung (NSCL & SCLC), Glioblastoma, Melanoma, Ovarian & Thyroid Cancers
More

Contact

Value chain

  • Research
  • Preclinical
  • Clinical

Business Model

  • Service Provider - CRO
  • Product Developer - biopharmaceuticals

Activities

  • Gene / Genomics
  • Tissue / Cells
  • Diagnostics / Analysis Methods
  • Drug Discovery
  • Models (animal, cellular, ...)
  • Biobank

Application Fields

  • Cancer

Needs and interest

  • R&d Partnership
  • Commercial Development
Close

UNCONNECT - USA

UNICONNECT is an innovative life science software company specializing in process managment, laboratory software and advanced data analytics. Our core product is the UNIFlow™ Laboratory Process Management System UNIFlow by UNIConnect is a powerful and unique software solution that provides the flexibility, adaptability and control laboratories and their customers need to achieve their objectives...
UNICONNECT is an innovative life science software company specializing in process managment, laboratory software and advanced data analytics. Our core product is the UNIFlow™ Laboratory Process Management System UNIFlow by UNIConnect is a powerful and unique software solution that provides the flexibility, adaptability and control laboratories and their customers need to achieve their objectives. UNIFlow is completely different. Infinitely better. UNIFlow does what off-the-shelf LIMS can’t: Tracks & manages any level of process complexity Enables user customized applications Allows easy, ongoing modifications after implementation And UNIFlow makes conventional systems obsolete: Configuration and implementation takes weeks, not months. It removes limits of other systems, enabling capabilities that would otherwise be impossible Special capabilities in genomic science for personalized medicine. Scalable from small organizations to global organizations requiring global distributed laboratory networks.
More

Contact

Value chain

  • Research
  • Preclinical
  • Clinical
  • Manufacturing / Production
  • Marketing / Distribution

Business Model

  • Other

Activities

  • Protein / Proteomics
  • Vaccine
  • Diagnostics / Analysis Methods
  • Clinical Trials
  • Drug Discovery
  • Biobank
  • Bioinformatics / Modeling
  • Other

Application Fields

  • Animal Health
  • Human Health
  • Immunology
  • Infectious Diseases
  • Allergology
  • Genetic / Rare Diseases
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Orhpan Diseases
  • Metabolic Diseases
  • Cancer
  • CNS related Diseases

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
Close

Valens Therapeutics, Inc. - USA

Developing the next generation novel therapeutics for the ophthalmology, oncology and infectious diseases markets. The company is seeking partners/funding/collaborations to develop its proprietary technology platform of molecules.
Developing the next generation novel therapeutics for the ophthalmology, oncology and infectious diseases markets. The company is seeking partners/funding/collaborations to develop its proprietary technology platform of molecules.
More

Contact

Activities

  • Other

Application Fields

  • Infectious Diseases
  • Cancer
Close

ValiRx Plc - UNITED KINGDOM

ValiRx Plc is a biopharmaceutical company developing novel technologies and products in oncology therapeutics and diagnostics. The product focus is in the epigenomic analysis and treatment of cancer, but the technologies can be applied to other fields as well, such as neurology and inflammatory diseases.
ValiRx Plc is a biopharmaceutical company developing novel technologies and products in oncology therapeutics and diagnostics. The product focus is in the epigenomic analysis and treatment of cancer, but the technologies can be applied to other fields as well, such as neurology and inflammatory diseases.
More

Contact

Value chain

  • Research
  • Preclinical

Business Model

  • Product Developer - biopharmaceuticals

Activities

  • Gene / Genomics

Application Fields

  • Human Health
  • Orhpan Diseases
  • Cancer

Needs and interest

  • R&d Partnership
  • Commercial Development
Close

Valysco - FRANCE

VALYSCO is an “operational consultancy organization” dedicated to the development of Life Sciences through the counselling of private and public stake holders in human, animal, plant health and nutrition. Today, in the Life Sciences world, globalisation and multiple scientific breakthroughs generate the need for both broad multidisciplinary vision and in depth expertise. In an international en...
VALYSCO is an “operational consultancy organization” dedicated to the development of Life Sciences through the counselling of private and public stake holders in human, animal, plant health and nutrition. Today, in the Life Sciences world, globalisation and multiple scientific breakthroughs generate the need for both broad multidisciplinary vision and in depth expertise. In an international environment, VALYSCO contributes to a more efficient global & transversal development of your projects through the commitment of its senior professionals. . VALYSCO masters the Life Sciences value chain from research to market, from prevention (nutrition, vaccines, diagnostics…) to treatment (pharmaceuticals, diagnostics…) and well being monitoring.
More

Contact

Business Model

  • Service Provider - scientifique
  • Service Provider - non scientifique
  • Product Developer - biopharmaceuticals

Activities

  • Vaccine
  • Diagnostics / Analysis Methods
  • Biomanufacturing

Application Fields

  • Animal Health
  • Human Health
  • Immunology
  • Infectious Diseases

Needs and interest

  • Commercial Development
Close

VARNISS, LLC - USA

VARNISS, L.L.C. is a life science company focused on advancing the discovery and development of products and services for imaging, diagnostics, and therapy. The company is specialized in providing custom contract services in Basic and Applied Research, and in production of recombinant fusion proteins in bacterial cells for clients in academia, government, and industry.
VARNISS, L.L.C. is a life science company focused on advancing the discovery and development of products and services for imaging, diagnostics, and therapy. The company is specialized in providing custom contract services in Basic and Applied Research, and in production of recombinant fusion proteins in bacterial cells for clients in academia, government, and industry.
More

Contact

Value chain

  • Research
  • Manufacturing / Production

Business Model

  • Service Provider - CRO
  • Service Provider - scientifique
  • Product Developer - biopharmaceuticals

Activities

  • Gene / Genomics
  • Protein / Proteomics
  • Tissue / Cells
  • Biomanufacturing
  • Drug Discovery
  • Nanotechnology

Application Fields

  • Geriatrics
  • Inflammatory Diseases
  • Cancer

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
  • Commercial Development
Close

VARNISS, LLC - USA

More

Contact

Value chain

  • Research
  • Manufacturing / Production
  • Marketing / Distribution

Business Model

  • Service Provider - CRO
  • Service Provider - scientifique
  • Product Developer - biopharmaceuticals

Activities

  • Gene / Genomics
  • Protein / Proteomics
  • Tissue / Cells
  • Imagery
  • Lab Equipment
  • Biomanufacturing
  • Drug Discovery
  • Drug Delivery
  • Cell Therapy
  • Bioinformatics / Modeling
  • Nanotechnology

Application Fields

  • Infectious Diseases
  • Inflammatory Diseases
  • Cancer
  • Dermocosmetics

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
  • Commercial Development
Close

Venture Valuation - SWITZERLAND

Venture Valuation specializes in independent assessment and valuation of technology-driven companies in growth industries, such as the Life Sciences (Biotech, Pharma, Medtech), ICT, high-tech, Nanotech, Cleantech and Renewable energy. In addition to valuation products, Venture Valuation offers high-quality, focused information services. Through our focus and unique position, we strive to fulfill a...
Venture Valuation specializes in independent assessment and valuation of technology-driven companies in growth industries, such as the Life Sciences (Biotech, Pharma, Medtech), ICT, high-tech, Nanotech, Cleantech and Renewable energy. In addition to valuation products, Venture Valuation offers high-quality, focused information services. Through our focus and unique position, we strive to fulfill and surpass our customer needs and add value to the partnership. Clients include investors, companies and development agencies.
More

Contact

Value chain

  • Other

Business Model

  • Service Provider - non scientifique

Activities

  • Other

Needs and interest

  • Commercial Alliance - Comarketing
Close

VIVALIS - FRANCE

VIVALIS (Euronext: VLS) is a biopharmaceutical company that provides innovative cell-based solutions to the pharmaceutical industry for the manufacture of vaccines and proteins, and develops drugs for the prevention and treatment of unmet medical needs.
VIVALIS (Euronext: VLS) is a biopharmaceutical company that provides innovative cell-based solutions to the pharmaceutical industry for the manufacture of vaccines and proteins, and develops drugs for the prevention and treatment of unmet medical needs.
More

Contact

  • Firstname / Lastname :
    Frederic Legros
  • Job title :
    Director Business Development
  • Email :
    fredericlegros@vivalis.com
  • Phone :
    +33 2 28 07 37 10

Value chain

  • Research
  • Preclinical
  • Clinical
  • Manufacturing / Production

Business Model

  • Product Developer - pharmaceuticals
  • Product Developer - biopharmaceuticals

Activities

  • Vaccine
  • Biomanufacturing
  • Drug Discovery

Application Fields

  • Human Health
  • Infectious Diseases
  • Cancer

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
Close

Voisin Consulting Life Sciences - FRANCE

Voisin Consulting Life Sciences assists in the design and implementation of customized regulatory strategies for the development and registration of innovative healthcare products. We support product developers in their efforts to respond to current and future regulatory requirements while enabling them to manage their stakeholders demands through high-quality scientific and regulatory expertise. ...
Voisin Consulting Life Sciences assists in the design and implementation of customized regulatory strategies for the development and registration of innovative healthcare products. We support product developers in their efforts to respond to current and future regulatory requirements while enabling them to manage their stakeholders demands through high-quality scientific and regulatory expertise. We prepare lean submissions containing only essential data. We have proven this works and trust this makes us different. Motivated by the innovation of our client’s products and our drive to move products from Research to Development and then on to Market, we provide a broad range of synergistic, client-orientated services. Our contemporary approach to product development is delivered by experienced scientific and regulatory experts. Created in 1997 by Dr. Emmanuelle M. Voisin, Voisin Consulting Life Sciences is an ISO 9001:2008 certified company with a presence in France, USA, Switzerland, Singapore and India. We strive to maintain a close-to-client, integrated structure working as a single team that provides enhanced communication, reactivity and flexibility.
More

Contact

Value chain

  • Preclinical
  • Clinical
  • Manufacturing / Production

Business Model

  • Service Provider - scientifique
  • Service Provider - non scientifique
  • Product Developer - pharmaceuticals
  • Product Developer - biopharmaceuticals
  • Product Developer - other health

Activities

  • Gene / Genomics
  • Protein / Proteomics
  • Chemistry
  • Vaccine
  • Tissue / Cells
  • Diagnostics / Analysis Methods
  • Biomanufacturing
  • Clinical Trials
  • Preclinical Trials
  • Drug Discovery
  • Medical Device
  • Drug Delivery
  • Cell Therapy
  • Biobank
  • Nanotechnology

Application Fields

  • Human Health
  • Immunology
  • Infectious Diseases
  • Allergology
  • Genetic / Rare Diseases
  • Nutrition / Food
  • Pediatrics
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Orhpan Diseases
  • Metabolic Diseases
  • Cancer
  • Dermocosmetics
  • CNS related Diseases

Needs and interest

  • R&d Partnership
Close

Voisin Consulting Life Sciences - USA

More

Contact

Value chain

  • Other

Activities

  • Other

Application Fields

  • Immunology
  • Infectious Diseases
  • Genetic / Rare Diseases
  • Pediatrics
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Orhpan Diseases
  • Metabolic Diseases
  • Cancer
Close

Womble Carlyle Sandridge & Rice, PLLC - USA

Full-service business law firm
Full-service business law firm
More

Contact

  • Firstname / Lastname :
    Kel Chin
  • Job title :
    Sales Director
  • Email :
    kchin@wcsr.com
  • Phone :
    7037907918

Activities

  • Other
Close

WTS Patent Attorneys - POLAND

The WTS Partnership is a patent attor- ney practice whose goal is to provide aid in all matters connected with the protection, transfer and commerciali- sation of intellectual property rights. The partnership was formed in 2002 by three patent attorneys who combined their experience, gathered over sev- eral years, from working at other pat- ent agencies. The patent attorneys representing our pract...
The WTS Partnership is a patent attor- ney practice whose goal is to provide aid in all matters connected with the protection, transfer and commerciali- sation of intellectual property rights. The partnership was formed in 2002 by three patent attorneys who combined their experience, gathered over sev- eral years, from working at other pat- ent agencies. The patent attorneys representing our practice are licensed to represent clients in matters relating to the protection of intellectual prop- erty rights before Polish administrative bodies, as well as their counterparts in the European Union, meaning the Eu- ropean Patent Office (EPO) as well as the Office of Harmonisation of the In- ternal Market (OHIM). Our firm has of- fices in Wroc?aw and Warsaw, and the Munich office opened in 2004.
More

Contact

  • Firstname / Lastname :
    Marcin Ciuk
  • Job title :
    Patent Agent
  • Email :
    ciuk@wtspatent.pl

Value chain

  • Other

Business Model

  • Other

Activities

  • Other
Close

WTS Patent Attorneys - POLAND

More

Contact

  • Firstname / Lastname :
    Anna Grzelak
  • Job title :
    Patent Attorney
  • Email :
    grzelak@wtspatent.pl
  • Phone :
    +48 601541345

Value chain

  • Other

Business Model

  • Other

Activities

  • Gene / Genomics
  • Protein / Proteomics
  • Chemistry
  • Vaccine
  • Tissue / Cells
  • Drug Discovery
  • Medical Device
  • Drug Delivery
  • Bioinformatics / Modeling
  • Other
  • Nanotechnology

Application Fields

  • Other

Needs and interest

  • R&d Partnership
  • Commercial Development
Close

Research Center or laboratory

Assistance Publique - Hôpitaux de Paris - FRANCE

Paris Public Hospital Authority gathers 37 hospitals, a homecare unit, a pharmaceutical establishment, and 37 training centers. It employs more than 90 000 persons and manages more than 1 million admissions per year for its medical activities. Researches performed at AP-HP include many therapeutic areas among which infectious, oncology, neurology, inflammatory, cardiology, paediatrics... The Offic...
Paris Public Hospital Authority gathers 37 hospitals, a homecare unit, a pharmaceutical establishment, and 37 training centers. It employs more than 90 000 persons and manages more than 1 million admissions per year for its medical activities. Researches performed at AP-HP include many therapeutic areas among which infectious, oncology, neurology, inflammatory, cardiology, paediatrics... The Office of Technology Transfer & Industrial Partnerships (OTT&PI) proposes technologies offers from its portfolio of 400 active patents for medical products in various fields: health care delivery, medical device, gene and cell therapies, drug discovery, genetics, diagnostics...
More

Contact

  • Firstname / Lastname :
    Emanuelle Pascolo-Rebouillat
  • Job title :
    Head of Business Development
  • Email :
    emanuelle.pascolo@sls.aphp.fr
  • Phone :
    (33) 144841718

Value chain

  • Research
  • Preclinical
  • Clinical
  • Manufacturing / Production

Business Model

  • Service Provider - CRO
  • Product Developer - pharmaceuticals
  • Product Developer - biopharmaceuticals
  • Product Developer - other health

Activities

  • Gene / Genomics
  • Protein / Proteomics
  • Vaccine
  • Tissue / Cells
  • Imagery
  • Lab Equipment
  • Diagnostics / Analysis Methods
  • Clinical Trials
  • Drug Discovery
  • Medical Device
  • Drug Delivery
  • Instrumentation
  • Cell Therapy
  • Models (animal, cellular, ...)
  • Biobank
  • Bioinformatics / Modeling

Application Fields

  • Animal Health
  • Human Health
  • Immunology
  • Infectious Diseases
  • Allergology
  • Genetic / Rare Diseases
  • Nutrition / Food
  • Pediatrics
  • Geriatrics
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Orhpan Diseases
  • Metabolic Diseases
  • Cancer
  • Dermocosmetics
  • CNS related Diseases

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
  • Commercial Development
Close

Assistance Publique - Hôpitaux de Paris - FRANCE

More

Contact

Value chain

  • Research
  • Preclinical
  • Clinical
  • Manufacturing / Production

Business Model

  • Service Provider - CRO
  • Product Developer - pharmaceuticals
  • Product Developer - biopharmaceuticals
  • Product Developer - other health

Activities

  • Gene / Genomics
  • Protein / Proteomics
  • Vaccine
  • Tissue / Cells
  • Imagery
  • Lab Equipment
  • Diagnostics / Analysis Methods
  • Clinical Trials
  • Drug Discovery
  • Medical Device
  • Drug Delivery
  • Instrumentation
  • Cell Therapy
  • Models (animal, cellular, ...)
  • Biobank
  • Bioinformatics / Modeling

Application Fields

  • Animal Health
  • Human Health
  • Immunology
  • Infectious Diseases
  • Allergology
  • Genetic / Rare Diseases
  • Nutrition / Food
  • Pediatrics
  • Geriatrics
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Orhpan Diseases
  • Metabolic Diseases
  • Cancer
  • Dermocosmetics
  • CNS related Diseases

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
  • Commercial Development
Close

BioMimetic Therapeutics, Inc. - USA

BioMimetic Therapeutics (NASDAQ: BMTI) is a biotechnology company specializing in the development and commercialization of innovative drug-device combination products to promote the healing of musculoskeletal injuries and diseases, including orthopedic, spine and sports injury applications. All products developed by BioMimetic are based upon recombinant human platelet-derived growth factor (rhPDGF...
BioMimetic Therapeutics (NASDAQ: BMTI) is a biotechnology company specializing in the development and commercialization of innovative drug-device combination products to promote the healing of musculoskeletal injuries and diseases, including orthopedic, spine and sports injury applications. All products developed by BioMimetic are based upon recombinant human platelet-derived growth factor (rhPDGF-BB) platform technology, which is a synthetic form of PDGF, one of the body's principal agents to stimulate and direct healing and regeneration. Through the commercialization of this patented technology, BioMimetic seeks to become the leading company in the field of regenerative medicine by providing new treatment options for the repair of bone, cartilage, tendons and ligaments, thus helping patients recover faster from their orthopedic injuries.
More

Contact

Activities

  • Drug Discovery
  • Medical Device
Close

BIOTRIAL International - UNITED KINGDOM

Founded in 1989, Biotrial is a leading full-service provider specialized in Early Development with a large range of services from Non-Clinical Pharmacology, Phase I studies, Phase II-IV Trial Management, Oncology, Data Management, Biostatistics, ECG & Imaging Core Lab, Regulatory Affairs to Medical Writing. Based in France (Paris & Rennes), the United Kingdom (London), and Belgium (Brussel...
Founded in 1989, Biotrial is a leading full-service provider specialized in Early Development with a large range of services from Non-Clinical Pharmacology, Phase I studies, Phase II-IV Trial Management, Oncology, Data Management, Biostatistics, ECG & Imaging Core Lab, Regulatory Affairs to Medical Writing. Based in France (Paris & Rennes), the United Kingdom (London), and Belgium (Brussels), with an international team of 250 people, Biotrial performs hundreds of studies a year and offers tailor-made solutions to Pharma and Biotech companies. For 2011, Biotrial is pleased to announce a doubling of research capacity in Rennes, an increase in beds in the Paris Unit, a sales presence in Belgium and the disclosure of the site for the US Phase I Clinic.
More

Contact

Business Model

  • Service Provider - CRO

Activities

  • Clinical Trials
  • Preclinical Trials
  • Drug Discovery

Application Fields

  • Animal Health
  • Human Health
  • Immunology
  • Infectious Diseases
  • Allergology
  • Genetic / Rare Diseases
  • Nutrition / Food
  • Geriatrics
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Orhpan Diseases
  • Metabolic Diseases
  • Cancer
  • Dermocosmetics
  • CNS related Diseases

Needs and interest

  • Commercial Development
Close

BIOTRIAL International - USA

More

Contact

  • Firstname / Lastname :
    Stephane Marin
  • Job title :
    Senior Director, Business Development
  • Email :
    smarin@biotrial.com

Value chain

  • Research
  • Preclinical
  • Clinical

Business Model

  • Service Provider - CRO

Activities

  • Clinical Trials
  • Preclinical Trials
  • Drug Discovery

Application Fields

  • Animal Health
  • Human Health
  • Immunology
  • Infectious Diseases
  • Allergology
  • Genetic / Rare Diseases
  • Nutrition / Food
  • Geriatrics
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Orhpan Diseases
  • Metabolic Diseases
  • Cancer
  • Dermocosmetics
  • CNS related Diseases

Needs and interest

  • Commercial Development
Close

Coldstream Laboratories Inc. - USA

Coldstream Laboratories utilizes a 20,000 sq.ft. state-of-the-art sterile manufacturing facility to provide advanced cGMP Manufacturing services to meet your needs. Our facility design is centered around mobile isolator technology that provides an ISO 5 environment during processing, as well as product containment for potent, cytotoxic, and radiolabeled products. Our facility is FDA approved and o...
Coldstream Laboratories utilizes a 20,000 sq.ft. state-of-the-art sterile manufacturing facility to provide advanced cGMP Manufacturing services to meet your needs. Our facility design is centered around mobile isolator technology that provides an ISO 5 environment during processing, as well as product containment for potent, cytotoxic, and radiolabeled products. Our facility is FDA approved and our regulatory history includes successful completion of numerous client audits.
More

Contact

Business Model

  • Service Provider - CRO
  • Service Provider - CMO

Activities

  • Other
Close

EXTRACTA MOLÉCULAS NATURAIS S.A. - BRAZIL

EXTRACTA MISSION is to exploit the immense genetic resources of Brazil to make full use of natural products in the discovery and development of better and safer medicines, in close collaboration with research-oriented industrial clients. EXTRACTA is a private, closed capital CRO fully dedicated to bring Brazilian biodiversity to the Pharma market. It is the only private company in Brazil with unre...
EXTRACTA MISSION is to exploit the immense genetic resources of Brazil to make full use of natural products in the discovery and development of better and safer medicines, in close collaboration with research-oriented industrial clients. EXTRACTA is a private, closed capital CRO fully dedicated to bring Brazilian biodiversity to the Pharma market. It is the only private company in Brazil with unrestricted territorial legal access to Brazillian biodiversity.
More

Contact

  • Firstname / Lastname :
    Antonio Paes de Carvalho
  • Job title :
    President - CEO
  • Email :
    apc@extracta.com.br

Value chain

  • Research

Business Model

  • Service Provider - CRO

Activities

  • Drug Discovery

Application Fields

  • Human Health
  • Infectious Diseases
  • Metabolic Diseases
  • Dermocosmetics

Needs and interest

  • R&d Partnership
Close

Fox Chase Cancer Center - USA

Combining research in many disciplines with patient care enables Fox Chase Cancer Center (FCCC) to translate new research findings into medical applications that may become models for improved cancer care. At any one time, about 170 clinical trials of new prevention, diagnostic and treatment techniques are under way. FCCC is also involved in developing trials to test new drugs that may prevent can...
Combining research in many disciplines with patient care enables Fox Chase Cancer Center (FCCC) to translate new research findings into medical applications that may become models for improved cancer care. At any one time, about 170 clinical trials of new prevention, diagnostic and treatment techniques are under way. FCCC is also involved in developing trials to test new drugs that may prevent cancer in high-risk individuals.
More

Contact

Value chain

  • Research
  • Preclinical
  • Clinical

Business Model

  • Other

Activities

  • Gene / Genomics
  • Clinical Trials
  • Preclinical Trials
  • Drug Discovery
  • Models (animal, cellular, ...)
  • Biobank

Application Fields

  • Immunology
  • Inflammatory Diseases
  • Orhpan Diseases
  • Cancer

Needs and interest

  • R&d Partnership
Close

Fox Chase Cancer Center - USA

More

Contact

Value chain

  • Research
  • Preclinical
  • Clinical

Business Model

  • Other

Activities

  • Vaccine
  • Clinical Trials
  • Preclinical Trials
  • Drug Discovery
  • Medical Device
  • Models (animal, cellular, ...)
  • Biobank

Application Fields

  • Immunology
  • Orhpan Diseases
  • Cancer

Needs and interest

  • R&d Partnership
Close

Fundación MEDINA - SPAIN

Fundación MEDINA is a non-profit Research Organization for the discovery of new compounds for unmet medical needs from internal R&D programs ( Infection and Parasitic Diseases, Oncology and Rare Diseases). Fundación MEDINA is a public–private partnership between Merck Sharp and Dohme de España S.A., the Junta de Andalucía, and the University of Granada. MEDINA focuses its activities in t...
Fundación MEDINA is a non-profit Research Organization for the discovery of new compounds for unmet medical needs from internal R&D programs ( Infection and Parasitic Diseases, Oncology and Rare Diseases). Fundación MEDINA is a public–private partnership between Merck Sharp and Dohme de España S.A., the Junta de Andalucía, and the University of Granada. MEDINA focuses its activities in two areas: - Proprietary research programs for the discovery of new leads from microbial natural products in top priority therapeutic areas. - Research contracts in high throughput screening and fee-for- service contracts for the preclinical evaluation of potential cardiovascular liabilities and adverse drug metabolism effects of novel candidates.
More

Contact

Value chain

  • Research
  • Preclinical

Business Model

  • Service Provider - CRO
  • Service Provider - scientifique
  • Product Developer - pharmaceuticals

Activities

  • Chemistry
  • Tissue / Cells
  • Drug Discovery

Application Fields

  • Animal Health
  • Human Health
  • Immunology
  • Infectious Diseases
  • Genetic / Rare Diseases
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Orhpan Diseases
  • Cancer
  • Dermocosmetics
  • CNS related Diseases

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
Close

GVK Biosciences Pvt. Ltd. - INDIA

GVK Biosciences (GVK BIO) is Asia’s leading Discovery Research and Development organization. GVK BIO provides a broad spectrum of services, stand-alone and integrated, across the R&D value chain. Our discovery services consist of Chemistry, Biology and Informatics; the development services include Clinical Research, Clinical Pharmacology and Process R&D. GVK BIO’s diverse portfolio of ...
GVK Biosciences (GVK BIO) is Asia’s leading Discovery Research and Development organization. GVK BIO provides a broad spectrum of services, stand-alone and integrated, across the R&D value chain. Our discovery services consist of Chemistry, Biology and Informatics; the development services include Clinical Research, Clinical Pharmacology and Process R&D. GVK BIO’s diverse portfolio of more than 150 customers includes some of the world’s largest pharmaceutical, biotechnology, agro, life-sciences companies and leading academic institutions. In line with its Vision to be a “Global Leader in Life-sciences Services”, GVK BIO has built capacities and capabilities across the R&D Value Chain. The service offering is aimed at accelerating the Time To Market (TTM) of the customer’s products by ensuring scientific delivery that is complemented with strong interdisciplinary project management across business units.
More

Contact

  • Firstname / Lastname :
    Ponarul Palanisamy
  • Job title :
    Sr. Manager, Business Development
  • Email :
    ponarul@gvkbio.com
  • Phone :
    +44 78468 44308

Value chain

  • Research
  • Preclinical
  • Clinical
  • Manufacturing / Production

Business Model

  • Service Provider - CRO
  • Service Provider - CMO
  • Service Provider - scientifique
  • Product Developer - pharmaceuticals

Activities

  • Chemistry
  • Clinical Trials
  • Preclinical Trials
  • Drug Discovery
  • Models (animal, cellular, ...)
  • Bioinformatics / Modeling
  • Other

Application Fields

  • Human Health
  • Infectious Diseases
  • Metabolic Diseases
  • Cancer
  • CNS related Diseases

Needs and interest

  • R&d Partnership
Close

ICARE LABORATORY - FRANCE

ICARE, a laboratory created in 1995, specializes in the control of contamination. This laboratory provides services in microbiology related sectors and works for national and international firms in the pharmaceutical, medical devices, veterinary and cosmetic sectors. The laboratory’s core activities are microbiological testing with validation, determining the effectiveness of disinfectants or an...
ICARE, a laboratory created in 1995, specializes in the control of contamination. This laboratory provides services in microbiology related sectors and works for national and international firms in the pharmaceutical, medical devices, veterinary and cosmetic sectors. The laboratory’s core activities are microbiological testing with validation, determining the effectiveness of disinfectants or antiseptics, process validations (steam sterilization, cleaning/decontamination …), qualifications, particulate and bacteriological testings as well as physical measurements of areas under controlled contamination. It provides, also, through its expertise, consulting, advice, training and support to control contamination. All the tests are carried out within an insurance quality system management, strictly respecting the ISO 9001, NF ISO 17025 standards and GLP, cGMP practises and also the requirements of the Food and Drug Administration. ICARE has been certified ISO 9001 since 1998 and accredited by COFRAC since 1999 and has obtained the status of pharmaceutical establishment since September 2007. ICARE chose the Clermont-Limagne biotechnology park to build its 2,000 m2 premises, half of which are pharmaceutical class D to class A cleanrooms.
More

Contact

Value chain

  • Other

Business Model

  • Service Provider - CRO
  • Service Provider - CMO

Activities

  • Diagnostics / Analysis Methods
  • Medical Device
  • Other

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
  • Commercial Development
Close

ICARE LABORATORY - FRANCE

More

Contact

Value chain

  • Other

Business Model

  • Service Provider - CRO

Activities

  • Diagnostics / Analysis Methods
  • Medical Device
  • Other

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
  • Commercial Development
Close

institut curie - FRANCE

Institut Curie is a leading comprehensive Cancer Center in Paris, France. It is a private foundation created by Marie Curie in 1909 with a staff of 3000 people (2000 in Hospital and 1000 in Research). Institut Curie's Technology Transfer & Licensing Dpt is looking for industrial partners to: - license our patents (120 families) - enter into preclinical R&D collaboration (drug discovery...)...
Institut Curie is a leading comprehensive Cancer Center in Paris, France. It is a private foundation created by Marie Curie in 1909 with a staff of 3000 people (2000 in Hospital and 1000 in Research). Institut Curie's Technology Transfer & Licensing Dpt is looking for industrial partners to: - license our patents (120 families) - enter into preclinical R&D collaboration (drug discovery...) - enter into early-stage clinical collaborations (our center received the label for French National Cancer Institute for early-stage clinical trials).
More

Contact

Activities

  • Gene / Genomics
  • Chemistry
  • Vaccine
  • Drug Discovery
  • Cell Therapy
  • Models (animal, cellular, ...)
  • Biobank
Close

Institut Pasteur - FRANCE

Private Foundation
Private Foundation
More

Contact

Value chain

  • Research

Business Model

  • Service Provider - scientifique

Activities

  • Gene / Genomics
  • Vaccine
  • Tissue / Cells
  • Preclinical Trials
  • Drug Discovery
  • Cell Therapy
  • Models (animal, cellular, ...)
  • Biobank

Application Fields

  • Immunology
  • Infectious Diseases
  • Allergology
  • Autoimmune Diseases

Needs and interest

  • R&d Partnership
Close

LORIA/CNRS - FRANCE

Our lab is focuing on chemoinformartics and structural bioinformatics
Our lab is focuing on chemoinformartics and structural bioinformatics
More

Contact

Value chain

  • Research

Business Model

  • Service Provider - scientifique

Activities

  • Chemistry
  • Drug Discovery
  • Bioinformatics / Modeling

Application Fields

  • Human Health
  • Infectious Diseases
  • Inflammatory Diseases
  • Metabolic Diseases
  • Cancer
  • CNS related Diseases

Needs and interest

  • R&d Partnership
Close

Lyon Science Transfert - FRANCE

Lyon Science Transfert is the technology transfer office of Université de Lyon.
Lyon Science Transfert is the technology transfer office of Université de Lyon.
More

Contact

Value chain

  • Research

Business Model

  • Product Developer - biopharmaceuticals

Activities

  • Gene / Genomics
  • Chemistry
  • Vaccine
  • Diagnostics / Analysis Methods
  • Drug Delivery
  • Instrumentation
  • Bioinformatics / Modeling
  • Nanotechnology

Application Fields

  • Human Health
  • Immunology
  • Infectious Diseases
  • Cancer
  • Dermocosmetics

Needs and interest

  • R&d Partnership
  • Commercial Development
Close

Mass Tech Tranfer Center - USA

The MTTC supports the commercialization of technology and supports start-up entrepreneurs.
The MTTC supports the commercialization of technology and supports start-up entrepreneurs.
More

Contact

Value chain

  • Research

Business Model

  • Other

Activities

  • Nanotechnology
Close

NasVax - ISRAEL

NasVax (TASE: NSVX) develops improved vaccines and immunotherapeutic products. The company has four distinct programs: anti-CD3 oral immunotherapy employing a monoclonal antibody for down-regulating pathogenic immune cells in inflammatory and auto-immune diseases; VaxiSome®, an adjuvant for enhancing the immunogenicity of vaccines and immunotherapeutics; group-common protein-based pneumococcal va...
NasVax (TASE: NSVX) develops improved vaccines and immunotherapeutic products. The company has four distinct programs: anti-CD3 oral immunotherapy employing a monoclonal antibody for down-regulating pathogenic immune cells in inflammatory and auto-immune diseases; VaxiSome®, an adjuvant for enhancing the immunogenicity of vaccines and immunotherapeutics; group-common protein-based pneumococcal vaccine; and BBS, an immunotherapeutic monoclonal antibody (MAb) for Alzheimer’s disease (AD). The company has ongoing collaborations with GlaxoSmithKline (GSK) for part of the pneumococcal vaccine program, and with Novartis for VaxiSome®.
More

Contact

  • Firstname / Lastname :
    Rom Eliaz
  • Job title :
    CEO
  • Email :
    rom@nasvax.com
  • Phone :
    972-8-9396577

Business Model

  • Product Developer - biopharmaceuticals

Activities

  • Vaccine

Application Fields

  • Immunology
Close

NIH - USA

National Institutes of Health
National Institutes of Health
More

Contact

Activities

  • Gene / Genomics
  • Tissue / Cells
Close

NJIT - USA

NJIT is the state's technological research university, committed to the pursuit of excellence-- in undergraduate, graduate, and continuing professional education, preparing students for productive careers and amplifying their potential for lifelong personal and professional growth; in the conduct of research with emphasis on applied, interdisciplinary efforts encompassing architecture, the science...
NJIT is the state's technological research university, committed to the pursuit of excellence-- in undergraduate, graduate, and continuing professional education, preparing students for productive careers and amplifying their potential for lifelong personal and professional growth; in the conduct of research with emphasis on applied, interdisciplinary efforts encompassing architecture, the sciences, including the health sciences, engineering, mathematics, transportation and infrastructure systems, information and communications technologies; in contributing to the state's economic development through the state's largest business incubator system, workforce development, joint ventures with government and the business community, and through the development of intellectual property; in service to both its urban environment and the broader society of the state and nation by conducting public policy studies, making educational opportunities widely available, and initiating community-building projects
More

Contact

  • Firstname / Lastname :
    Judith Sheft
  • Job title :
    Associate Vice President Technology Development
  • Email :
    sheft@njit.edu
  • Phone :
    973-596-5825

Value chain

  • Research

Business Model

  • Other

Activities

  • Chemistry
  • Tissue / Cells
  • Drug Discovery
  • Medical Device
  • Bioinformatics / Modeling
  • Nanotechnology

Needs and interest

  • R&d Partnership
Close

Theranostics Health, Inc. - USA

Theranostics Health is a proteomics-based diagnostics company that provides research services to drug development companies and is developing diagnostic tests to enable personalized cancer therapies tailored to each patient’s tumor. Our technologies are of particular use for companies developing Molecular Targeted and/or Combination Therapies as they allow insights into the phospho-activation st...
Theranostics Health is a proteomics-based diagnostics company that provides research services to drug development companies and is developing diagnostic tests to enable personalized cancer therapies tailored to each patient’s tumor. Our technologies are of particular use for companies developing Molecular Targeted and/or Combination Therapies as they allow insights into the phospho-activation status of drug targets and receptors, their downstream pathways, and potential survival or adaptive mechanisms within targeted cell populations.
More

Contact

Value chain

  • Research
  • Preclinical
  • Clinical

Business Model

  • Service Provider - CRO
  • Service Provider - scientifique

Activities

  • Protein / Proteomics
  • Diagnostics / Analysis Methods

Application Fields

  • Immunology
  • Cancer

Needs and interest

  • R&d Partnership
Close

Université Libre de Bruxelles - BELGIUM

The Biotechnology research activities of the Université Libre de Bruxelles (ULB) are led in top-level research units which are located in up-to-date facilities in Brussels and in Charleroi (Belgium), with a science park around Institutes for Biology and Molecular Medicine and for Medical Immunology. ULB also relies upon a network of an academic hospital and several university hospitals. Last but ...
The Biotechnology research activities of the Université Libre de Bruxelles (ULB) are led in top-level research units which are located in up-to-date facilities in Brussels and in Charleroi (Belgium), with a science park around Institutes for Biology and Molecular Medicine and for Medical Immunology. ULB also relies upon a network of an academic hospital and several university hospitals. Last but not least, a number of successful spin-off companies have emerged from ULB research activities
More

Contact

Value chain

  • Research

Activities

  • Gene / Genomics
  • Protein / Proteomics
  • Chemistry
  • Vaccine
  • Tissue / Cells
  • Imagery
  • Diagnostics / Analysis Methods
  • Drug Discovery
  • Medical Device
  • Drug Delivery
  • Cell Therapy
  • Models (animal, cellular, ...)
  • Biobank

Needs and interest

  • R&d Partnership
Close

University of Liege - BELGIUM

The University of Liege has strong assets in the fields of : - genoproteomics (GIGA) - medical imaging (cyclotron research center) - protein engineering (CIP) - cell therapy (LTCG) ... For more detailed information, see : www.ulg.ac.be or contact us
The University of Liege has strong assets in the fields of : - genoproteomics (GIGA) - medical imaging (cyclotron research center) - protein engineering (CIP) - cell therapy (LTCG) ... For more detailed information, see : www.ulg.ac.be or contact us
More

Contact

  • Firstname / Lastname :
    Isabelle RAUSIN
  • Job title :
    Senior Manager Project and Business Dev
  • Email :
    i.rausin@ulg.ac.be
  • Phone :
    + 32 4 349 85 14

Value chain

  • Research

Activities

  • Gene / Genomics
  • Imagery
  • Clinical Trials
  • Cell Therapy
  • Biobank

Needs and interest

  • R&d Partnership
Close

Vanderbilt University Medical Center - USA

Vanderbilt University Medical Center (VUMC) is a comprehensive healthcare facility dedicated to patient care, research, and biomedical education. Its reputation for excellence in each of these areas has made Vanderbilt a major patient referral center for the Mid-South. Each year, people throughout Tennessee and the Southeast choose Vanderbilt for their health care needs, not only because of its ex...
Vanderbilt University Medical Center (VUMC) is a comprehensive healthcare facility dedicated to patient care, research, and biomedical education. Its reputation for excellence in each of these areas has made Vanderbilt a major patient referral center for the Mid-South. Each year, people throughout Tennessee and the Southeast choose Vanderbilt for their health care needs, not only because of its excellence in medical science, but also because the faculty and staff are dedicated to treating patients with dignity and compassion. Vanderbilt's mission is to advance health and wellness through preeminent programs in patient care, education, and research.
More

Contact

Activities

  • Gene / Genomics
Close

Vanderbilt University School of Medicine - USA

More

Contact

Activities

  • Chemistry
Close

Cluster

Alsace BioValley - FRANCE

Alsace BioValley cluster, the gateway to biobusiness development in Europe! Its main mission is to federate all players – companies, research laboratories, universities – involved in life sciences/healthcare, efficiently supporting their growth in Alsace. Alsace BioValley being one of the 3 main bioclusters in France is your ideal partner for an easy access to: - Licensing opportunities -...

Alsace BioValley cluster, the gateway to biobusiness development in Europe! Its main mission is to federate all players – companies, research laboratories, universities – involved in life sciences/healthcare, efficiently supporting their growth in Alsace. Alsace BioValley being one of the 3 main bioclusters in France is your ideal partner for an easy access to: - Licensing opportunities - R&D collaborations and projects funding - Innovative technology platforms - Establishment of European subsidiaries. BioValley is also a leading trinational biocluster in Europe spreading over Alsace-France, South Baden-Germany, and Basel area-Switzerland.

More

Contact

Business Model

  • Service Provider - scientifique
  • Service Provider - non scientifique

Activities

  • Gene / Genomics
  • Chemistry
  • Imagery
  • Diagnostics / Analysis Methods
  • Biomanufacturing
  • Clinical Trials
  • Preclinical Trials
  • Drug Discovery
  • Medical Device
  • Drug Delivery
  • Models (animal, cellular, ...)
  • Biobank

Application Fields

  • Human Health
  • Genetic / Rare Diseases
  • Metabolic Diseases
  • Cancer
  • CNS related Diseases

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
Close

Alsace BioValley - FRANCE

More

Contact

Value chain

  • Research
  • Preclinical

Activities

  • Chemistry
  • Vaccine
  • Drug Discovery
  • Models (animal, cellular, ...)

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
  • Commercial Development
Close

ALSACE BIOVALLEY - FRANCE

Alsace Biovalley Cluster
Alsace Biovalley Cluster
More

Contact

  • Firstname / Lastname :
    Jean-Yves BONNEFOY
  • Job title :
    PRESIDENT
  • Email :
    brandt@transgene.fr
  • Phone :
    +33620885092

Activities

  • Vaccine

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
  • Commercial Development
Close

Alsace International/Alsace BioValley - USA

Focused on life science development through investment, partnership, R&D collaboration, licensing, transfer etc.
Focused on life science development through investment, partnership, R&D collaboration, licensing, transfer etc.
More

Contact

  • Firstname / Lastname :
    Andrew Clutz
  • Job title :
    Director
  • Email :
    a.clutz@alsace.com
  • Phone :
    7818947486

Activities

  • Other

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
  • Commercial Development
Close

Analgesia Partnership - FRANCE

Analgesia Partnership was founded in 2008 as a result of the outstanding dynamism of academics and businesses driven on the same idea: fostering the bench ? bedside Continuum in Pain Innovation. This One-Stop-Shop solution offers a platform of integrated services focused on pain profiling and proposes “à la carte” services, custom-tailored for your project and flexible to adapt to your result...
Analgesia Partnership was founded in 2008 as a result of the outstanding dynamism of academics and businesses driven on the same idea: fostering the bench ? bedside Continuum in Pain Innovation. This One-Stop-Shop solution offers a platform of integrated services focused on pain profiling and proposes “à la carte” services, custom-tailored for your project and flexible to adapt to your results. Academic and private experts bringing together their cultures towards innovation, will provide you with comprehensive and complementary services from drug discovery to clinics.
More

Contact

Value chain

  • Research
  • Preclinical
  • Clinical

Business Model

  • Service Provider - CRO
  • Service Provider - scientifique
  • Product Developer - pharmaceuticals

Activities

  • Chemistry
  • Clinical Trials
  • Preclinical Trials
  • Drug Discovery
  • Drug Delivery
  • Models (animal, cellular, ...)

Application Fields

  • CNS related Diseases

Needs and interest

  • R&d Partnership
  • Commercial Development
Close

ATLANPOLE BIOTHERAPIES - FRANCE

Atlanpole Biotherapies gives you access to extended skills, from biodiagnostic to biomedicine. For pharmaceutical and biotech companies or research laboratories looking for high level partners devoted to healthcare and biotechnologies, Atlanpole Biotherapies is a biocluster that draws together a network which offers comprehensive and competitive solutions along the entire biotherapeutic value chai...
Atlanpole Biotherapies gives you access to extended skills, from biodiagnostic to biomedicine. For pharmaceutical and biotech companies or research laboratories looking for high level partners devoted to healthcare and biotechnologies, Atlanpole Biotherapies is a biocluster that draws together a network which offers comprehensive and competitive solutions along the entire biotherapeutic value chain, from discovery to patient.
More

Contact

  • Firstname / Lastname :
    Gregory BAUER
  • Job title :
    International Marketing Manager
  • Email :
    bauer@atlanpole.fr
  • Phone :
    0033 (0)240251313

Value chain

  • Other

Business Model

  • Other

Activities

  • Other

Needs and interest

  • R&d Partnership
Close

BARCELONA SCIENCE PARK - SPAIN

The Barcelona Science Park is a meeting point where university, business and society come together. Its objective is to promote innovation, particularly in the life sciences. Parc Científic Barcelona Founded by the University of Barcelona in 1997, it was the first science park in Spain and is an international point of reference today in the promotion of innovation, with more than 2,000 profession...
The Barcelona Science Park is a meeting point where university, business and society come together. Its objective is to promote innovation, particularly in the life sciences. Parc Científic Barcelona Founded by the University of Barcelona in 1997, it was the first science park in Spain and is an international point of reference today in the promotion of innovation, with more than 2,000 professionals working there. The Barcelona Science Park goals: To potentiate quality research with the support of a wide range of technologies To revitalise the relation between university and business To promote the creation of new companies and institutions To further the science-society dialogue and encourage careers in science At present the park is home to 3 research institutes, 75 companies, an incubator for biotechnology companies and a wide range of research support technology. In addition, it organises more than 120 activities for the promotion of scientific culture and new careers in science, in which close to 6,000 people participate each year.
More

Contact

  • Firstname / Lastname :
    JESUS Purroy
  • Job title :
    SCIENTIFIC DIRECTOR
  • Email :
    jpurroy@pcb.ub.cat
  • Phone :
    +34934031243

Value chain

  • Research

Activities

  • Gene / Genomics
  • Protein / Proteomics
  • Chemistry
  • Tissue / Cells
  • Imagery
  • Diagnostics / Analysis Methods
  • Clinical Trials
  • Drug Discovery
  • Drug Delivery
  • Instrumentation
  • Cell Therapy
  • Models (animal, cellular, ...)
  • Biobank
  • Bioinformatics / Modeling
  • Nanotechnology

Application Fields

  • Animal Health
  • Human Health
  • Immunology
  • Infectious Diseases
  • Genetic / Rare Diseases
  • Nutrition / Food
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Orhpan Diseases
  • Metabolic Diseases
  • Cancer
  • Dermocosmetics
  • CNS related Diseases

Needs and interest

  • R&d Partnership
  • Commercial Development
Close

BayBio - USA

BayBio is an independent, non-profit 501(c)(6) trade association serving the life science industry in Northern California. The staff and services of BayBio are paid primarily through memberships, sponsorships, and event registration fees. BayBio provides these services through representatives in South San Francisco and through coalition partners in Washington, DC.
BayBio is an independent, non-profit 501(c)(6) trade association serving the life science industry in Northern California. The staff and services of BayBio are paid primarily through memberships, sponsorships, and event registration fees. BayBio provides these services through representatives in South San Francisco and through coalition partners in Washington, DC.
More

Contact

  • Firstname / Lastname :
    Misha Tsirulnikov
  • Job title :
    Vice President, Development and Program Strategy
  • Email :
    misha@baybio.org
  • Phone :
    650-871-7101 x205

Value chain

  • Other

Business Model

  • Other

Activities

  • Other
Close

Bioindustry Park Silvano Fumero/bioPmed - ITALY

Bioindustry Park Silvano Fumero S.p.A. is a science and technology park located in Canavese, near Turin in the north of Italy. The Park promotes and develops research in biotechnologies and Life Sciences, hosting enterprises of the chemical, pharmaceutical, diagnostic, bioengineering and information science fields. It offers research facilities, scientific and support services, such as technology ...
Bioindustry Park Silvano Fumero S.p.A. is a science and technology park located in Canavese, near Turin in the north of Italy. The Park promotes and develops research in biotechnologies and Life Sciences, hosting enterprises of the chemical, pharmaceutical, diagnostic, bioengineering and information science fields. It offers research facilities, scientific and support services, such as technology transfer, patent support, tutorin/mentoring of start-ups and spin-offs.bioPmed is the new Italian innovation cluster dedicated to bio and medical technologies created thanks to the intervention of Piemonte Region. bioPmed is based on a community of around 300 companies, 3 universities and different research center, foundations and associations acive in life sciences fields. 67 of such organizations have have signed in may 2009 an agreement to create, build, support and animate the local cluster. Such organizations are the core organizations of bioPmed cluster The initiative is led by Bioindustry Park Silvano Fumero, the local science & technology park founded in 1998 which, since its creation, worked as system integrator for the development of Life Sciences in the Region.
More

Contact

Value chain

  • Preclinical
  • Other

Business Model

  • Service Provider - CRO
  • Service Provider - scientifique
  • Service Provider - non scientifique

Activities

  • Imagery
  • Preclinical Trials
  • Drug Discovery
  • Other

Application Fields

  • Human Health

Needs and interest

  • R&d Partnership
Close

Cancer Campus - FRANCE

Cancer Campus aims at building the Paris biocluster dedicated to cancer innovation. On a site housing the largest European comprehensive cancer center (Institut Gustave Roussy, Villejuif, France), local authorities, academic and industrial partners are setting up together this ambitious project, located just a few minutes from Paris downtown. Alongside other large-scale structuring projects such a...
Cancer Campus aims at building the Paris biocluster dedicated to cancer innovation. On a site housing the largest European comprehensive cancer center (Institut Gustave Roussy, Villejuif, France), local authorities, academic and industrial partners are setting up together this ambitious project, located just a few minutes from Paris downtown. Alongside other large-scale structuring projects such as Genopole®, “Institut de la Vision” and “Institut du Cerveau et de la Moelle”, Cancer Campus is, in its field, contributing to positioning Paris region as one of the most attractive regions in Europe for medical innovation. Our Objectives: -Innovation Cancer Campus biocluster is based on a top-level research and training entity, working in synergy with innovative companies with the objective of accelerating therapeutic innovation for the benefit of patients. -Economics Cancer Campus is landscaping and developing a site where high added values activities and new jobs are being created.
More

Contact

Business Model

  • Other

Activities

  • Gene / Genomics
  • Protein / Proteomics
  • Imagery
  • Clinical Trials
  • Drug Discovery
  • Models (animal, cellular, ...)
  • Biobank
  • Bioinformatics / Modeling

Application Fields

  • Cancer

Needs and interest

  • R&d Partnership
Close

Cancer-Bio-Sante cluster - FRANCE

Cancer-Bio-Santé Cluster, located in Toulouse, is the French competitiveness cluster in France fully dedicated to the fight against Cancer, throughout a broad continuum approach involving prevention, diagnostics, therapeutics and patient monitoring. CBS supports companies from the Midi Pyrénées and Limousin regions, which develop innovative products in the fields of food & Health, Diagnosti...
Cancer-Bio-Santé Cluster, located in Toulouse, is the French competitiveness cluster in France fully dedicated to the fight against Cancer, throughout a broad continuum approach involving prevention, diagnostics, therapeutics and patient monitoring. CBS supports companies from the Midi Pyrénées and Limousin regions, which develop innovative products in the fields of food & Health, Diagnostics, Biomarkers, Nanotechnologies, Medical Devices, Immunotherapy, Therapeutics, Bioproduction, Biotechnologies and Telemedicine. These companies benefit from the second largest region in France in terms of academic research activity, with 500 laboratories and 9,000 researchers as well as clinicians from University hospitals and cancer centers.
More

Contact

Activities

  • Vaccine
  • Imagery
  • Drug Discovery
  • Medical Device
  • Drug Delivery
  • Models (animal, cellular, ...)
  • Nanotechnology

Application Fields

  • Cancer

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
Close

Cancer-Bio-Sante cluster - FRANCE

More

Contact

Activities

  • Vaccine
  • Imagery
  • Clinical Trials
  • Drug Discovery
  • Medical Device
  • Drug Delivery
  • Models (animal, cellular, ...)
  • Nanotechnology

Application Fields

  • Cancer

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
Close

Capbiotek - FRANCE

Capbiotek, the Bretagne biocluster where nature meets innovation. Thanks to Bretagne's exceptional marine and agricultural resources, a unique greentech environment, a world-class agrifood industry, high-level technological expertise and academic firepower, Bretagne is a major player in biotech and a leader in blue and green biotechnologies in France and in Europe as a whole.
Capbiotek, the Bretagne biocluster where nature meets innovation. Thanks to Bretagne's exceptional marine and agricultural resources, a unique greentech environment, a world-class agrifood industry, high-level technological expertise and academic firepower, Bretagne is a major player in biotech and a leader in blue and green biotechnologies in France and in Europe as a whole.
More

Contact

Business Model

  • Other

Activities

  • Other

Application Fields

  • Animal Health
  • Human Health
  • Nutrition / Food
  • Dermocosmetics

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
  • Commercial Development
Close

Eurobiomed

Eurobiomed is a non-for-profit organisation which has been accredited by the French government as a "competitive cluster". There are 71 "competitive clusters" in France and Eurobiomed is one of the eight Biotechnology - Pharma clusters. Eurobiomed federates healthcare stakeholders in both "Provence-Alpes-Côte d'Azur" and "Languedoc-Roussillon" counties of S...
Eurobiomed is a non-for-profit organisation which has been accredited by the French government as a "competitive cluster". There are 71 "competitive clusters" in France and Eurobiomed is one of the eight Biotechnology - Pharma clusters. Eurobiomed federates healthcare stakeholders in both "Provence-Alpes-Côte d'Azur" and "Languedoc-Roussillon" counties of South East of France. Considering the amount of companies, the research potential, the scientific excellence as well as the high-tech medical and research equipment dedicated to health innovation, Eurobiomed has been proposed as one of the main competitive clusters in Europe for healthcare. Historically, Eurobiomed was created on January 1st 2009 and is the results of the merger of three well-established clusters called Orpheme, Bioméditerranée and Holobiosud. This merger confirmed the industrial, clinical and scientific stakeholders' resolve to work together, gain in visibility, develop new collaborations and promote an R&D network along France's Mediterranean coast. Eurobiomed is now taking advantages of the synergies between the three original clusters to support the innovation in Life sciences. The merger results in a stronger structure, with a better strategic positioning, increased network, reinforced visibility and improved efficacy: With Eurobiomed, dive into the heart of medical innovation in the South of France! The dynamism of Eurobiomed's network is demonstrated by the strong day to day involvement of the industrials, the academic researchers and the governmental organizations that work towards the strategic development of this competitive cluster.
More

Contact

Value chain

  • Other

Business Model

  • Service Provider - non scientifique

Activities

  • Gene / Genomics
  • Protein / Proteomics
  • Chemistry
  • Vaccine
  • Tissue / Cells
  • Imagery
  • Diagnostics / Analysis Methods
  • Clinical Trials
  • Drug Discovery

Application Fields

  • Human Health
  • Immunology
  • Infectious Diseases
  • Genetic / Rare Diseases
  • Pediatrics
  • Orhpan Diseases
  • Cancer
  • Dermocosmetics
  • CNS related Diseases

Needs and interest

  • R&d Partnership
Close

EUROBIOMED - FRANCE

More

Contact

Activities

  • Other
Close

Genopole GIP - FRANCE

Genopole : A French Biotech and biotherapy dedicated science and business park, created in 1998 (under the impetus of the French Muscular Dystrophy Association (AFM) and with the support of the French Government and local authorities) is located in Evry, South-East of Paris. The number of campus labs and companies has kept on growing and currently stands at : - 21 academic laboratories - 67 biotec...
Genopole : A French Biotech and biotherapy dedicated science and business park, created in 1998 (under the impetus of the French Muscular Dystrophy Association (AFM) and with the support of the French Government and local authorities) is located in Evry, South-East of Paris. The number of campus labs and companies has kept on growing and currently stands at : - 21 academic laboratories - 67 biotech companies - 224,37 M€ raised by Genopole portfolio Companies - 24 molecules or biotherapies, from the regulatory preclinical phase through to market launch - 681 patents filed by Genopole portfolio Companies - 17 shared-use technology platforms and technical facilities. Genopole represents a total of 2,184 staff and constitutes a vast 87,000-sq.meter real estate development.
More

Contact

  • Firstname / Lastname :
    Gabriel Mergui
  • Job title :
    Director Genopole International
  • Email :
    gabriel.mergui@genopole.fr
  • Phone :
    +33(0)160878312

Business Model

  • Service Provider - scientifique
  • Service Provider - non scientifique

Activities

  • Gene / Genomics
  • Diagnostics / Analysis Methods
  • Drug Discovery
  • Medical Device
  • Cell Therapy
  • Models (animal, cellular, ...)
  • Bioinformatics / Modeling

Application Fields

  • Human Health
  • Infectious Diseases
  • Genetic / Rare Diseases
  • Nutrition / Food
Close

Genopole GIP - FRANCE

More

Contact

Business Model

  • Service Provider - scientifique
  • Service Provider - non scientifique

Activities

  • Gene / Genomics
  • Diagnostics / Analysis Methods
  • Drug Discovery
  • Cell Therapy
  • Models (animal, cellular, ...)
  • Bioinformatics / Modeling

Application Fields

  • Human Health
  • Infectious Diseases
  • Genetic / Rare Diseases
  • Nutrition / Food
Close

Genopole GIP - FRANCE

More

Contact

Business Model

  • Service Provider - scientifique
  • Service Provider - non scientifique

Activities

  • Gene / Genomics
  • Diagnostics / Analysis Methods
  • Drug Discovery
  • Medical Device
  • Cell Therapy
  • Models (animal, cellular, ...)
  • Bioinformatics / Modeling

Application Fields

  • Human Health
  • Infectious Diseases
  • Genetic / Rare Diseases
  • Nutrition / Food
Close

Genopole GIP - FRANCE

More

Contact

Business Model

  • Service Provider - scientifique
  • Service Provider - non scientifique

Activities

  • Gene / Genomics
  • Diagnostics / Analysis Methods
  • Drug Discovery
  • Medical Device
  • Cell Therapy
  • Models (animal, cellular, ...)
  • Bioinformatics / Modeling

Application Fields

  • Human Health
  • Infectious Diseases
  • Genetic / Rare Diseases
  • Nutrition / Food
Close

Genopole GIP - FRANCE

More

Contact

Business Model

  • Service Provider - scientifique
  • Service Provider - non scientifique

Activities

  • Gene / Genomics
  • Diagnostics / Analysis Methods
  • Drug Discovery
  • Medical Device
  • Cell Therapy
  • Bioinformatics / Modeling

Application Fields

  • Human Health
  • Infectious Diseases
  • Genetic / Rare Diseases
  • Nutrition / Food
Close

Genopole GIP - FRANCE

More

Contact

Business Model

  • Service Provider - scientifique
  • Service Provider - non scientifique

Activities

  • Gene / Genomics
  • Diagnostics / Analysis Methods
  • Drug Discovery
  • Cell Therapy
  • Models (animal, cellular, ...)
  • Bioinformatics / Modeling

Application Fields

  • Human Health
  • Infectious Diseases
  • Genetic / Rare Diseases
  • Nutrition / Food
Close

Genopole GIP - FRANCE

More

Contact

  • Firstname / Lastname :
    Yves Champey
  • Job title :
    Conseiller auprès de la Direction Générale
  • Email :
    yves.champay@genopole.fr

Business Model

  • Service Provider - scientifique
  • Service Provider - non scientifique

Activities

  • Gene / Genomics
  • Diagnostics / Analysis Methods
  • Drug Discovery
  • Medical Device
  • Cell Therapy
  • Models (animal, cellular, ...)
  • Bioinformatics / Modeling

Application Fields

  • Human Health
  • Infectious Diseases
  • Genetic / Rare Diseases
  • Nutrition / Food
Close

Lyonbiopole - FRANCE

Lyonbiopole is a world competitiveness cluster focused on infectious diseases, immune disorders, and cancers. Designed as a "factory" for multi-partner R&D projects, Lyonbiopole helps to link the industrial and academic spheres and bring them closer together. It aims to become an innovation driver, making the region and its firms ever more competitive. Lyonbiopole can put compan...

Lyonbiopole is a world competitiveness cluster focused on infectious diseases, immune disorders, and cancers. Designed as a "factory" for multi-partner R&D projects, Lyonbiopole helps to link the industrial and academic spheres and bring them closer together. It aims to become an innovation driver, making the region and its firms ever more competitive. Lyonbiopole can put companies in contact with strategic partners or integrate them into already existing collaborations for the development of vaccines, new biotherapies, diagnostics, theranostics, and drug delivery systems in the field of infectious diseases, immune disorders and cancers. Lyonbiopole helps companies: - Develop your network and identify strategic partners; - Innovate and set up R&D projects; - Gain access to public and private financing; - Development of your activity (internationalization, business development, etc.); - Settle your activity in fully equipped platform of excellence (BSL 2/3 labs, biomanufacturing, bioanalyses, etc.); - Access to equipped platform of excellence such as the Infectious Diseases Center, open in April 1st, 2009. Lyonbiopole reached in 2010 the second step of its infrastructure development policy by launching in Lyon-Gerland the construction of acCInov. AcCInov is an innovation platform of 6,000 sq.m dedicated to hosting start-ups and SMBs that will provide services in the areas of biological analysis and biomanufacturing.

In 2010, the main objectives of LYONBIOPOLE will be to strengthen our efforts for regarding funding and growth support of our SMBs as well as the emergence of collaborative projects and the preparation of the 3rd phase in the cluster development which should reach the creation of a real campus focused on technological innovation.

 In 2011, in the framework of the Investment for the Future program launched by French State, Lyonbiopole accredited the TRI (Technological Research Institute) project LyonBioTech jointly developed with the Institut Pasteur in Paris. This TRI project aims to develop a comprehensive and personalized management of infectious diseases.

More

Contact

  • Firstname / Lastname :
    Kevin Romani
  • Job title :
    International Project Manager
  • Email :
    kevin.romani@lyonbiopole.com
  • Phone :
    +33 (0)4 72 76 53 37

Activities

  • Vaccine
  • Diagnostics / Analysis Methods
  • Biomanufacturing
  • Drug Discovery
  • Drug Delivery

Application Fields

  • Animal Health
  • Human Health
  • Immunology
  • Infectious Diseases
  • Allergology
  • Nutrition / Food
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Orhpan Diseases
  • Cancer

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
Close

Lyonbiopole - FRANCE

More

Contact

Activities

  • Vaccine
  • Diagnostics / Analysis Methods
  • Biomanufacturing
  • Drug Discovery
  • Drug Delivery

Application Fields

  • Animal Health
  • Human Health
  • Immunology
  • Infectious Diseases
  • Allergology
  • Nutrition / Food
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Orhpan Diseases
  • Cancer

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
Close

Lyonbiopole - FRANCE

More

Contact

Activities

  • Vaccine
  • Diagnostics / Analysis Methods
  • Biomanufacturing
  • Drug Discovery
  • Drug Delivery

Application Fields

  • Animal Health
  • Human Health
  • Immunology
  • Infectious Diseases
  • Allergology
  • Nutrition / Food
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Orhpan Diseases
  • Cancer

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
Close

LYONBIOPOLE - FRANCE

More

Contact

  • Firstname / Lastname :
    Philippe ARCHINARD
  • Job title :
    PRESIDENT
  • Email :
    archinard@transgene.fr
  • Phone :
    +33 676 68 08 86

Activities

  • Other
Close

MEDICEN - FRANCE

Cluster for innovative therapies and advanced technologies in healthcare.

Medicen Paris Region is the cluster for innovative therapies and advanced technologies in healthcare of the Paris Region. It has three core activities: 1) Catalizing economic growth and employement in thriving markets by successfully interlacing start-ups/SMEs, multinationals, academic laboratories, hospita...

Cluster for innovative therapies and advanced technologies in healthcare.

Medicen Paris Region is the cluster for innovative therapies and advanced technologies in healthcare of the Paris Region. It has three core activities: 1) Catalizing economic growth and employement in thriving markets by successfully interlacing start-ups/SMEs, multinationals, academic laboratories, hospitals, training organizations and healthcare providers and promoting innovative technology transfer; 2) Reinforcing the international competitiveness of the healthcare and medtech sector by stimulating the region's innovative capacity; Boosting the Paris region's attractiveness and dynamism

More

Contact

Business Model

  • Service Provider - non scientifique

Activities

  • Other

Application Fields

  • Human Health
  • Infectious Diseases
  • Genetic / Rare Diseases
  • Orhpan Diseases
  • Metabolic Diseases
  • Cancer

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
Close

Medicen Paris Region - FRANCE

More

Contact

  • Firstname / Lastname :
    Igor Beitia Ortiz de Zarate
  • Job title :
    Senior Project Manager - Europe and International
  • Email :
    ibeitia@medicen.org
  • Phone :
    +33144493184

Activities

  • Other

Needs and interest

  • R&d Partnership
Close

Nansen Neuroscience Network - NORWAY

Neuroscience Network Connecting Industry and science
Neuroscience Network Connecting Industry and science
More

Contact

Value chain

  • Research
  • Preclinical
  • Clinical
  • Other

Activities

  • Clinical Trials
  • Preclinical Trials
  • Other

Application Fields

  • Human Health

Needs and interest

  • Commercial Development
Close

Oslo Cancer Cluster - NORWAY

Oslo Cancer Cluster is a non-profit member organization dedicated to accelerate the development of new cancer diagnostics and medicines. We will achieve this through: Local collaboration and international partnership. Increasing our member companies’ ability to attract capital. Creating an efficient clinical trials network to shorten development timelines. Building Oslo Cancer Cluster Innovation...
Oslo Cancer Cluster is a non-profit member organization dedicated to accelerate the development of new cancer diagnostics and medicines. We will achieve this through: Local collaboration and international partnership. Increasing our member companies’ ability to attract capital. Creating an efficient clinical trials network to shorten development timelines. Building Oslo Cancer Cluster Innovation Park bridging research, biopharma and education. Oslo Cancer Cluster was established in 2006, and has more than 60 members from all over Scandinavia. Our members comprise innovative biotechnology companies, large pharmaceutical companies, university hospitals, biobanks and registries, technology transfer offices, academic research institutions and patient groups. The Oslo Cancer Cluster and its partner, the Cancer-Bio-Sante Cluster from Toulouse jointy organize the annual European Cancer Cluster Partnering Event ECCP - for more information visit: www.ecc-partnering.com
More

Contact

  • Firstname / Lastname :
    Jutta Heix
  • Job title :
    International Advisor
  • Email :
    jh@radforsk.no

Value chain

  • Other

Business Model

  • Other

Activities

  • Other

Application Fields

  • Cancer
Close

Oslo Cancer Cluster - NORWAY

More

Contact

Activities

  • Vaccine
  • Clinical Trials
  • Preclinical Trials
  • Drug Discovery
  • Drug Delivery
  • Cell Therapy
  • Biobank
Close

Pharmavalley - FRANCE

Pharmavalley : The outcome of an interregional alliance of three partner networks (Polepharma, Grepic and the Chemistry-Biology-Health Technopole), PharmaValley brings together the entire range of expertise in production, research and training for the pharmaceutical industry and accounts for half of France’s medicinal drug output. PharmaValley promotes its skills and expertise and develops its c...
Pharmavalley : The outcome of an interregional alliance of three partner networks (Polepharma, Grepic and the Chemistry-Biology-Health Technopole), PharmaValley brings together the entire range of expertise in production, research and training for the pharmaceutical industry and accounts for half of France’s medicinal drug output. PharmaValley promotes its skills and expertise and develops its competitive advantage internationally. 3 main challenges : Maintaining and developing industrial competitiveness on our sites, Promoting innovation, the source of tomorrow’s success, Developing a trademark with international visibility
More

Contact

Activities

  • Other
Close

Sherbrooke Innopole - CANADA

More

Contact

Activities

  • Other
Close

State of Maryland - FRANCE / USA

I represent the government of the US State of Maryland in Europe and I am a director at Maryland’s European Office located in Paris, France. My mission is to identify, attract, and assist European companies who are interested in setting up a facility in the US. I work with Maryland’s Department of Business and Economic Development and we offer free relocation services to international companie...
I represent the government of the US State of Maryland in Europe and I am a director at Maryland’s European Office located in Paris, France. My mission is to identify, attract, and assist European companies who are interested in setting up a facility in the US. I work with Maryland’s Department of Business and Economic Development and we offer free relocation services to international companies that can include partner searches, location and facility searches, business meeting itineraries in Maryland, liaison services, etc.
More

Contact

  • Firstname / Lastname :
    Elise Lyons
  • Job title :
    Director, European Office
  • Email :
    elyons@choosemaryland.org
  • Phone :
    +33614596478

Business Model

  • Other

Activities

  • Other

Needs and interest

  • Commercial Alliance - Comarketing
  • Commercial Development
Close

University of Maryland - USA

University of Maryland Baltimore is a leading academic health center generating almost $600M in sponsored research. (www.umaryland.edu ) The UM BioPark supports a growing cluster of life sciences companies collaborating with the University. The UM BioPark offers a BioInnovation Center designed to house international companies expanding to the US as well as US based companies that wish to be locate...
University of Maryland Baltimore is a leading academic health center generating almost $600M in sponsored research. (www.umaryland.edu ) The UM BioPark supports a growing cluster of life sciences companies collaborating with the University. The UM BioPark offers a BioInnovation Center designed to house international companies expanding to the US as well as US based companies that wish to be located close to the National Institutes of Health and the Federal Drug Administration.
More

Contact

Value chain

  • Research

Activities

  • Gene / Genomics
  • Vaccine
  • Tissue / Cells
  • Biomanufacturing
  • Clinical Trials
  • Preclinical Trials
  • Drug Discovery
  • Medical Device
  • Cell Therapy
  • Models (animal, cellular, ...)

Needs and interest

  • R&d Partnership
Close

Public organization

ADERLY - FRANCE

ADERLY, the Lyon Area Economic Development Agency, is a public-private partnership aimed to help foreign companies develop their business in Lyon/France by setting up operations in the Lyon area. We will assist you at every step of your development project: 1-TO DEVELOP YOUR BUSINESS : ADERLY has access to the top management of biotech and pharma company. Based on your specifications ADERLY o...

ADERLY, the Lyon Area Economic Development Agency, is a public-private partnership aimed to help foreign companies develop their business in Lyon/France by setting up operations in the Lyon area. We will assist you at every step of your development project: 1-TO DEVELOP YOUR BUSINESS : ADERLY has access to the top management of biotech and pharma company. Based on your specifications ADERLY organizes for you one-to-one business meetings with potential customers and R&D partners. 2-M&A : Based on your specifications, our business intelligence unit screens and evaluates opportunities all year long we provide you a list of selected companies with detailed information. 3-FUNDING : ADERLY connects you with R&D funding sources for grants and introduces you to VCs and the local network of business angels. 4-COST EFFICIENT : Lyon is the 2nd largest city in France and the best opportunity to be cost efficient compared to other city in Europe - For your business ADERLY has access to dedicated subsidized building. 5-PEOPLE : ADERLY will act as headhunters to find the best staff possible for your company in Lyon and will organize recruiting meetings for you.

ADERLY's key strength is to provide a customized business development service. This includes one-to-one meetings with potential customers, R&D partners and key opinion leaders, as well as lawyers, accountants, public investors, venture capitalists and business angels. In Lyon, join leaders such as Genzyme, Biomérieux, Merial, Becton Dickinson, Mylan, Covidien, Sanofi-Pasteur, Merck Serono, Integra Life Sciences, Baxter, Abbott Pharma and Olympus Biotechnology, along with other companies who have been assisted by ADERLY in the boosting of their European business: Singulex, Oncotherapy Sciences, Prediction Sciences, CellSeed and more.

More

Contact

  • Firstname / Lastname :
    Laetitia FORTIN
  • Job title :
    Inward Investment Manager
  • Email :
    fortin@aderly.com
  • Phone :
    0033617817428

Activities

  • Other
Close

ADERLY - FRANCE

More

Contact

  • Firstname / Lastname :
    Thierry de Lumley
  • Job title :
    Business Unit Director
  • Email :
    delumley@hotmail.com
  • Phone :
    +33 628 417 370

Activities

  • Vaccine
  • Diagnostics / Analysis Methods
  • Biomanufacturing
  • Drug Delivery
Close

Alsace International - FRANCE

Alsace International is the economic development agency of the Alsace region. We accompany international companies interested in doing business in ALSACE’s BIOVALLEY, the leading trinational life sciences cluster in Europe
Alsace International is the economic development agency of the Alsace region. We accompany international companies interested in doing business in ALSACE’s BIOVALLEY, the leading trinational life sciences cluster in Europe
More

Contact

Value chain

  • Other

Business Model

  • Other

Activities

  • Other
Close

Bioindustrypark - ITALY

Biondustry Park Silvano Fumero is a Science & Technology Park located in the Piemonte region, near Turin, in the North-West of Italy. Mission of the Park is to promote and develop biotechnological research, hosting companies operating research, development and pilot production in the life science sector. The Park offers a complete set of support services for R&D, offering research faciliti...
Biondustry Park Silvano Fumero is a Science & Technology Park located in the Piemonte region, near Turin, in the North-West of Italy. Mission of the Park is to promote and develop biotechnological research, hosting companies operating research, development and pilot production in the life science sector. The Park offers a complete set of support services for R&D, offering research facilities, scientific services and business support services. The Park has formal collaboration agreements with Incubators/Science parks around the world. Bioindustry Park is also acting as cluster management company for the development of the regional cluster bioPmed (http://www.biopmed.eu/) on biotech and medtech. The cluster groups more than 60 organisations, including big, medium and small companies, start-ups and spin-offs, the 3 Universities of the region and some public research centres and foundations.
More

Contact

  • Firstname / Lastname :
    Andrea Giuliani
  • Job title :
    Business Developer
  • Email :
    giuliani@bipcamail.it
  • Phone :

Value chain

  • Other

Business Model

  • Service Provider - scientifique

Activities

  • Diagnostics / Analysis Methods
  • Preclinical Trials
  • Drug Discovery
  • Models (animal, cellular, ...)
  • Other

Needs and interest

  • R&d Partnership
Close

BioVision - the World Life Sciences Forum - FRANCE

BioVision, a non-for-profit foundation, engages key international leaders from different backgrounds in debates on global issues involving science and society. Every other year in Lyon, BioVision brings together government and business leaders, scholars, policy makers and NGO directors. Participants analyze scientific breakthroughs, pressing global challenges, discuss the most effective solutions,...
BioVision, a non-for-profit foundation, engages key international leaders from different backgrounds in debates on global issues involving science and society. Every other year in Lyon, BioVision brings together government and business leaders, scholars, policy makers and NGO directors. Participants analyze scientific breakthroughs, pressing global challenges, discuss the most effective solutions, and build lasting partnerships that enable them to create positive social change. The 7th edition of the World Life Sciences Forum that took place in March welcomed Ministers from China, France, Mexico, VietNam, CEOs from multinational corporations, Nobel Prize Laureates, UN and European Commission representatives and international NGOs Directors. As mentioned briefly earlier this year, following the success of BioVision 2011 and a request from the Chinese Government, we are now working on a new exciting global Forum, which should be held in Shanghai, China, late spring 2012, in collaboration with the Chinese Ministry of Health and the Shanghai Municipality.
More

Contact

Value chain

  • Other

Activities

  • Protein / Proteomics
  • Vaccine
  • Tissue / Cells
  • Imagery
  • Lab Equipment
  • Diagnostics / Analysis Methods
  • Biomanufacturing
  • Clinical Trials
  • Preclinical Trials
  • Drug Discovery
  • Medical Device
  • Drug Delivery
  • Instrumentation
  • Cell Therapy
  • Models (animal, cellular, ...)
  • Biobank
  • Bioinformatics / Modeling
  • Other
  • Nanotechnology

Application Fields

  • Animal Health
  • Human Health
  • Immunology
  • Infectious Diseases
  • Allergology
  • Genetic / Rare Diseases
  • Nutrition / Food
  • Pediatrics
  • Geriatrics
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Orhpan Diseases
  • Metabolic Diseases
  • Cancer
  • Dermocosmetics
  • CNS related Diseases

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
  • Commercial Development
Close

CCI of Lyon - FRANCE

The Lyon CCI‘s mission is to promote Lyon’s assets, attract inward investment, assist companies in their development and manage facilities for local economic development. The Lyon CCI's international department provides local French companies with consulting by giving strategic economic information to integrate foreign markets.
The Lyon CCI‘s mission is to promote Lyon’s assets, attract inward investment, assist companies in their development and manage facilities for local economic development. The Lyon CCI's international department provides local French companies with consulting by giving strategic economic information to integrate foreign markets.
More

Contact

  • Firstname / Lastname :
    Julie-Capucine HOURS
  • Job title :
    Business Development Manager
  • Email :
    hours@lyon.cci.fr

Activities

  • Other
Close

Chamber of Commerce Midi Pyrenees - FRANCE

public institution dedicated to supporting Biotech companies in international development.
public institution dedicated to supporting Biotech companies in international development.
More

Contact

Value chain

  • Other

Business Model

  • Service Provider - non scientifique

Activities

  • Other
Close

Communauté Urbaine LE GRAND TOULOUSE - FRANCE

Economic Intelligence
Economic Intelligence
More

Contact

Activities

  • Other

Needs and interest

  • R&d Partnership
  • Commercial Development
Close

CQVB - CANADA

Le CQVB (Centre québécois de valorization des biotechnologies) is a liaison and transfer centre, that aims to stimulate and support technology transfer and innovation within small to medium-sized bio-industry companies in Québec.
Le CQVB (Centre québécois de valorization des biotechnologies) is a liaison and transfer centre, that aims to stimulate and support technology transfer and innovation within small to medium-sized bio-industry companies in Québec.
More

Contact

Value chain

  • Other

Business Model

  • Other

Activities

  • Gene / Genomics
  • Protein / Proteomics
  • Chemistry
  • Vaccine
  • Tissue / Cells
  • Imagery
  • Lab Equipment
  • Diagnostics / Analysis Methods
  • Biomanufacturing
  • Clinical Trials
  • Preclinical Trials
  • Drug Discovery
  • Medical Device
  • Drug Delivery
  • Instrumentation
  • Cell Therapy
  • Models (animal, cellular, ...)
  • Biobank
  • Bioinformatics / Modeling
  • Nanotechnology

Application Fields

  • Animal Health
  • Human Health
  • Immunology
  • Infectious Diseases
  • Allergology
  • Genetic / Rare Diseases
  • Nutrition / Food
  • Pediatrics
  • Geriatrics
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Orhpan Diseases
  • Metabolic Diseases
  • Cancer
  • Dermocosmetics
  • CNS related Diseases

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
  • Commercial Development
Close

Economic Development Administration - USA

A bureau within the U.S. Department of Commerce, EDA's mission is to lead the federal economic development agenda by promoting innovation and competitiveness, preparing American regions for growth and success in the worldwide economy.
A bureau within the U.S. Department of Commerce, EDA's mission is to lead the federal economic development agenda by promoting innovation and competitiveness, preparing American regions for growth and success in the worldwide economy.
More

Contact

  • Firstname / Lastname :
    Rebecca Moudry
  • Job title :
    Program Analyst - Innovation Clusters
  • Email :
    rmoudry@eda.doc.gov

Activities

  • Other
Close

French BIO Beach - USA

French Bio Beach is a San Diego based Biotech Networking Organization collaborating with French development agencies and both French and US based Biotech companies and academic institutions to put together transatlantic partnerships and collaborations as well as helping the creation of French funded biotech from US based scientific IP.
French Bio Beach is a San Diego based Biotech Networking Organization collaborating with French development agencies and both French and US based Biotech companies and academic institutions to put together transatlantic partnerships and collaborations as well as helping the creation of French funded biotech from US based scientific IP.
More

Contact

Activities

  • Other
Close

French consulate in Boston - USA

The Office for Science and Technology’s mission consists in fostering cooperation project between actors of research and technology transfer on both sides of the Atlantic, and in identifying the local initiatives in terms of support to research and innovation.
The Office for Science and Technology’s mission consists in fostering cooperation project between actors of research and technology transfer on both sides of the Atlantic, and in identifying the local initiatives in terms of support to research and innovation.
More

Contact

Value chain

  • Other

Business Model

  • Other

Activities

  • Other
Close

Georgia Institute of Technology - USA

The Advanced Technology Development Center (ATDC) is a start-up accelerator that helps Georgia technology entrepreneurs launch and build successful companies. Founded in 1980, ATDC has helped create millions of dollars in tax revenues by graduating more than 120 companies, which together have raised more than a billion dollars in outside financing. ATDC has provided business incubation and acceler...
The Advanced Technology Development Center (ATDC) is a start-up accelerator that helps Georgia technology entrepreneurs launch and build successful companies. Founded in 1980, ATDC has helped create millions of dollars in tax revenues by graduating more than 120 companies, which together have raised more than a billion dollars in outside financing. ATDC has provided business incubation and acceleration services to hundreds of Georgia startups—most of which are not based on Georgia Tech research, but which benefit from the close proximity to the university. Recently ATDC expanded its mission by merging with Georgia Tech’s VentureLab and with the Georgia SBIR Assistance Program. The change will enable ATDC to greatly extend its reach to serve more technology companies along multiple growth paths and at all stages of development. ATDC has opened its membership to all technology entrepreneurs in Georgia, from those at the earliest conception stage to the well-established, venture-fundable companies. ATDC is part of the Enterprise Innovation Institute (EI2) at Georgia Tech, which helps Georgia enterprises improve their competitiveness through the application of science, technology and innovation. ATDC currently has three facilities; two at Georgia Tech’s main campus in Atlanta, and one at Georgia Tech’s satellite campus in Savannah.
More

Contact

  • Firstname / Lastname :
    Harold Shlevin
  • Job title :
    Gen Mgr Advanced Technology Development Center - Biosciences
  • Email :
    shlevin@gatech.edu
  • Phone :
    404-569-0670

Value chain

  • Research
  • Preclinical
  • Clinical
  • Manufacturing / Production

Business Model

  • Product Developer - pharmaceuticals
  • Product Developer - biopharmaceuticals
  • Product Developer - other health

Activities

  • Vaccine
  • Drug Discovery
  • Medical Device
  • Drug Delivery
  • Bioinformatics / Modeling
  • Nanotechnology

Application Fields

  • Animal Health
  • Human Health
  • Immunology
  • Infectious Diseases
  • Genetic / Rare Diseases
  • Pediatrics
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Orhpan Diseases
  • Metabolic Diseases
  • Cancer
  • CNS related Diseases

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
  • Commercial Development
Close

Georgia Institute of Technology - USA

The Georgia Institute of Technology (Georgia Tech) provides a rich research environment that drives innovation at the convergence of bioscience, engineering and computational science and technology. Key interdisciplinary research areas are in cancer research, diagnostics, drug delivery, nanotechnology, systems biology, regenerative medicine, stem cell therapies, medical devices, biofuel technologi...
The Georgia Institute of Technology (Georgia Tech) provides a rich research environment that drives innovation at the convergence of bioscience, engineering and computational science and technology. Key interdisciplinary research areas are in cancer research, diagnostics, drug delivery, nanotechnology, systems biology, regenerative medicine, stem cell therapies, medical devices, biofuel technologies. Georgia Tech ranks in the top five universities in research funding without a medical school, and derives almost 20% of its $525M research budget from partnerships with industry. Georgia Tech strongly encourages commercialization and technology transfer through its VentureLab early-stage commercialization program, the Advanced Technology Development Center (ATDC) incubator system, and Technology Enterprise Park, Georgia Tech’s science business park. The economic impact of these programs and infrastructure are apparent: ATDC has attracted over $1B in start-up company investment in the last ten years, and it is estimated Georgia Tech is an annual $3.9B economic engine for the state of Georgia. Georgia Tech is on a steep trajectory of growth and economic impact—come and experience the excitement of innovation in action at Georgia Tech.
More

Contact

Value chain

  • Research
  • Preclinical

Activities

  • Gene / Genomics
  • Protein / Proteomics
  • Chemistry
  • Vaccine
  • Tissue / Cells
  • Imagery
  • Diagnostics / Analysis Methods
  • Biomanufacturing
  • Medical Device
  • Drug Delivery
  • Cell Therapy
  • Models (animal, cellular, ...)
  • Bioinformatics / Modeling
  • Nanotechnology

Application Fields

  • Human Health
  • Immunology
  • Pediatrics
  • Geriatrics
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Metabolic Diseases
  • Cancer
  • Dermocosmetics
  • CNS related Diseases

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
  • Commercial Development
Close

Greater Lyon - FRANCE

Greater Lyon, Companies' Services Direction : services provided to local companies in life sciences in order to develop their activities.
Greater Lyon, Companies' Services Direction : services provided to local companies in life sciences in order to develop their activities.
More

Contact

Activities

  • Other
Close

Greater Lyon - FRANCE

More

Contact

Activities

  • Other
Close

Invest in France - USA

The Invest in France Agency helps US based companies, free of charge, find the most profitable and competitive business solutions in France - the gateway to Europe. We provide customized and confidential services: site selection studies and regulatory information, assistance in identifying potential partners and accessing financial and tax incentives. Please visit our new website: www.invest-in-fr...
The Invest in France Agency helps US based companies, free of charge, find the most profitable and competitive business solutions in France - the gateway to Europe. We provide customized and confidential services: site selection studies and regulatory information, assistance in identifying potential partners and accessing financial and tax incentives. Please visit our new website: www.invest-in-france.org.
More

Contact

Value chain

  • Other

Business Model

  • Other

Activities

  • Other
Close

Invest in France - USA

More

Contact

  • Firstname / Lastname :
    Philippe Yvergniaux
  • Job title :
    directeur
  • Email :
    pyvergniaux@afii.fr
  • Phone :
    212 757 9340

Value chain

  • Other

Business Model

  • Other

Activities

  • Other
Close

Invest in France - USA

 
 
More

Contact

  • Firstname / Lastname :
    Constance BRETON
  • Job title :
    Vice President, Business Development - Greentech, Energy, Mechanical Industry
  • Email :
    cbreton@investinfrance.org

Value chain

  • Other

Business Model

  • Other

Activities

  • Other

Application Fields

  • Other
Close

Invest in France - USA

More

Contact

  • Firstname / Lastname :
    Julie LEBLANC
  • Job title :
    Vice President - Energy, Life Sciences, Infrastructure, and Agri-food
  • Email :
    julie.leblanc@afii.fr
  • Phone :
    +1.212.757.9340 x5202

Value chain

  • Other

Business Model

  • Other

Activities

  • Other

Application Fields

  • Other
Close

Invest in France Agency - USA

More

Contact

Value chain

  • Other

Business Model

  • Other

Activities

  • Other
Close

Invest in Western France - FRANCE

Invest in Western France is your one-stop-shop partner to establish your first business & partnering contacts in France, and supporting all your setting up & investment plans in Western France, from strategic partnerships, to the opening of your first office/branch/lab in France/Europe.
Invest in Western France is your one-stop-shop partner to establish your first business & partnering contacts in France, and supporting all your setting up & investment plans in Western France, from strategic partnerships, to the opening of your first office/branch/lab in France/Europe.
More

Contact

Activities

  • Other

Application Fields

  • Animal Health
  • Human Health
  • Immunology
  • Infectious Diseases
  • Allergology
  • Genetic / Rare Diseases
  • Nutrition / Food
  • Pediatrics
  • Geriatrics
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Orhpan Diseases
  • Metabolic Diseases
  • Cancer
  • Dermocosmetics
  • CNS related Diseases

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
Close

INVEST NI - QUEEN'S UNIVERSITY BELFAST - UNITED KINGDOM

Queen's University Belfast is th eleading University in Northern Ireland, witrh great expertise in the Life and VBBiolgical Sciences
Queen's University Belfast is th eleading University in Northern Ireland, witrh great expertise in the Life and VBBiolgical Sciences
More

Contact

  • Firstname / Lastname :
    PASCHAL MCCLOSKEY
  • Job title :
    TECHNOLOGY TRANSFER OFFICER
  • Email :
    p.mccloskey@qub.ac.uk

Value chain

  • Other

Business Model

  • Other

Activities

  • Other

Application Fields

  • Human Health
  • Immunology
  • Infectious Diseases
  • Allergology
  • Genetic / Rare Diseases
  • Pediatrics
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Metabolic Diseases
  • Cancer
  • Dermocosmetics
  • Other

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
  • Commercial Development
Close

Invest Northern Ireland - IRELAND

InvestNI is the economic development agency of Northern Ireland
InvestNI is the economic development agency of Northern Ireland
More

Contact

  • Firstname / Lastname :
    Samuel Kinghan
  • Job title :
    Technology Manager
  • Email :
    sam.kinghan@investni.com
  • Phone :
    44 02890 698850

Value chain

  • Research

Activities

  • Diagnostics / Analysis Methods
  • Drug Discovery

Application Fields

  • Human Health
  • Nutrition / Food
  • Cancer

Needs and interest

  • R&d Partnership
Close

Invest Northern Ireland - UNITED KINGDOM

Economic Development agency
Economic Development agency
More

Contact

  • Firstname / Lastname :
    Teresa Madden
  • Job title :
    Head of Life Sciences Trade Team
  • Email :
    teresa.madden@investni.com
  • Phone :
    07884438589

Value chain

  • Other

Business Model

  • Other

Activities

  • Other
Close

Medicon Valley Alliance - DENMARK

MVA is a Life Science cluster organization covering Southern Sweden and the Capital of Denmark.
MVA is a Life Science cluster organization covering Southern Sweden and the Capital of Denmark.
More

Contact

Value chain

  • Other

Business Model

  • Other

Activities

  • Other
Close

Ministry of Economy and Industry - FRANCE

Ministry of Economy and Industry, Health and biotechnology departement
Ministry of Economy and Industry, Health and biotechnology departement
More

Contact

  • Firstname / Lastname :
    Claire Coqueblin
  • Job title :
    Biotech project Manager
  • Email :
    les4coq@free.fr
  • Phone :
    06.63.01.63.95

Business Model

  • Other

Activities

  • Other
Close

MINISTRY OF ECONOMY, FINANCE AND INDUSTRY - FRANCE

Administration
Administration
More

Contact

Activities

  • Other
Close

Montgomery County (Maryland) Dept. of Economic Development - USA

Montgomery County, Maryland, located literally next door to Washington, DC is home to one of the largest biotechnology clusters in the United States. Over 300 biotech industry leaders (including HGS & Medimmune) are headquartered here. In addition, nineteen federal agencies including the National Institutes of Health (NIH), and the U.S. Food and Drug Administration (FDA) also are located in Mo...
Montgomery County, Maryland, located literally next door to Washington, DC is home to one of the largest biotechnology clusters in the United States. Over 300 biotech industry leaders (including HGS & Medimmune) are headquartered here. In addition, nineteen federal agencies including the National Institutes of Health (NIH), and the U.S. Food and Drug Administration (FDA) also are located in Montgomery County, Maryland. Our award-winning Business Innovation Network, comprising 5 business incubators offer foreign companies the ideal soft landing spot for entry into the U.S. market. Currently, more than 130 foreign companies (80 from Europe) have a presence here. The Department of Economic Development offers site selection, fast track permit and partner search assistance, among many other services. I look forward to helping you locate and expand here.
More

Contact

Activities

  • Gene / Genomics
  • Chemistry
  • Vaccine
  • Tissue / Cells
  • Imagery
  • Lab Equipment
  • Diagnostics / Analysis Methods
  • Biomanufacturing
  • Clinical Trials
  • Preclinical Trials
  • Drug Discovery
  • Medical Device
  • Drug Delivery
  • Instrumentation
  • Cell Therapy
  • Models (animal, cellular, ...)
  • Bioinformatics / Modeling
  • Nanotechnology

Application Fields

  • Human Health
  • Infectious Diseases
  • Genetic / Rare Diseases
  • Orhpan Diseases
  • Cancer
  • CNS related Diseases
Close

OSEO - FRANCE

OSEO is a french public sector institution dedicated to economic development and key source of financing and other support for french SMEs. Our mission is to back innovation and growth of SMEs at decisive phases in their development: start-up, innovation, growth and business transfer.
OSEO is a french public sector institution dedicated to economic development and key source of financing and other support for french SMEs. Our mission is to back innovation and growth of SMEs at decisive phases in their development: start-up, innovation, growth and business transfer.
More

Contact

  • Firstname / Lastname :
    eric tainsh
  • Job title :
    responsable partenariats
  • Email :
    eric.tainsh@oseo.fr
  • Phone :
    0673511873

Business Model

  • Other

Activities

  • Other

Needs and interest

  • R&d Partnership
Close

Paris Chamber of Commerce and Industry - FRANCE

The Paris Chamber of Commerce and Industry strongly supports Life Sciences as a leading industry.
The Paris Chamber of Commerce and Industry strongly supports Life Sciences as a leading industry.
More

Contact

  • Firstname / Lastname :
    Isabelle POTTIER
  • Job title :
    Biotech & Health Sector Manager
  • Email :
    ipottier@ccip.fr
  • Phone :
    +33155653513

Value chain

  • Other

Business Model

  • Other

Activities

  • Gene / Genomics
  • Protein / Proteomics
  • Chemistry
  • Vaccine
  • Tissue / Cells
  • Imagery
  • Lab Equipment
  • Diagnostics / Analysis Methods
  • Biomanufacturing
  • Clinical Trials
  • Preclinical Trials
  • Drug Discovery
  • Medical Device
  • Drug Delivery
  • Instrumentation
  • Cell Therapy
  • Models (animal, cellular, ...)
  • Biobank
  • Bioinformatics / Modeling
  • Nanotechnology

Application Fields

  • Other
Close

Paris/Ile-de-France Regional Council - FRANCE

financing r&d project
financing r&d project
More

Contact

Business Model

  • Other

Activities

  • Other
Close

PROVENCE PROMOTION - FRANCE

Provence Promotion is the Official Inward Investment agency of Marseille-Provence area, South of France. We assist free of charge companies relocate and/or develop their business in our Mediterranean region, which has become a strategic destination for biotechnology companies. Provence hosts worldwide known academic laboratories like the Luminy Immunology centre CIML, the infectious disease Univer...
Provence Promotion is the Official Inward Investment agency of Marseille-Provence area, South of France. We assist free of charge companies relocate and/or develop their business in our Mediterranean region, which has become a strategic destination for biotechnology companies. Provence hosts worldwide known academic laboratories like the Luminy Immunology centre CIML, the infectious disease University Hospital Institute led by Pr Raoult, or the oncology research institute of Paoli-Calmettes, one of France's most concentrated networks of hospital/university structures with important drug development activities, as well as leading firms such as Innate Pharma, Ipsogen, Supersonic Imagine, Provepharm, Trophos… The Provence Partnership is your unique partner for building and growing your business in Provence.
More

Contact

Business Model

  • Service Provider - non scientifique

Activities

  • Other

Application Fields

  • Animal Health
  • Human Health
  • Immunology
  • Infectious Diseases
  • Allergology
  • Genetic / Rare Diseases
  • Pediatrics
  • Geriatrics
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Orhpan Diseases
  • Metabolic Diseases
  • Cancer
  • Dermocosmetics
  • CNS related Diseases

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
  • Commercial Development
Close

Technologiepark Heidelberg GmbH - GERMANY

The Heidelberg Technology Park is a science park where effective joint projects can be realized through the cooperation of national research centers and international companies. A knowledge-based environment where science can forge links with business, and research can gain new perspectives through international cooperation.
The Heidelberg Technology Park is a science park where effective joint projects can be realized through the cooperation of national research centers and international companies. A knowledge-based environment where science can forge links with business, and research can gain new perspectives through international cooperation.
More

Contact

Value chain

  • Marketing / Distribution

Activities

  • Clinical Trials
  • Drug Discovery
  • Bioinformatics / Modeling
  • Other
Close

U.S. Department of Commerce - USA

government ministry
government ministry
More

Contact

Activities

  • Other
Close

Ubifrance - USA

Ubifrance is the French agency in charge of facilitating partnerships and collaborations between French and foreign companies. Each year, the Ubifrance biotech team works with more than 450 US and 150 French biotech companies, providing them with transatlantic collaborative opportunities (licensing, R&D collaborations, commercial partnerships, etc.). Our main recurring partnering event is the ...
Ubifrance is the French agency in charge of facilitating partnerships and collaborations between French and foreign companies. Each year, the Ubifrance biotech team works with more than 450 US and 150 French biotech companies, providing them with transatlantic collaborative opportunities (licensing, R&D collaborations, commercial partnerships, etc.). Our main recurring partnering event is the French Biotech Tour, a streamlined B2B platform aiming to foster US/French collaborations. Our next French Biotech Tour in 2011 will focus on Infectious Diseases (in September in Boston - http://frenchbiotechtour.ubifrance-events.com) and will bring together selected US/French companies specialized in this field (vaccine, antibiotics, antivirals, diagnostic, etc.).
More

Contact

Value chain

  • Preclinical
  • Clinical

Business Model

  • Other

Activities

  • Other

Application Fields

  • Human Health
  • Immunology
  • Infectious Diseases
  • Allergology
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Metabolic Diseases
  • Cancer
  • CNS related Diseases

Needs and interest

  • Commercial Development
Close

UBIFRANCE - USA

More

Contact

Business Model

  • Service Provider - non scientifique

Activities

  • Other

Application Fields

  • Infectious Diseases
  • Cancer
  • CNS related Diseases

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
  • Commercial Development
Close

Université Libre de Bruxelles BELGIUM

See Website
See Website
More

Contact

Value chain

  • Other

Business Model

  • Other

Activities

  • Other

Application Fields

  • Human Health
  • Infectious Diseases
  • Inflammatory Diseases
  • Cancer
  • CNS related Diseases

Needs and interest

  • R&d Partnership
Close

Other

acCInov - FRANCE

Non profit organization
The construction of acCInov platform started in September 2010. This project marks the second step of Lyonbiopole’s infrastructure policy dedicated to cover all links in the innovation chain to fight infectious diseases. AcCInov follows Lyonbiopole’s Infectious Diseases Center, open in April 2009 on the Charles Merieux campus in Lyon Gerland. The new platform will allow to triple the innovatio...
The construction of acCInov platform started in September 2010. This project marks the second step of Lyonbiopole’s infrastructure policy dedicated to cover all links in the innovation chain to fight infectious diseases. AcCInov follows Lyonbiopole’s Infectious Diseases Center, open in April 2009 on the Charles Merieux campus in Lyon Gerland. The new platform will allow to triple the innovation area dedicated to hosting projects in pre-clinical and clinical research in biotechnology and biopharmaceuticals of its members, more particular in the three key areas of Lyonbiopole: diagnostic, vaccines and new biotherapies to fight infectious diseases and cancers.
More

Contact

Value chain

  • Research
  • Preclinical
  • Clinical
  • Manufacturing / Production

Business Model

  • Service Provider - CRO
  • Service Provider - CMO
  • Service Provider - scientifique
  • Product Developer - biopharmaceuticals

Activities

  • Protein / Proteomics
  • Vaccine
  • Biomanufacturing
  • Drug Delivery
  • Cell Therapy

Application Fields

  • Animal Health
  • Human Health
  • Immunology
  • Infectious Diseases
  • Inflammatory Diseases
  • Orhpan Diseases
  • Cancer

Needs and interest

  • R&d Partnership
Close

AdvaMed's MedTech Conference - USA

Medical Technology Association
AdvaMed is the world's largest medical technology trade association. Membership includes 25 of the world's 30 largest medical device manufacturers, the ten largest IVD makers and hundreds of others. We produce an annual business development and partnering conference for the device and diagnostic industry.
AdvaMed is the world's largest medical technology trade association. Membership includes 25 of the world's 30 largest medical device manufacturers, the ten largest IVD makers and hundreds of others. We produce an annual business development and partnering conference for the device and diagnostic industry.
More

Contact

  • Firstname / Lastname :
    Ray Briscuso
  • Job title :
    CEO & Managing Partner
  • Email :
    rbriscuso@advamed.org
  • Phone :
    (202) 434-7213

Value chain

  • Other

Business Model

  • Other

Activities

  • Imagery
  • Diagnostics / Analysis Methods
  • Medical Device

Application Fields

  • Human Health

Needs and interest

  • Commercial Development
Close

Alice Communications Inc. - QUINTEN - USA

I am coming with both as a member of the press to write a piece on the possibilities of tech transfer between biotech and the consumer product world and with my client, QUINTEN, a data analysis company servicing pharma, biotech and the consumer product industries.
I am coming with both as a member of the press to write a piece on the possibilities of tech transfer between biotech and the consumer product world and with my client, QUINTEN, a data analysis company servicing pharma, biotech and the consumer product industries.
More

Contact

Business Model

  • Other

Activities

  • Other
Close

Beacon Council - USA

Economic Development
Official economic development partner for Miami Dade County. Assists Life Science Companies in locating in the area
Official economic development partner for Miami Dade County. Assists Life Science Companies in locating in the area
More

Contact

  • Firstname / Lastname :
    Stephen Beatus
  • Job title :
    Associate Executive President
  • Email :
    sbeatus@beaconcouncil.com
  • Phone :
    305 579 1343

Value chain

  • Other

Business Model

  • Other

Activities

  • Other

Needs and interest

  • Commercial Development
Close

Biohealth Management, LLC - USA

Advisory/consultancy
BioHealth Management, LLC is an international commercial strategy and business development advisory firm based just outside of Boston, Massachusetts. We specialize in value creation at the pivotal intersection of science, technology and business. The company, founded over 15 years ago, works with biomedical companies, entrepreneurial academics, and government agencies to create quantifiable and ta...
BioHealth Management, LLC is an international commercial strategy and business development advisory firm based just outside of Boston, Massachusetts. We specialize in value creation at the pivotal intersection of science, technology and business. The company, founded over 15 years ago, works with biomedical companies, entrepreneurial academics, and government agencies to create quantifiable and tangible results from biomedical innovation. The group serves the strategic needs of biomedical organizations for the development and commercialization of innovation. Hired on a project- by-project basis, the company specializes in creative growth strategies tied to expertise in business, clinical, and market development. We work closely with our clients to understand their technology and develop clear and achievable strategies and goals. We have a hands-on style and high level of involvement to implement and guarantee the success of our projects. Members of BioHealth are actively involved in financing and work closely with venture capitalists and investment banks, translating their criteria for investment to their clients. BioHealth prides itself on its international presence, delivering global access to its clients. BioHealth was founded in 1994 and has built its reputation on the basis of strong analytical capabilities coupled with a solid foundation of industry knowledge and experience. Nancy Levy, Ph.D. the founder and managing partner of BioHealth Management, LLC, is a strategic and tactical commercial development executive. She has extensive start-up and later stage experience, in corporate strategy and business development in the USA, Canada and Europe. She has a strong business-building track record and a demonstrated ability to formulate and implement strategies to build valuation. She has built a solid reputation through her broad biopharmaceutical experience base and deep industry knowledge, combined with a strong technical background. Dr. Levy has worked with a wide range of clients, from pre-IPO to mid-market companies, and from venture capitalists to investment bankers.
More

Contact

Activities

  • Gene / Genomics
  • Protein / Proteomics
  • Diagnostics / Analysis Methods
  • Clinical Trials
  • Preclinical Trials
  • Drug Discovery
  • Medical Device
  • Models (animal, cellular, ...)

Needs and interest

  • R&d Partnership
  • Commercial Development
Close

Boston Biotech Clinical Research - USA

Consulting Firm
clinical strategy and trial design specialist implementing biomarkers, bioinformatic modeling, and limiting risk options
clinical strategy and trial design specialist implementing biomarkers, bioinformatic modeling, and limiting risk options
More

Contact

Value chain

  • Clinical

Business Model

  • Service Provider - scientifique
  • Other

Activities

  • Vaccine
  • Clinical Trials
  • Preclinical Trials
  • Medical Device
  • Bioinformatics / Modeling
  • Nanotechnology

Application Fields

  • Immunology
  • Infectious Diseases
  • Allergology
  • Genetic / Rare Diseases
  • Pediatrics
  • Geriatrics
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Orhpan Diseases
  • CNS related Diseases

Needs and interest

  • R&d Partnership
Close

Bretagne International - FRANCE

Non profit Association
We assist non French companies looking to expand their business in France.
We assist non French companies looking to expand their business in France.
More

Contact

Value chain

  • Other

Business Model

  • Service Provider - non scientifique

Activities

  • Other

Application Fields

  • Animal Health
  • Human Health
  • Nutrition / Food

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
  • Commercial Development
Close

CRITT Santé Bretagne - FRANCE

Innovative and technological center
CRITT Santé Bretagne works for research units and companies involved in the R&D of health-care applications in Western France. Our missions are to develop and support partnerships, to provide technological assistance, to assist project leaders and to promote development of SMEs. Our fields of expertise include: (i) Medical devices, medical imaging, health technologies, (ii) Nutrition for huma...
CRITT Santé Bretagne works for research units and companies involved in the R&D of health-care applications in Western France. Our missions are to develop and support partnerships, to provide technological assistance, to assist project leaders and to promote development of SMEs. Our fields of expertise include: (i) Medical devices, medical imaging, health technologies, (ii) Nutrition for human health and (iii) Biotechnology, drug development, new therapies. We participate to Capbiotek, the Bretagne biocluster.
More

Contact

Activities

  • Other
Close

Deutsche Messe - FRANCE

Trade show organizer
Europe's No. 1 event for Biotechnology and Life Sciences (11 - 13 Oct. 11, Hannover /Germany) will focus on applied biotechnology, laboratory equipment, services and tech transfer. Together with our partners in Europe and the USA we will provide you with an exciting conference program in 2011. Conference themes include molecular diagnostics, proteins & antibodies, bioinformatics, food analysis...
Europe's No. 1 event for Biotechnology and Life Sciences (11 - 13 Oct. 11, Hannover /Germany) will focus on applied biotechnology, laboratory equipment, services and tech transfer. Together with our partners in Europe and the USA we will provide you with an exciting conference program in 2011. Conference themes include molecular diagnostics, proteins & antibodies, bioinformatics, food analysis and industrial biotechnology.
More

Contact

Activities

  • Drug Delivery
  • Other

Needs and interest

  • Commercial Alliance - Comarketing
Close

Deutsche Messe - BIOTECHNICA - GERMANY

Trade show organizer
More

Contact

Activities

  • Other
Close

Deutsche Messe - BIOTECHNICA - GERMANY

Trade show organizer
More

Contact

Business Model

  • Other

Activities

  • Other
Close

Deutsche Messe - BIOTECHNICA - GERMANY

Trade show organizer
More

Contact

Activities

  • Other
Close

EAPB European Association of Pharma Biotechnology - GERMANY

Association
The European Association of Pharma Biotechnology (EAPB) is a professional association dedicated to the advancement of biotechnology in pharmaceutical sciences, specifically as applied to medicinal drugs, industrial materials, processes, products and their associated issues. Its members constitute specialists employed in industry, government and university laboratories, biotech companies and scient...
The European Association of Pharma Biotechnology (EAPB) is a professional association dedicated to the advancement of biotechnology in pharmaceutical sciences, specifically as applied to medicinal drugs, industrial materials, processes, products and their associated issues. Its members constitute specialists employed in industry, government and university laboratories, biotech companies and scientific organisations. Members are scientists (individual membership), companies, departments of companies and organisations from academia (corporate membership), but also industry, especially pharmaceutical industry and related sciences involved in pharma biotechnology.
More

Contact

  • Firstname / Lastname :
    Marion Kronabel
  • Job title :
    Managing Director
  • Email :
    marion.kronabel@eapb.org
  • Phone :
    +49 172 7764645

Activities

  • Other
Close

Embassy of France - USA

Embassy of France to the United States
More

Contact

Activities

  • Other
Close

Embassy of France - USA

Embassy of France
Office of Commerce, Trade and the Treasury at the Embassy of France
Office of Commerce, Trade and the Treasury at the Embassy of France
More

Contact

Activities

  • Other
Close

Eurasanté - FRANCE

Economic Development
Eurasanté is the Lille Northern France Economic Development agency specialized in Biotech, medtech and Nutrition activities. We promote a bio-business Park 100% dedicated to healthcare activities where 120 companies, 7 hospitals and 4 faculties are already hosted. More widely, the Lille area boasts of 800 healthcare related companies. We assist regional companies in their development and foreign ...
Eurasanté is the Lille Northern France Economic Development agency specialized in Biotech, medtech and Nutrition activities. We promote a bio-business Park 100% dedicated to healthcare activities where 120 companies, 7 hospitals and 4 faculties are already hosted. More widely, the Lille area boasts of 800 healthcare related companies. We assist regional companies in their development and foreign companies in stting up in our region
More

Contact

  • Firstname / Lastname :
    RONDEL Christelle
  • Job title :
    International Operations Manager
  • Email :
    crondel@eurasante.com

Value chain

  • Other

Activities

  • Other

Application Fields

  • Human Health
  • Immunology
  • Infectious Diseases
  • Nutrition / Food
  • Geriatrics
  • Inflammatory Diseases
  • Metabolic Diseases
  • Cancer
  • CNS related Diseases

Needs and interest

  • R&d Partnership
  • Commercial Development
Close

Foley & Lardner LLP - USA

Law firm
With offices throughout the United States and across the globe, Foley combines powerful resources and award-winning client service to help you achieve your business objectives — efficiently and cost-effectively. We draw on the legal knowledge and hands-on industry experience of attorneys in more than 60 practice areas to provide the full spectrum of legal services — any of which can be tailore...
With offices throughout the United States and across the globe, Foley combines powerful resources and award-winning client service to help you achieve your business objectives — efficiently and cost-effectively. We draw on the legal knowledge and hands-on industry experience of attorneys in more than 60 practice areas to provide the full spectrum of legal services — any of which can be tailored to meet your unique challenges.
More

Contact

  • Firstname / Lastname :
    Rouget Henschel
  • Job title :
    Partner
  • Email :
    rhenschel@foley.com
  • Phone :
    202-295-4059

Value chain

  • Other

Business Model

  • Other

Activities

  • Other
Close

Georgetown University - USA

Private University
Research in Oncology, Neuroscience and other disease areas
Research in Oncology, Neuroscience and other disease areas
More

Contact

  • Firstname / Lastname :
    Ruchika NIjhara
  • Job title :
    Director, Office of Technology Commercialization
  • Email :
    rn86@georgetown.edu

Value chain

  • Research

Activities

  • Drug Discovery
Close

Greater Phoenix Economic Council - USA

Non-profit organization for economic development
The Greater Phoenix Economic Council and our members work cooperatively to project a regional identity and ensure a competitive, vibrant and self-sustaining regional economy. We also collaborate with other organizations and rely on our talented, technologically advanced, diverse workforce to achieve these goals.
The Greater Phoenix Economic Council and our members work cooperatively to project a regional identity and ensure a competitive, vibrant and self-sustaining regional economy. We also collaborate with other organizations and rely on our talented, technologically advanced, diverse workforce to achieve these goals.
More

Contact

  • Firstname / Lastname :
    Chris Camacho
  • Job title :
    Executive VP of Business Development
  • Email :
    ccamacho@gpec.org
  • Phone :
    602-881-5446

Activities

  • Gene / Genomics
  • Chemistry
  • Tissue / Cells
  • Lab Equipment
  • Preclinical Trials
  • Medical Device
  • Bioinformatics / Modeling

Application Fields

  • Infectious Diseases
  • Genetic / Rare Diseases
  • Pediatrics
  • Geriatrics
  • Inflammatory Diseases
  • Cancer

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
  • Commercial Development
Close

Greater Phoenix Economic Council - USA

Non-profit organization for economic development
More

Contact

Value chain

  • Research
  • Preclinical
  • Clinical
  • Manufacturing / Production
  • Marketing / Distribution

Activities

  • Gene / Genomics
  • Chemistry
  • Biomanufacturing
  • Preclinical Trials
  • Medical Device
  • Instrumentation

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
  • Commercial Development
Close

Greater Phoenix Economic Council - USA

Non-profit organization for economic development
More

Contact

  • Firstname / Lastname :
    Chris Petroff
  • Job title :
    VP of BD
  • Email :
    cpetroff@gpec.org
  • Phone :
    480-518-0013

Value chain

  • Research
  • Preclinical
  • Clinical
  • Manufacturing / Production
  • Marketing / Distribution

Activities

  • Gene / Genomics
  • Chemistry
  • Lab Equipment
  • Biomanufacturing
  • Preclinical Trials
  • Medical Device
  • Bioinformatics / Modeling

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
  • Commercial Development
Close

Johns Hopkins Technology Transfer - USA

University

Tech Transfer

The Johns Hopkins Technology Transfer Office (JHTT) is the University's intellectual property administration center, serving Johns Hopkins researchers and inventors as a licensing, patent, and technology commercialization office and acting as an active liaison to parties interested in leveraging JHU research or materials for academic or corporate endeavors.

Tech Transfer

The Johns Hopkins Technology Transfer Office (JHTT) is the University's intellectual property administration center, serving Johns Hopkins researchers and inventors as a licensing, patent, and technology commercialization office and acting as an active liaison to parties interested in leveraging JHU research or materials for academic or corporate endeavors.

More

Contact

  • Firstname / Lastname :
    Montserrat Capedevila
  • Job title :
    Director
  • Email :
    mcapdev1@jhu.edu

Value chain

  • Preclinical

Business Model

  • Other

Activities

  • Gene / Genomics
  • Protein / Proteomics
  • Vaccine
  • Tissue / Cells
  • Imagery
  • Diagnostics / Analysis Methods
  • Clinical Trials
  • Drug Discovery
  • Medical Device
  • Drug Delivery
  • Cell Therapy
  • Models (animal, cellular, ...)
  • Biobank
  • Bioinformatics / Modeling
  • Nanotechnology

Application Fields

  • Animal Health
  • Human Health
  • Immunology
  • Infectious Diseases
  • Allergology
  • Genetic / Rare Diseases
  • Nutrition / Food
  • Pediatrics
  • Geriatrics
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Orhpan Diseases
  • Metabolic Diseases
  • Cancer
  • Dermocosmetics
  • CNS related Diseases

Needs and interest

  • R&d Partnership
Close

Johns Hopkins Technology Transfer - USA

University
More

Contact

Value chain

  • Research
  • Preclinical
  • Clinical

Activities

  • Chemistry
  • Vaccine
  • Tissue / Cells
  • Imagery
  • Diagnostics / Analysis Methods
  • Clinical Trials
  • Preclinical Trials
  • Drug Discovery
  • Medical Device
  • Drug Delivery
  • Cell Therapy
  • Bioinformatics / Modeling
  • Nanotechnology

Application Fields

  • Animal Health
  • Human Health
  • Immunology
  • Infectious Diseases
  • Allergology
  • Genetic / Rare Diseases
  • Pediatrics
  • Geriatrics
  • Inflammatory Diseases
  • Autoimmune Diseases
  • Orhpan Diseases
  • Metabolic Diseases
  • Cancer
  • CNS related Diseases

Needs and interest

  • R&d Partnership
Close

Mass Life Sciences Center - USA

Government
The Massachusetts Life Sciences Center (MLSC) is a quasi-public agency of the Commonwealth of Massachusetts, created by the Massachusetts legislature in June 2006. The MLSC was established to promote the life sciences within the Commonwealth of Massachusetts. It is tasked with investing in life sciences research and economic development.
The Massachusetts Life Sciences Center (MLSC) is a quasi-public agency of the Commonwealth of Massachusetts, created by the Massachusetts legislature in June 2006. The MLSC was established to promote the life sciences within the Commonwealth of Massachusetts. It is tasked with investing in life sciences research and economic development.
More

Contact

Value chain

  • Other

Business Model

  • Other

Activities

  • Other

Application Fields

  • Other
Close

Mass Life Sciences Center - USA

Government
More

Contact

Activities

  • Other
Close

Seaton Hall Law - USA

Patent Law
Center for Health & Pharmaceutical Law & Policy - Assistance with complex issues posed by health and pharmaceutical law for companies in expansion between US & EU. Look to provide assistance with state, federal, and international mandates that apply to the development, safety, use and promotion of drugs and devices.
Center for Health & Pharmaceutical Law & Policy - Assistance with complex issues posed by health and pharmaceutical law for companies in expansion between US & EU. Look to provide assistance with state, federal, and international mandates that apply to the development, safety, use and promotion of drugs and devices.
More

Contact

Activities

  • Gene / Genomics
  • Protein / Proteomics
  • Chemistry
  • Vaccine
  • Tissue / Cells
  • Imagery
  • Lab Equipment
  • Diagnostics / Analysis Methods
  • Biomanufacturing
  • Clinical Trials
  • Preclinical Trials
  • Drug Discovery
  • Medical Device
  • Drug Delivery
  • Instrumentation
  • Cell Therapy
  • Models (animal, cellular, ...)
  • Biobank
  • Bioinformatics / Modeling
  • Nanotechnology
Close

Sherbrooke Innopole - CANADA

Economic development
More

Contact

Activities

  • Other
Close

Spratt & Associates - FRANCE

R&D consultant
I am American, resident in France, bi-lingual, specialized in automated ethology techniques, information and, project management (systems, technology development, international cooperation).
I am American, resident in France, bi-lingual, specialized in automated ethology techniques, information and, project management (systems, technology development, international cooperation).
More

Contact

Value chain

  • Research
  • Manufacturing / Production
  • Other

Business Model

  • Service Provider - scientifique
  • Service Provider - non scientifique
  • Laboratory Equipment Supplier
  • Product Developer - other health

Activities

  • Lab Equipment
  • Instrumentation
  • Bioinformatics / Modeling

Application Fields

  • Animal Health
  • Nutrition / Food
  • Other

Needs and interest

  • R&d Partnership
  • Commercial Alliance - Comarketing
  • Commercial Development
Close

U.S. Department of Commerce - USA

Government
The mission of the Department of Commerce Economic Development Administration’s Trade Adjustment Assistance for Firms (TAAF) program is to help import-impacted U.S. firms develop and implement business recovery strategies to strengthen their competitiveness in the global marketplace, thereby increasing sales and creating U.S. jobs.
The mission of the Department of Commerce Economic Development Administration’s Trade Adjustment Assistance for Firms (TAAF) program is to help import-impacted U.S. firms develop and implement business recovery strategies to strengthen their competitiveness in the global marketplace, thereby increasing sales and creating U.S. jobs.
More

Contact

Activities

  • Other

Needs and interest

  • R&d Partnership
  • Commercial Development
Close

U.S. Economic Development Administration - USA

U.S. Department of Commerce
U.S. Department of Commerce, Economic Development Administration
U.S. Department of Commerce, Economic Development Administration
More

Contact

Activities

  • Other
Close

West Virginia Development Office - USA

Government
The West Virginia Development Office - International Development Division identifies and develops international business opportunities that retain or create jobs in West Virginia.
The West Virginia Development Office - International Development Division identifies and develops international business opportunities that retain or create jobs in West Virginia.
More

Contact

  • Firstname / Lastname :
    Angela Mascia
  • Job title :
    Project Manager, Europe
  • Email :
    Angela.Mascia@wv.gov
  • Phone :
    +1-304-558-2234

Business Model

  • Other

Activities

  • Other

Application Fields

  • Other

Needs and interest

  • Commercial Development
Close